|
OMIM |
Link |
Information gain |
01 |
|
apnea, obstructive sleep
|
[NCBI]
|
0.0289394
|
|
|
VRNI
|
[NCBI]
|
0.0138771
|
|
|
RA
|
[NCBI]
|
0.00887985
|
|
|
SLE
|
[NCBI]
|
0.00437292
|
|
|
MAFD1
|
[NCBI]
|
0.00385738
|
|
|
MAFD2
|
[NCBI]
|
0.00384232
|
|
|
IS1
|
[NCBI]
|
0.00381482
|
|
|
CF
|
[NCBI]
|
0.00267872
|
|
|
SCZD3
|
[NCBI]
|
0.00255315
|
|
|
MRX1
|
[NCBI]
|
0.00217365
|
|
|
leber optic atrophy, susceptibility to
|
[NCBI]
|
0.00208377
|
|
|
CRC
|
[NCBI]
|
0.00185088
|
|
|
MEAX
|
[NCBI]
|
0.00161573
|
|
|
mental health wellness 1
|
[NCBI]
|
0.00161573
|
|
|
arthrogryposis multiplex congenita, distal, x-linked
|
[NCBI]
|
0.00142117
|
|
|
asthma-related traits, susceptibility to, 3
|
[NCBI]
|
0.00142117
|
|
|
hypertension, essential, susceptibility to, 1
|
[NCBI]
|
0.00142117
|
|
|
MYP1
|
[NCBI]
|
0.00142117
|
|
|
myoclonic epilepsy, juvenile, 3
|
[NCBI]
|
0.00133668
|
|
|
MCOPS1
|
[NCBI]
|
0.00133668
|
|
|
SCAX1
|
[NCBI]
|
0.00129202
|
|
|
systemic lupus erythematosus, susceptibility to, 6
|
[NCBI]
|
0.00129202
|
|
|
HBFQTL2
|
[NCBI]
|
0.00128858
|
|
|
SCZD7
|
[NCBI]
|
0.00113376
|
|
|
IGES
|
[NCBI]
|
0.00113376
|
|
|
PSORS2
|
[NCBI]
|
0.00109102
|
|
|
MG
|
[NCBI]
|
0.0010739
|
|
|
OPA2
|
[NCBI]
|
0.00106567
|
|
|
IDDM17
|
[NCBI]
|
0.00106567
|
|
|
stature quantitative trait locus 5
|
[NCBI]
|
0.00106567
|
|
|
MRX20
|
[NCBI]
|
0.00106567
|
|
|
cowchock syndrome
|
[NCBI]
|
0.00106567
|
|
|
MCOPS4
|
[NCBI]
|
0.00106567
|
|
|
cataract, central saccular, with sutural opacities
|
[NCBI]
|
0.00106567
|
|
|
EJM2
|
[NCBI]
|
0.00106567
|
|
|
IBD6
|
[NCBI]
|
0.00106567
|
|
|
ORW3
|
[NCBI]
|
0.00106567
|
|
|
MTM1
|
[NCBI]
|
0.00105406
|
|
|
PHP
|
[NCBI]
|
0.00104041
|
|
|
VEGF
|
[NCBI]
|
0.00100769
|
|
|
IBD3
|
[NCBI]
|
0.000974927
|
|
|
MRX3
|
[NCBI]
|
0.000974927
|
|
|
plasmodium falciparum blood infection level
|
[NCBI]
|
0.000974927
|
|
|
electroencephalogram, low-voltage
|
[NCBI]
|
0.000974927
|
|
|
IDDM4
|
[NCBI]
|
0.000966117
|
|
|
MCKD1
|
[NCBI]
|
0.000966117
|
|
|
IDDM
|
[NCBI]
|
0.000954052
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
0.000937287
|
|
|
CDPX2
|
[NCBI]
|
0.000929653
|
|
|
MDD
|
[NCBI]
|
0.000904731
|
|
|
EGF
|
[NCBI]
|
0.000866784
|
|
|
BTK
|
[NCBI]
|
0.000865621
|
|
|
THAS
|
[NCBI]
|
0.000861494
|
|
|
IDDM7
|
[NCBI]
|
0.000861494
|
|
|
ATRX
|
[NCBI]
|
0.000851026
|
|
|
CMTX1
|
[NCBI]
|
0.000840485
|
|
|
ED1
|
[NCBI]
|
0.000762936
|
|
|
AD
|
[NCBI]
|
0.000738489
|
|
|
RP2
|
[NCBI]
|
0.000724181
|
|
|
myopia 9
|
[NCBI]
|
0.00071031
|
|
|
malaria, mild, susceptibility to
|
[NCBI]
|
0.00071031
|
|
|
convulsions, benign familial infantile, 2
|
[NCBI]
|
0.00071031
|
|
|
BMND2
|
[NCBI]
|
0.00071031
|
|
|
brooks-wisniewski-brown syndrome
|
[NCBI]
|
0.00071031
|
|
|
DYT13
|
[NCBI]
|
0.00071031
|
|
|
LGMD1F
|
[NCBI]
|
0.00071031
|
|
|
myopia 8
|
[NCBI]
|
0.00071031
|
|
|
BMND5
|
[NCBI]
|
0.00071031
|
|
|
prostate cancer, hereditary, 9
|
[NCBI]
|
0.00071031
|
|
|
deafness, high-frequency sensorineural, x-linked
|
[NCBI]
|
0.00071031
|
|
|
MGC1
|
[NCBI]
|
0.00071031
|
|
|
ENUR2
|
[NCBI]
|
0.00071031
|
|
|
CHR
|
[NCBI]
|
0.00071031
|
|
|
IDDM6
|
[NCBI]
|
0.00071031
|
|
|
myopia 10
|
[NCBI]
|
0.00071031
|
|
|
DYX8
|
[NCBI]
|
0.00071031
|
|
|
restless legs syndrome, susceptibility to, 2
|
[NCBI]
|
0.00071031
|
|
|
MRX50
|
[NCBI]
|
0.00071031
|
|
|
high density lipoprotein cholesterol level quantitative trait locus 4
|
[NCBI]
|
0.00071031
|
|
|
EA3
|
[NCBI]
|
0.00071031
|
|
|
DFNA41
|
[NCBI]
|
0.00071031
|
|
|
myopia 7
|
[NCBI]
|
0.00071031
|
|
|
CHNG3
|
[NCBI]
|
0.00071031
|
|
|
AKE
|
[NCBI]
|
0.00071031
|
|
|
GLC3B
|
[NCBI]
|
0.00071031
|
|
|
MCOPCB2
|
[NCBI]
|
0.00071031
|
|
|
cataract, autosomal recessive congenital 2
|
[NCBI]
|
0.00071031
|
|
|
myopia 5
|
[NCBI]
|
0.00071031
|
|
|
prostate cancer, hereditary, 6
|
[NCBI]
|
0.00071031
|
|
|
myopia 14
|
[NCBI]
|
0.00071031
|
|
|
IBD4
|
[NCBI]
|
0.00071031
|
|
|
IDDM8
|
[NCBI]
|
0.00071031
|
|
|
epilepsy, partial, with variable foci
|
[NCBI]
|
0.00071031
|
|
|
ENUR1
|
[NCBI]
|
0.00071031
|
|
|
IBD7
|
[NCBI]
|
0.00071031
|
|
|
MNG2
|
[NCBI]
|
0.00071031
|
|
|
ALD
|
[NCBI]
|
0.000690096
|
|
|
RP3
|
[NCBI]
|
0.0006892
|
|
|
OFC1
|
[NCBI]
|
0.000679458
|
|
|
stature quantitative trait locus 6
|
[NCBI]
|
0.000667794
|
|
|
RP6
|
[NCBI]
|
0.000667794
|
|
|
CCV
|
[NCBI]
|
0.000667794
|
|
|
ICCA
|
[NCBI]
|
0.000667794
|
|
|
obesity quantitative trait locus on chromosome 20
|
[NCBI]
|
0.000667794
|
|
|
HBFQTL4
|
[NCBI]
|
0.000667794
|
|
|
HMPS1
|
[NCBI]
|
0.000667794
|
|
|
parkinson disease 12
|
[NCBI]
|
0.000667794
|
|
|
CORD8
|
[NCBI]
|
0.000667794
|
|
|
psoriasis susceptibility 8
|
[NCBI]
|
0.000667794
|
|
|
MEHMO
|
[NCBI]
|
0.000667794
|
|
|
SCA19
|
[NCBI]
|
0.000667794
|
|
|
CTAA2
|
[NCBI]
|
0.000667794
|
|
|
DFN4
|
[NCBI]
|
0.000667794
|
|
|
OB10P
|
[NCBI]
|
0.000667794
|
|
|
SCZD5
|
[NCBI]
|
0.000667794
|
|
|
ND
|
[NCBI]
|
0.000646269
|
|
|
CJD
|
[NCBI]
|
0.000633916
|
|
|
urogenital adysplasia, hereditary
|
[NCBI]
|
0.000621275
|
|
|
hypotrichosis, marie unna type
|
[NCBI]
|
0.000603916
|
|
|
schistosoma mansoni infection, susceptibility/resistance to
|
[NCBI]
|
0.000603916
|
|
|
thyroid carcinoma, nonmedullary, with or without cell oxyphilia
|
[NCBI]
|
0.000603916
|
|
|
hodgkin disease, x-linked pseudoautosomal
|
[NCBI]
|
0.000603916
|
|
|
SGBS1
|
[NCBI]
|
0.000592152
|
|
|
IGER
|
[NCBI]
|
0.000583825
|
|
|
TNF
|
[NCBI]
|
0.000583294
|
|
|
CMM
|
[NCBI]
|
0.000556672
|
|
|
asthma, susceptibility to
|
[NCBI]
|
0.000522476
|
|
|
alzheimer disease 6
|
[NCBI]
|
0.000521297
|
|
|
ichthyosis, x-linked
|
[NCBI]
|
0.000513349
|
|
|
SCA1
|
[NCBI]
|
0.00050701
|
|
|
XLP1
|
[NCBI]
|
0.000494336
|
|
|
alzheimer disease 5
|
[NCBI]
|
0.000490036
|
|
|
neuroticism
|
[NCBI]
|
0.000490036
|
|
|
AUTS9
|
[NCBI]
|
0.000490036
|
|
|
DFN2
|
[NCBI]
|
0.000490036
|
|
|
SCIDX1
|
[NCBI]
|
0.000488796
|
|
|
SPG12
|
[NCBI]
|
0.000486798
|
|
|
diabetes mellitus, insulin-dependent, x-linked, susceptibility to
|
[NCBI]
|
0.000486798
|
|
|
AD14
|
[NCBI]
|
0.000486798
|
|
|
AD13
|
[NCBI]
|
0.000486798
|
|
|
CELIAC2
|
[NCBI]
|
0.000486798
|
|
|
GLC1C
|
[NCBI]
|
0.000486798
|
|
|
BZX
|
[NCBI]
|
0.000486798
|
|
|
OPA4
|
[NCBI]
|
0.000486798
|
|
|
spondyloepiphyseal dysplasia tarda, autosomal dominant
|
[NCBI]
|
0.000486798
|
|
|
malignant hyperthermia, susceptibility to, 2
|
[NCBI]
|
0.000486798
|
|
|
CORD7
|
[NCBI]
|
0.000486798
|
|
|
hereditary motor and sensory neuropathy, type iic
|
[NCBI]
|
0.000486798
|
|
|
CTPP1
|
[NCBI]
|
0.000486798
|
|
|
OFC3
|
[NCBI]
|
0.000486798
|
|
|
NGFB
|
[NCBI]
|
0.000466445
|
|
|
CPX
|
[NCBI]
|
0.000458756
|
|
|
PRL
|
[NCBI]
|
0.000452652
|
|
|
EDMD
|
[NCBI]
|
0.000450006
|
|
|
HIGM1
|
[NCBI]
|
0.000441498
|
|
|
holoprosencephaly
|
[NCBI]
|
0.000434754
|
|
|
CSNB1A
|
[NCBI]
|
0.000429247
|
|
|
masa syndrome
|
[NCBI]
|
0.000416209
|
|
|
AHDS
|
[NCBI]
|
0.00040592
|
|
|
FA
|
[NCBI]
|
0.000404592
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
0.000404177
|
|
|
IBD2
|
[NCBI]
|
0.000400523
|
|
|
SCZD6
|
[NCBI]
|
0.000400523
|
|
|
FSHMD1A
|
[NCBI]
|
0.000388502
|
|
|
IBD1
|
[NCBI]
|
0.000387317
|
|
|
KLK3
|
[NCBI]
|
0.000384218
|
|
|
FEB1
|
[NCBI]
|
0.00037906
|
|
|
neuropathy, hereditary motor and sensory, okinawa type
|
[NCBI]
|
0.000377466
|
|
|
cataract, autosomal recessive, early-onset, pulverulent
|
[NCBI]
|
0.000377466
|
|
|
macular dystrophy, butterfly-shaped pigmentary, 2
|
[NCBI]
|
0.000377466
|
|
|
autoimmune thyroid disease, susceptibility to, 2
|
[NCBI]
|
0.000377466
|
|
|
stature quantitative trait locus 2
|
[NCBI]
|
0.000377466
|
|
|
RMD1
|
[NCBI]
|
0.000377466
|
|
|
systemic lupus erythematosus, susceptibility to, 7
|
[NCBI]
|
0.000377466
|
|
|
van der woude syndrome modifier
|
[NCBI]
|
0.000377466
|
|
|
IDDM13
|
[NCBI]
|
0.000377466
|
|
|
PFHB2
|
[NCBI]
|
0.000377466
|
|
|
PDR
|
[NCBI]
|
0.000377466
|
|
|
mental retardation with optic atrophy, deafness, and seizures
|
[NCBI]
|
0.000377466
|
|
|
myopia 6
|
[NCBI]
|
0.000377466
|
|
|
stature quantitative trait locus 8
|
[NCBI]
|
0.000377466
|
|
|
IDDM11
|
[NCBI]
|
0.000377466
|
|
|
IDDM15
|
[NCBI]
|
0.000377466
|
|
|
vacuolar neuromyopathy
|
[NCBI]
|
0.000377466
|
|
|
CVD1
|
[NCBI]
|
0.000377466
|
|
|
orofacial cleft 4
|
[NCBI]
|
0.000377466
|
|
|
persistent hyperplastic primary vitreous, autosomal recessive
|
[NCBI]
|
0.000377466
|
|
|
MRX2
|
[NCBI]
|
0.000377466
|
|
|
wieacker syndrome
|
[NCBI]
|
0.000377466
|
|
|
AUTS7
|
[NCBI]
|
0.000377466
|
|
|
PSORS3
|
[NCBI]
|
0.000377466
|
|
|
DFNB5
|
[NCBI]
|
0.000377466
|
|
|
IDDM3
|
[NCBI]
|
0.000377466
|
|
|
ALSFTD2
|
[NCBI]
|
0.000377466
|
|
|
restless legs syndrome, susceptibility to, 3
|
[NCBI]
|
0.000377466
|
|
|
HHC2
|
[NCBI]
|
0.000377466
|
|
|
asthma-related traits, susceptibility to, 6
|
[NCBI]
|
0.000377466
|
|
|
DYT15
|
[NCBI]
|
0.000377466
|
|
|
wilms tumor 4
|
[NCBI]
|
0.000377466
|
|
|
SPG19
|
[NCBI]
|
0.000377466
|
|
|
bullous dystrophy, hereditary macular type
|
[NCBI]
|
0.000377466
|
|
|
RPGR
|
[NCBI]
|
0.000377043
|
|
|
SEDT
|
[NCBI]
|
0.000375438
|
|
|
ATS
|
[NCBI]
|
0.000371845
|
|
|
CCA1
|
[NCBI]
|
0.00036739
|
|
|
ATOD6
|
[NCBI]
|
0.00036739
|
|
|
EKD2
|
[NCBI]
|
0.00036739
|
|
|
HSAS
|
[NCBI]
|
0.000363514
|
|
|
lipomatosis, multiple
|
[NCBI]
|
0.00035816
|
|
|
coronary heart disease, susceptibility to, 1
|
[NCBI]
|
0.000355087
|
|
|
li-fraumeni syndrome 3
|
[NCBI]
|
0.000355087
|
|
|
S CRAMP
|
[NCBI]
|
0.000355087
|
|
|
tukel syndrome
|
[NCBI]
|
0.000355087
|
|
|
DFNB44
|
[NCBI]
|
0.000355087
|
|
|
leukemia, chronic lymphocytic, susceptibility to, 1
|
[NCBI]
|
0.000355087
|
|
|
BMND4
|
[NCBI]
|
0.000355087
|
|
|
asperger syndrome, susceptibility to, 4
|
[NCBI]
|
0.000355087
|
|
|
panic disorder 2
|
[NCBI]
|
0.000355087
|
|
|
AD15
|
[NCBI]
|
0.000355087
|
|
|
HSCR5
|
[NCBI]
|
0.000355087
|
|
|
MSSD
|
[NCBI]
|
0.000355087
|
|
|
PPR3
|
[NCBI]
|
0.000355087
|
|
|
IS2
|
[NCBI]
|
0.000355087
|
|
|
GLC1F
|
[NCBI]
|
0.000355087
|
|
|
renal hypodysplasia, nonsyndromic, 1
|
[NCBI]
|
0.000355087
|
|
|
MRXS11
|
[NCBI]
|
0.000355087
|
|
|
MAFD5
|
[NCBI]
|
0.000355087
|
|
|
SQTL2
|
[NCBI]
|
0.000355087
|
|
|
circulating adiponectin quantitative trait locus on chromosome 14
|
[NCBI]
|
0.000355087
|
|
|
MRX73
|
[NCBI]
|
0.000355087
|
|
|
MMVP3
|
[NCBI]
|
0.000355087
|
|
|
MRX53
|
[NCBI]
|
0.000355087
|
|
|
carotid intimal medial thickness 2
|
[NCBI]
|
0.000355087
|
|
|
ETL4
|
[NCBI]
|
0.000355087
|
|
|
RP23
|
[NCBI]
|
0.000355087
|
|
|
plasmodium falciparum fever episodes quantitative trait locus 1
|
[NCBI]
|
0.000355087
|
|
|
migraine with or without aura, susceptibility to, 8
|
[NCBI]
|
0.000355087
|
|
|
STHAG5
|
[NCBI]
|
0.000355087
|
|
|
CORDX2
|
[NCBI]
|
0.000355087
|
|
|
myopia 13
|
[NCBI]
|
0.000355087
|
|
|
restless legs syndrome, susceptibility to, 5
|
[NCBI]
|
0.000355087
|
|
|
prostate cancer, hereditary, 7
|
[NCBI]
|
0.000355087
|
|
|
aneurysm, intracranial berry, 5
|
[NCBI]
|
0.000355087
|
|
|
SCKL3
|
[NCBI]
|
0.000355087
|
|
|
hypertension, essential, susceptibility to, 6
|
[NCBI]
|
0.000355087
|
|
|
exfoliative ichthyosis, autosomal recessive, ichthyosis bullosa of siemens-like
|
[NCBI]
|
0.000355087
|
|
|
circulating adiponectin quantitative trait locus on chromosome 5
|
[NCBI]
|
0.000355087
|
|
|
metaphyseal dysplasia, braun-tinschert type
|
[NCBI]
|
0.000355087
|
|
|
hodgkin disease, y-linked pseudoautosomal
|
[NCBI]
|
0.000355087
|
|
|
body mass index quantitative trait locus on chromosome 16, in children
|
[NCBI]
|
0.000355087
|
|
|
SCA23
|
[NCBI]
|
0.000355087
|
|
|
restless legs syndrome, susceptibility to, 4
|
[NCBI]
|
0.000355087
|
|
|
attention deficit-hyperactivity disorder, susceptibility to, 1
|
[NCBI]
|
0.000355087
|
|
|
orofacial cleft 9
|
[NCBI]
|
0.000355087
|
|
|
CMD1Q
|
[NCBI]
|
0.000355087
|
|
|
MRX72
|
[NCBI]
|
0.000355087
|
|
|
cataract, nuclear progressive
|
[NCBI]
|
0.000355087
|
|
|
abidi x-linked mental retardation syndrome
|
[NCBI]
|
0.000355087
|
|
|
STHAG2
|
[NCBI]
|
0.000355087
|
|
|
hypertension, essential, susceptibility to, 7
|
[NCBI]
|
0.000355087
|
|
|
polydactyly, postaxial, type a3
|
[NCBI]
|
0.000355087
|
|
|
aneurysm, intracranial berry, 4
|
[NCBI]
|
0.000355087
|
|
|
gene expression, variation in, quantitative trait locus on chromosome 20
|
[NCBI]
|
0.000355087
|
|
|
hypertension, essential, susceptibility to, 4
|
[NCBI]
|
0.000355087
|
|
|
lung cancer 1
|
[NCBI]
|
0.000355087
|
|
|
myopia 11
|
[NCBI]
|
0.000355087
|
|
|
systemic lupus erythematosus, susceptibility to, 4
|
[NCBI]
|
0.000355087
|
|
|
S EYE
|
[NCBI]
|
0.000355087
|
|
|
olivopontocerebellar atrophy ii, autosomal recessive
|
[NCBI]
|
0.000355087
|
|
|
GLC1D
|
[NCBI]
|
0.000355087
|
|
|
martin-probst deafness-mental retardation syndrome
|
[NCBI]
|
0.000355087
|
|
|
hyperlipidemia, combined, 2
|
[NCBI]
|
0.000355087
|
|
|
IOPQTL
|
[NCBI]
|
0.000355087
|
|
|
PFM3
|
[NCBI]
|
0.000355087
|
|
|
SCA28
|
[NCBI]
|
0.000355087
|
|
|
bone size quantitative trait locus 2
|
[NCBI]
|
0.000355087
|
|
|
alopecia areata 2
|
[NCBI]
|
0.000355087
|
|
|
intelligence quantitative trait locus 3
|
[NCBI]
|
0.000355087
|
|
|
gene expression, variation in, quantitative trait locus on chromosome 14
|
[NCBI]
|
0.000355087
|
|
|
amelogenesis imperfecta, hypoplastic/hypomaturation, x-linked 2
|
[NCBI]
|
0.000355087
|
|
|
OTSC4
|
[NCBI]
|
0.000355087
|
|
|
EMWX
|
[NCBI]
|
0.000355087
|
|
|
ovarian cancer, epithelial, susceptibility to
|
[NCBI]
|
0.000355087
|
|
|
major depressive disorder 1
|
[NCBI]
|
0.000355087
|
|
|
moyamoya disease 3
|
[NCBI]
|
0.000355087
|
|
|
GLC1H
|
[NCBI]
|
0.000355087
|
|
|
CATCN1
|
[NCBI]
|
0.000355087
|
|
|
bone size quantitative trait locus 3
|
[NCBI]
|
0.000355087
|
|
|
polydactyly, postaxial, type a4
|
[NCBI]
|
0.000355087
|
|
|
ATFB2
|
[NCBI]
|
0.000355087
|
|
|
SLEN3
|
[NCBI]
|
0.000355087
|
|
|
MRX42
|
[NCBI]
|
0.000355087
|
|
|
SPAX3
|
[NCBI]
|
0.000355087
|
|
|
myopia 12
|
[NCBI]
|
0.000355087
|
|
|
high density lipoprotein cholesterol level quantitative trait locus 5
|
[NCBI]
|
0.000355087
|
|
|
stature quantitative trait locus 4
|
[NCBI]
|
0.000355087
|
|
|
malignant hyperthermia, susceptibility to, 4
|
[NCBI]
|
0.000355087
|
|
|
DYT4
|
[NCBI]
|
0.000355087
|
|
|
immunoneurologic disorder, x-linked
|
[NCBI]
|
0.000355087
|
|
|
narcolepsy 3
|
[NCBI]
|
0.000355087
|
|
|
longevity 1
|
[NCBI]
|
0.000355087
|
|
|
DFNA31
|
[NCBI]
|
0.000355087
|
|
|
ATOD3
|
[NCBI]
|
0.000355087
|
|
|
LAP
|
[NCBI]
|
0.000355087
|
|
|
CFEOM3A
|
[NCBI]
|
0.000355087
|
|
|
OFD8
|
[NCBI]
|
0.000355087
|
|
|
intelligence quantitative trait locus 2
|
[NCBI]
|
0.000355087
|
|
|
FEB7
|
[NCBI]
|
0.000355087
|
|
|
KTCN2
|
[NCBI]
|
0.000355087
|
|
|
adenosine triphosphatase deficiency, anemia due to
|
[NCBI]
|
0.000355087
|
|
|
retinitis pigmentosa 34
|
[NCBI]
|
0.000355087
|
|
|
wittwer syndrome
|
[NCBI]
|
0.000355087
|
|
|
EIG3
|
[NCBI]
|
0.000355087
|
|
|
FMTLE
|
[NCBI]
|
0.000355087
|
|
|
DFNB35
|
[NCBI]
|
0.000355087
|
|
|
DFNB17
|
[NCBI]
|
0.000355087
|
|
|
periodontitis, aggressive, 2
|
[NCBI]
|
0.000355087
|
|
|
nephropathy, progressive, with deafness
|
[NCBI]
|
0.000355087
|
|
|
GLC1N
|
[NCBI]
|
0.000355087
|
|
|
GLC1K
|
[NCBI]
|
0.000355087
|
|
|
MRT4
|
[NCBI]
|
0.000355087
|
|
|
IBD8
|
[NCBI]
|
0.000355087
|
|
|
MRX29
|
[NCBI]
|
0.000355087
|
|
|
GINGF2
|
[NCBI]
|
0.000355087
|
|
|
alzheimer disease 12
|
[NCBI]
|
0.000355087
|
|
|
SLEH1
|
[NCBI]
|
0.000355087
|
|
|
alzheimer disease 10
|
[NCBI]
|
0.000355087
|
|
|
spinal muscular atrophy, distal, x-linked recessive
|
[NCBI]
|
0.000355087
|
|
|
preauricular tag, isolated, autosomal dominant, 1
|
[NCBI]
|
0.000355087
|
|
|
migraine with aura, susceptibility to, 9
|
[NCBI]
|
0.000355087
|
|
|
MRX82
|
[NCBI]
|
0.000355087
|
|
|
DFN6
|
[NCBI]
|
0.000355087
|
|
|
high density lipoprotein cholesterol level quantitative trait locus 6
|
[NCBI]
|
0.000355087
|
|
|
cryoglobulinemia, familial mixed
|
[NCBI]
|
0.000355087
|
|
|
EIG1
|
[NCBI]
|
0.000355087
|
|
|
abdominal obesity-metabolic syndrome quantitative trait locus 2
|
[NCBI]
|
0.000355087
|
|
|
LGMD1G
|
[NCBI]
|
0.000355087
|
|
|
LOH18CR1
|
[NCBI]
|
0.000355087
|
|
|
SPOAN
|
[NCBI]
|
0.000355087
|
|
|
AGMX2
|
[NCBI]
|
0.000355087
|
|
|
DFNA49
|
[NCBI]
|
0.000355087
|
|
|
EIG2
|
[NCBI]
|
0.000355087
|
|
|
GLC1J
|
[NCBI]
|
0.000355087
|
|
|
armfield x-linked mental retardation syndrome
|
[NCBI]
|
0.000355087
|
|
|
BMND7
|
[NCBI]
|
0.000355087
|
|
|
DFNB39
|
[NCBI]
|
0.000355087
|
|
|
MAFD3
|
[NCBI]
|
0.000355087
|
|
|
CTPP5
|
[NCBI]
|
0.000355087
|
|
|
DFNA16
|
[NCBI]
|
0.000355087
|
|
|
epilepsy, partial, with pericentral spikes
|
[NCBI]
|
0.000355087
|
|
|
AN
|
[NCBI]
|
0.000355087
|
|
|
DFNB48
|
[NCBI]
|
0.000355087
|
|
|
AIS4
|
[NCBI]
|
0.000355087
|
|
|
deafness, congenital neurosensory, autosomal recessive 38
|
[NCBI]
|
0.000355087
|
|
|
DFNB14
|
[NCBI]
|
0.000355087
|
|
|
SPG27
|
[NCBI]
|
0.000355087
|
|
|
LKE
|
[NCBI]
|
0.000355087
|
|
|
DFNA30
|
[NCBI]
|
0.000355087
|
|
|
RP22
|
[NCBI]
|
0.000355087
|
|
|
major depressive disorder 2
|
[NCBI]
|
0.000355087
|
|
|
cataract, ataxia, short stature, and mental retardation
|
[NCBI]
|
0.000355087
|
|
|
asthma-related traits, susceptibility to, 4
|
[NCBI]
|
0.000355087
|
|
|
MRX52
|
[NCBI]
|
0.000355087
|
|
|
MCPH2
|
[NCBI]
|
0.000355087
|
|
|
body mass index quantitative trait locus on chromosome 20, in children
|
[NCBI]
|
0.000355087
|
|
|
SLEN1
|
[NCBI]
|
0.000355087
|
|
|
AMCX5
|
[NCBI]
|
0.000355087
|
|
|
SCA26
|
[NCBI]
|
0.000355087
|
|
|
MMVP2
|
[NCBI]
|
0.000355087
|
|
|
PORC
|
[NCBI]
|
0.000355087
|
|
|
schizophrenia 12
|
[NCBI]
|
0.000355087
|
|
|
DFNA43
|
[NCBI]
|
0.000355087
|
|
|
MRXS12
|
[NCBI]
|
0.000355087
|
|
|
prostate cancer, hereditary, 5
|
[NCBI]
|
0.000355087
|
|
|
FEB2
|
[NCBI]
|
0.000355087
|
|
|
cholesterol level quantitative trait locus 2
|
[NCBI]
|
0.000355087
|
|
|
migraine with aura, susceptibility to, 7
|
[NCBI]
|
0.000355087
|
|
|
ADSD
|
[NCBI]
|
0.000355087
|
|
|
bleeding disorder, east texas type
|
[NCBI]
|
0.000355087
|
|
|
hypertension, essential, susceptibility to, 5
|
[NCBI]
|
0.000355087
|
|
|
MCOPCB1
|
[NCBI]
|
0.000355087
|
|
|
PPR2
|
[NCBI]
|
0.000355087
|
|
|
ETM3
|
[NCBI]
|
0.000355087
|
|
|
OTSC3
|
[NCBI]
|
0.000355087
|
|
|
alzheimer disease 9
|
[NCBI]
|
0.000355087
|
|
|
AUTS11
|
[NCBI]
|
0.000355087
|
|
|
narcolepsy 2
|
[NCBI]
|
0.000355087
|
|
|
SLEN2
|
[NCBI]
|
0.000355087
|
|
|
schizophrenia 11
|
[NCBI]
|
0.000355087
|
|
|
MYMY2
|
[NCBI]
|
0.000355087
|
|
|
FGS4
|
[NCBI]
|
0.000355087
|
|
|
aneurysm, intracranial berry, 2
|
[NCBI]
|
0.000355087
|
|
|
coronary heart disease, susceptibility to, 4
|
[NCBI]
|
0.000355087
|
|
|
DFNB68
|
[NCBI]
|
0.000355087
|
|
|
SPG29
|
[NCBI]
|
0.000355087
|
|
|
mental retardation, truncal obesity, retinal dystrophy, and micropenis
|
[NCBI]
|
0.000355087
|
|
|
RP1
|
[NCBI]
|
0.00035255
|
|
|
MEN2A
|
[NCBI]
|
0.000352346
|
|
|
SPG4
|
[NCBI]
|
0.000351981
|
|
|
NPY
|
[NCBI]
|
0.000349431
|
|
|
PWS
|
[NCBI]
|
0.00034859
|
|
|
EGFR
|
[NCBI]
|
0.000348176
|
|
|
MRXHF1
|
[NCBI]
|
0.000345309
|
|
|
RS1
|
[NCBI]
|
0.000336154
|
|
|
fragile x mental retardation syndrome
|
[NCBI]
|
0.000331074
|
|
|
CORDX1
|
[NCBI]
|
0.000330307
|
|
|
SHFM3
|
[NCBI]
|
0.000329468
|
|
|
HYPX
|
[NCBI]
|
0.000328236
|
|
|
stiff skin syndrome
|
[NCBI]
|
0.000328236
|
|
|
spatial visualization, aptitude for
|
[NCBI]
|
0.000328236
|
|
|
HPCX
|
[NCBI]
|
0.000328236
|
|
|
deafness, conductive, with stapes fixation
|
[NCBI]
|
0.000327737
|
|
|
SCZD2
|
[NCBI]
|
0.00032516
|
|
|
FCHL
|
[NCBI]
|
0.000322832
|
|
|
GFAP
|
[NCBI]
|
0.000322273
|
|
|
BTHS
|
[NCBI]
|
0.00030959
|
|
|
hypophosphatemic rickets, x-linked dominant
|
[NCBI]
|
0.000302062
|
|
|
BMD
|
[NCBI]
|
0.000294803
|
|
|
SMAX1
|
[NCBI]
|
0.000289321
|
|
|
EEC1
|
[NCBI]
|
0.000284276
|
|
|
RENS1
|
[NCBI]
|
0.000283243
|
|
|
mental health wellness 2
|
[NCBI]
|
0.000281626
|
|
|
asthma-related traits, susceptibility to, 5
|
[NCBI]
|
0.000281573
|
|
|
CTPP3
|
[NCBI]
|
0.000281573
|
|
|
hypogammaglobulinemia and isolated growth hormone deficiency, x-linked
|
[NCBI]
|
0.000281573
|
|
|
HMN1
|
[NCBI]
|
0.00028096
|
|
|
MNG1
|
[NCBI]
|
0.00028096
|
|
|
duane retraction syndrome 2
|
[NCBI]
|
0.00028096
|
|
|
CFEOM3
|
[NCBI]
|
0.00028096
|
|
|
NYS2
|
[NCBI]
|
0.00028096
|
|
|
PSORS4
|
[NCBI]
|
0.00028096
|
|
|
AVP
|
[NCBI]
|
0.00027879
|
|
|
hemophagocytic lymphohistiocytosis, familial, 1
|
[NCBI]
|
0.000275861
|
|
|
NYS1
|
[NCBI]
|
0.000275573
|
|
|
twinning, dizygotic
|
[NCBI]
|
0.00027442
|
|
|
GLC1A
|
[NCBI]
|
0.000274234
|
|
|
OKS
|
[NCBI]
|
0.000273836
|
|
|
IBD5
|
[NCBI]
|
0.000268825
|
|
|
WDM
|
[NCBI]
|
0.000268825
|
|
|
AUTS6
|
[NCBI]
|
0.000268825
|
|
|
OTSC1
|
[NCBI]
|
0.000268825
|
|
|
HD
|
[NCBI]
|
0.000266019
|
|
|
C4B
|
[NCBI]
|
0.000262716
|
|
|
dubowitz syndrome
|
[NCBI]
|
0.000260373
|
|
|
MVP
|
[NCBI]
|
0.000260373
|
|
|
ACHE
|
[NCBI]
|
0.000260337
|
|
|
L1CAM
|
[NCBI]
|
0.000259849
|
|
|
hypertension, essential
|
[NCBI]
|
0.000254896
|
|
|
CEACAM5
|
[NCBI]
|
0.000250969
|
|
|
RP
|
[NCBI]
|
0.000245322
|
|
|
MYP3
|
[NCBI]
|
0.000244836
|
|
|
LGMD1D
|
[NCBI]
|
0.000244836
|
|
|
ALSFTD1
|
[NCBI]
|
0.000244836
|
|
|
RP24
|
[NCBI]
|
0.000244836
|
|
|
PARK11
|
[NCBI]
|
0.000244836
|
|
|
peeling skin syndrome
|
[NCBI]
|
0.000244836
|
|
|
AXPC1
|
[NCBI]
|
0.000244836
|
|
|
CORD5
|
[NCBI]
|
0.000244836
|
|
|
amyotrophy, neurogenic scapuloperoneal, new england type
|
[NCBI]
|
0.000244836
|
|
|
nasopharyngeal carcinoma 1
|
[NCBI]
|
0.000244836
|
|
|
CNA1
|
[NCBI]
|
0.000244836
|
|
|
spinal muscular atrophy, distal, congenital nonprogressive
|
[NCBI]
|
0.000244836
|
|
|
pulmonary function
|
[NCBI]
|
0.000244836
|
|
|
dandy-walker malformation with mental retardation, basal ganglia disease, and seizures
|
[NCBI]
|
0.000244836
|
|
|
MRX23
|
[NCBI]
|
0.000244836
|
|
|
EA4
|
[NCBI]
|
0.000244836
|
|
|
SLEB3
|
[NCBI]
|
0.000244836
|
|
|
kala-azar, susceptibility to, 1
|
[NCBI]
|
0.000244836
|
|
|
cenani syndactylism
|
[NCBI]
|
0.000244836
|
|
|
AHC
|
[NCBI]
|
0.00024478
|
|
|
MS
|
[NCBI]
|
0.000242701
|
|
|
CGD
|
[NCBI]
|
0.000240362
|
|
|
dystrophia myotonica 1
|
[NCBI]
|
0.000238695
|
|
|
scleroderma, familial progressive
|
[NCBI]
|
0.00023689
|
|
|
DYX1
|
[NCBI]
|
0.000236045
|
|
|
NHS
|
[NCBI]
|
0.000234485
|
|
|
PD
|
[NCBI]
|
0.000234344
|
|
|
CCK
|
[NCBI]
|
0.000233137
|
|
|
CMT1A
|
[NCBI]
|
0.000231036
|
|
|
PTH
|
[NCBI]
|
0.000230943
|
|
|
ragweed sensitivity
|
[NCBI]
|
0.000228654
|
|
|
cataract, lamellar
|
[NCBI]
|
0.000228654
|
|
|
NDP
|
[NCBI]
|
0.000228477
|
|
|
IP
|
[NCBI]
|
0.000228338
|
|
|
DYX2
|
[NCBI]
|
0.000226253
|
|
|
SCZD1
|
[NCBI]
|
0.000226253
|
|
|
HPC1
|
[NCBI]
|
0.000226253
|
|
|
ulcerative colitis, susceptibility to
|
[NCBI]
|
0.000224858
|
|
|
KAL1
|
[NCBI]
|
0.000224011
|
|
|
HFE
|
[NCBI]
|
0.000222804
|
|
|
ATRX
|
[NCBI]
|
0.000221486
|
|
|
SCZD
|
[NCBI]
|
0.0002203
|
|
|
VWS
|
[NCBI]
|
0.000219147
|
|
|
CHM
|
[NCBI]
|
0.000219147
|
|
|
BDNF
|
[NCBI]
|
0.000217702
|
|
|
DWS
|
[NCBI]
|
0.000215699
|
|
|
alzheimer disease 8
|
[NCBI]
|
0.000215449
|
|
|
prostate cancer, hereditary, 8
|
[NCBI]
|
0.000215449
|
|
|
properdin deficiency, x-linked
|
[NCBI]
|
0.000215249
|
|
|
CRH
|
[NCBI]
|
0.000214239
|
|
|
chiari malformation type i
|
[NCBI]
|
0.000213868
|
|
|
thrombocytopenia-absent radius syndrome
|
[NCBI]
|
0.000213868
|
|
|
HLA-A
|
[NCBI]
|
0.000212548
|
|
|
ARX
|
[NCBI]
|
0.000210863
|
|
|
SCZD9
|
[NCBI]
|
0.000208507
|
|
|
PKD3
|
[NCBI]
|
0.000208033
|
|
|
FRDA
|
[NCBI]
|
0.000207954
|
|
|
CMM2
|
[NCBI]
|
0.000207427
|
|
|
AIED
|
[NCBI]
|
0.000205137
|
|
|
PKD1
|
[NCBI]
|
0.000203586
|
|
|
PMD
|
[NCBI]
|
0.000202721
|
|
|
PDB
|
[NCBI]
|
0.000199494
|
|
|
PNKD1
|
[NCBI]
|
0.000199494
|
|
|
CLS
|
[NCBI]
|
0.000199435
|
|
|
NR0B1
|
[NCBI]
|
0.000198852
|
|
|
MPO
|
[NCBI]
|
0.00019813
|
|
|
SCZD4
|
[NCBI]
|
0.00019653
|
|
|
LGMD2B
|
[NCBI]
|
0.00019653
|
|
|
SHFM1
|
[NCBI]
|
0.000196402
|
|
|
MODY
|
[NCBI]
|
0.000196391
|
|
|
menkes disease
|
[NCBI]
|
0.000195705
|
|
|
DMD
|
[NCBI]
|
0.000194957
|
|
|
PKD2
|
[NCBI]
|
0.000190212
|
|
|
MAFD6
|
[NCBI]
|
0.000189501
|
|
|
IPEX
|
[NCBI]
|
0.000185727
|
|
|
CMT1B
|
[NCBI]
|
0.000184435
|
|
|
EKD1
|
[NCBI]
|
0.000181845
|
|
|
amyloidosis vi
|
[NCBI]
|
0.000180479
|
|
|
EPO
|
[NCBI]
|
0.000179732
|
|
|
SC
|
[NCBI]
|
0.000179266
|
|
|
MRXS13
|
[NCBI]
|
0.000178709
|
|
|
CMT2B
|
[NCBI]
|
0.000178709
|
|
|
usher syndrome, type i
|
[NCBI]
|
0.000178237
|
|
|
CCZS
|
[NCBI]
|
0.000176365
|
|
|
MRX54
|
[NCBI]
|
0.000176365
|
|
|
RP15
|
[NCBI]
|
0.000176365
|
|
|
LISX2
|
[NCBI]
|
0.000176365
|
|
|
thalassemia, beta+, silent allele
|
[NCBI]
|
0.000176365
|
|
|
SPG2
|
[NCBI]
|
0.000175903
|
|
|
periodontitis, aggressive, 1
|
[NCBI]
|
0.000175903
|
|
|
DMD
|
[NCBI]
|
0.000172096
|
|
|
alzheimer disease 3
|
[NCBI]
|
0.000171874
|
|
|
CCM
|
[NCBI]
|
0.000171066
|
|
|
IGHG1
|
[NCBI]
|
0.000170663
|
|
|
ATD1
|
[NCBI]
|
0.000169405
|
|
|
DHS
|
[NCBI]
|
0.000169405
|
|
|
MBS
|
[NCBI]
|
0.000169405
|
|
|
blood group--froese
|
[NCBI]
|
0.000168931
|
|
|
MRGH
|
[NCBI]
|
0.000168931
|
|
|
tetra-amelia, x-linked
|
[NCBI]
|
0.000168931
|
|
|
FHM2
|
[NCBI]
|
0.000166905
|
|
|
EDM1
|
[NCBI]
|
0.000166835
|
|
|
KFSD
|
[NCBI]
|
0.000166835
|
|
|
CMD3B
|
[NCBI]
|
0.000166835
|
|
|
STL1
|
[NCBI]
|
0.000165823
|
|
|
CDB2
|
[NCBI]
|
0.000164489
|
|
|
PSORS1
|
[NCBI]
|
0.000164342
|
|
|
ETM2
|
[NCBI]
|
0.000163975
|
|
|
coronary heart disease, susceptibility to, 2
|
[NCBI]
|
0.000163975
|
|
|
AUTS5
|
[NCBI]
|
0.000163975
|
|
|
convulsions, benign familial infantile, 1
|
[NCBI]
|
0.000163975
|
|
|
SCA4
|
[NCBI]
|
0.000163975
|
|
|
JBTS2
|
[NCBI]
|
0.000163975
|
|
|
WT3
|
[NCBI]
|
0.000163975
|
|
|
leptin, serum levels of
|
[NCBI]
|
0.000163975
|
|
|
chorioretinal atrophy, progressive bifocal
|
[NCBI]
|
0.000163975
|
|
|
USH2B
|
[NCBI]
|
0.000163975
|
|
|
HTC2
|
[NCBI]
|
0.000163975
|
|
|
migraine with or without aura, susceptibility to, 5
|
[NCBI]
|
0.000163975
|
|
|
graves disease, susceptibility to, 2
|
[NCBI]
|
0.000163975
|
|
|
CTAA1
|
[NCBI]
|
0.000163975
|
|
|
migraine, familial typical, susceptibility to, 2
|
[NCBI]
|
0.000163975
|
|
|
CMD1B
|
[NCBI]
|
0.000163975
|
|
|
scheuermann disease
|
[NCBI]
|
0.000163975
|
|
|
CMDR
|
[NCBI]
|
0.000163975
|
|
|
DYT7
|
[NCBI]
|
0.000163975
|
|
|
PPR
|
[NCBI]
|
0.000163545
|
|
|
arbitrary restriction polymorphism 1
|
[NCBI]
|
0.000162674
|
|
|
SPG11
|
[NCBI]
|
0.000162674
|
|
|
hyperlipidemia, combined, 1
|
[NCBI]
|
0.000162674
|
|
|
epidermolysis bullosa dystrophica, pasini type
|
[NCBI]
|
0.000162674
|
|
|
CMT2D
|
[NCBI]
|
0.000162674
|
|
|
BFLS
|
[NCBI]
|
0.000158618
|
|
|
EBN1
|
[NCBI]
|
0.000158618
|
|
|
hashimoto thyroiditis
|
[NCBI]
|
0.000158037
|
|
|
OCRL
|
[NCBI]
|
0.000157697
|
|
|
STGD3
|
[NCBI]
|
0.000156291
|
|
|
JME
|
[NCBI]
|
0.000156291
|
|
|
AMELX
|
[NCBI]
|
0.000152169
|
|
|
HNFJ
|
[NCBI]
|
0.000151395
|
|
|
anemia, sideroblastic, x-linked
|
[NCBI]
|
0.000151238
|
|
|
RP13
|
[NCBI]
|
0.00015122
|
|
|
ORW2
|
[NCBI]
|
0.000150948
|
|
|
F3
|
[NCBI]
|
0.000149609
|
|
|
PGL1
|
[NCBI]
|
0.000149302
|
|
|
OA1
|
[NCBI]
|
0.000148977
|
|
|
EBS2
|
[NCBI]
|
0.000148914
|
|
|
DFNA2
|
[NCBI]
|
0.000148914
|
|
|
CSNB2A
|
[NCBI]
|
0.000148914
|
|
|
CHAT
|
[NCBI]
|
0.000148551
|
|
|
GJB1
|
[NCBI]
|
0.00014687
|
|
|
ADLTE
|
[NCBI]
|
0.000146825
|
|
|
dent disease 1
|
[NCBI]
|
0.000146825
|
|
|
PHEX
|
[NCBI]
|
0.000146793
|
|
|
complement component 6 deficiency
|
[NCBI]
|
0.000140976
|
|
|
EMD
|
[NCBI]
|
0.000138971
|
|
|
glycogen storage disease ixa
|
[NCBI]
|
0.000138628
|
|
|
CMT2A2
|
[NCBI]
|
0.000137182
|
|
|
RP11
|
[NCBI]
|
0.000137182
|
|
|
HTX1
|
[NCBI]
|
0.000137182
|
|
|
EIG
|
[NCBI]
|
0.000136855
|
|
|
aneurysm, intracranial berry, 1
|
[NCBI]
|
0.000135897
|
|
|
OPA1
|
[NCBI]
|
0.000134843
|
|
|
BL
|
[NCBI]
|
0.000134698
|
|
|
prostate cancer
|
[NCBI]
|
0.000133988
|
|
|
TRAPPC2
|
[NCBI]
|
0.000133701
|
|
|
IL2RG
|
[NCBI]
|
0.000133411
|
|
|
AS
|
[NCBI]
|
0.000133403
|
|
|
MPD1
|
[NCBI]
|
0.000133204
|
|
|
CCA2
|
[NCBI]
|
0.000133204
|
|
|
EJM1
|
[NCBI]
|
0.000133204
|
|
|
ALS4
|
[NCBI]
|
0.000133204
|
|
|
XRN
|
[NCBI]
|
0.000133204
|
|
|
IDDM5
|
[NCBI]
|
0.000133204
|
|
|
GCK
|
[NCBI]
|
0.000131443
|
|
|
infantile spasm syndrome, x-linked
|
[NCBI]
|
0.000130436
|
|
|
CORD2
|
[NCBI]
|
0.000130436
|
|
|
REN
|
[NCBI]
|
0.000128652
|
|
|
TNFSF6
|
[NCBI]
|
0.000128158
|
|
|
AVPR2
|
[NCBI]
|
0.000128124
|
|
|
fecundity gene, booroola, of sheep, homolog of
|
[NCBI]
|
0.000125109
|
|
|
RD
|
[NCBI]
|
0.000125109
|
|
|
PRD
|
[NCBI]
|
0.000125109
|
|
|
SW
|
[NCBI]
|
0.000125109
|
|
|
coronary heart disease, susceptibility to, 5
|
[NCBI]
|
0.000125109
|
|
|
XS
|
[NCBI]
|
0.000125109
|
|
|
MRX30
|
[NCBI]
|
0.000125109
|
|
|
HOKPP
|
[NCBI]
|
0.000125095
|
|
|
AFP
|
[NCBI]
|
0.000124876
|
|
|
G6PD
|
[NCBI]
|
0.000124523
|
|
|
LGMD2C
|
[NCBI]
|
0.000124478
|
|
|
ABO
|
[NCBI]
|
0.000124401
|
|
|
dermatitis, atopic
|
[NCBI]
|
0.000124267
|
|
|
TOC
|
[NCBI]
|
0.000124267
|
|
|
WAS
|
[NCBI]
|
0.000123685
|
|
|
EA2
|
[NCBI]
|
0.000123263
|
|
|
FTLDU
|
[NCBI]
|
0.000123263
|
|
|
acute myelogenous leukemia
|
[NCBI]
|
0.000122372
|
|
|
neuropathy, hereditary sensory and autonomic, type i, with cough and gastroesophageal reflux
|
[NCBI]
|
0.000122372
|
|
|
dyskinesia, familial, with facial myokymia
|
[NCBI]
|
0.000122372
|
|
|
DFNB13
|
[NCBI]
|
0.000122372
|
|
|
necrotizing encephalopathy, acute, autosomal dominant
|
[NCBI]
|
0.000122372
|
|
|
hepatic fibrosis, severe, susceptibility to, due to schistosoma mansoni infection
|
[NCBI]
|
0.000122372
|
|
|
myasthenia, familial infantile, 1
|
[NCBI]
|
0.000122372
|
|
|
prostate cancer aggressiveness quantitative trait locus on chromosome 19
|
[NCBI]
|
0.000122372
|
|
|
WS2B
|
[NCBI]
|
0.000122372
|
|
|
glucocorticoid deficiency 3
|
[NCBI]
|
0.000122372
|
|
|
AIS3
|
[NCBI]
|
0.000122372
|
|
|
FSHMD1B
|
[NCBI]
|
0.000122372
|
|
|
terminal osseous dysplasia and pigmentary defects
|
[NCBI]
|
0.000122372
|
|
|
NYS3
|
[NCBI]
|
0.000122372
|
|
|
SLI1
|
[NCBI]
|
0.000122372
|
|
|
familial wilms tumor 2
|
[NCBI]
|
0.000122372
|
|
|
cinnamon odor, pleasantness of
|
[NCBI]
|
0.000122372
|
|
|
HDL3
|
[NCBI]
|
0.000122372
|
|
|
histiocytosis with joint contractures and sensorineural deafness
|
[NCBI]
|
0.000122372
|
|
|
orthostatic hypotensive disorder, streeten type
|
[NCBI]
|
0.000122372
|
|
|
CRSA
|
[NCBI]
|
0.000122372
|
|
|
CCAL1
|
[NCBI]
|
0.000122372
|
|
|
epidermolysis bullosa inversa dystrophica
|
[NCBI]
|
0.000122372
|
|
|
systemic lupus erythematosus, susceptibility to, 8
|
[NCBI]
|
0.000122372
|
|
|
fasting glucose and specific insulin levels
|
[NCBI]
|
0.000122372
|
|
|
MRSD
|
[NCBI]
|
0.000122372
|
|
|
aortic aneurysm, familial thoracic 2
|
[NCBI]
|
0.000122372
|
|
|
SLI3
|
[NCBI]
|
0.000122372
|
|
|
HHG
|
[NCBI]
|
0.000122372
|
|
|
RDPA
|
[NCBI]
|
0.000122372
|
|
|
leber congenital amaurosis, type ix
|
[NCBI]
|
0.000122372
|
|
|
aneurysm, intracranial berry, 3
|
[NCBI]
|
0.000122372
|
|
|
acute insulin response
|
[NCBI]
|
0.000122372
|
|
|
DYX9
|
[NCBI]
|
0.000122372
|
|
|
retinal cone dystrophy 2
|
[NCBI]
|
0.000122372
|
|
|
persistent hyperplastic primary vitreous, autosomal dominant
|
[NCBI]
|
0.000122372
|
|
|
microcephaly with chorioretinopathy, autosomal recessive
|
[NCBI]
|
0.000122372
|
|
|
angioma serpiginosum, x-linked
|
[NCBI]
|
0.000122372
|
|
|
HCFP2
|
[NCBI]
|
0.000122372
|
|
|
SCAR5
|
[NCBI]
|
0.000122372
|
|
|
psoriasis susceptibility 6
|
[NCBI]
|
0.000122372
|
|
|
ehlers-danlos syndrome, type v
|
[NCBI]
|
0.000122372
|
|
|
STUT2
|
[NCBI]
|
0.000122372
|
|
|
panic disorder 3
|
[NCBI]
|
0.000122372
|
|
|
SLI2
|
[NCBI]
|
0.000122372
|
|
|
microcoria, congenital
|
[NCBI]
|
0.000122372
|
|
|
PRS
|
[NCBI]
|
0.000122372
|
|
|
spondyloepiphyseal dysplasia tarda, autosomal recessive
|
[NCBI]
|
0.000122372
|
|
|
NEM6
|
[NCBI]
|
0.000122372
|
|
|
melanoma, cutaneous malignant, 4
|
[NCBI]
|
0.000122372
|
|
|
VMD1
|
[NCBI]
|
0.000122372
|
|
|
basal ganglia calcification, idiopathic, 2
|
[NCBI]
|
0.000122372
|
|
|
MRT12
|
[NCBI]
|
0.000122372
|
|
|
ptosis, hereditary congenital 2
|
[NCBI]
|
0.000122372
|
|
|
DFNA7
|
[NCBI]
|
0.000122372
|
|
|
PEE2
|
[NCBI]
|
0.000122372
|
|
|
CMTX2
|
[NCBI]
|
0.000122372
|
|
|
SCA21
|
[NCBI]
|
0.000122372
|
|
|
CRCS1
|
[NCBI]
|
0.000122372
|
|
|
MPD3
|
[NCBI]
|
0.000122372
|
|
|
pyloric stenosis, infantile hypertrophic, 2
|
[NCBI]
|
0.000122372
|
|
|
MF4
|
[NCBI]
|
0.000122372
|
|
|
ataxia, sensory, autosomal dominant
|
[NCBI]
|
0.000122372
|
|
|
blue rubber bleb nevus
|
[NCBI]
|
0.000122372
|
|
|
AIS2
|
[NCBI]
|
0.000122372
|
|
|
distichiasis
|
[NCBI]
|
0.000122372
|
|
|
GLC1I
|
[NCBI]
|
0.000122372
|
|
|
epilepsy, myoclonic, benign adult familial, type 2
|
[NCBI]
|
0.000122372
|
|
|
myopia 4
|
[NCBI]
|
0.000122372
|
|
|
ATOD2
|
[NCBI]
|
0.000122372
|
|
|
AUTS8
|
[NCBI]
|
0.000122372
|
|
|
spinal muscular atrophy, facioscapulohumeral type
|
[NCBI]
|
0.000122372
|
|
|
attention deficit-hyperactivity disorder, susceptibility to, 2
|
[NCBI]
|
0.000122372
|
|
|
MRXS7
|
[NCBI]
|
0.000122372
|
|
|
parkinsonism, early-onset, with mental retardation
|
[NCBI]
|
0.000122372
|
|
|
mucopolysaccharidosis type ii
|
[NCBI]
|
0.000120356
|
|
|
VMCM
|
[NCBI]
|
0.000119124
|
|
|
vacterl association with hydrocephalus, x-linked
|
[NCBI]
|
0.000119124
|
|
|
creatine deficiency syndrome, x-linked
|
[NCBI]
|
0.000119124
|
|
|
MRX9
|
[NCBI]
|
0.000119124
|
|
|
PIL
|
[NCBI]
|
0.000119124
|
|
|
DYT12
|
[NCBI]
|
0.000119124
|
|
|
EVR2
|
[NCBI]
|
0.000119124
|
|
|
autism
|
[NCBI]
|
0.00011886
|
|
|
CRYAA
|
[NCBI]
|
0.00011825
|
|
|
alzheimer disease 2
|
[NCBI]
|
0.000117978
|
|
|
OPD1
|
[NCBI]
|
0.000117978
|
|
|
amelogenesis imperfecta, hypoplastic/hypomaturation, x-linked 1
|
[NCBI]
|
0.000117978
|
|
|
BMND1
|
[NCBI]
|
0.000117978
|
|
|
phosphoribosylpyrophosphate synthetase superactivity
|
[NCBI]
|
0.000117978
|
|
|
TAZ
|
[NCBI]
|
0.000117459
|
|
|
WAS
|
[NCBI]
|
0.000116139
|
|
|
NF1
|
[NCBI]
|
0.000114934
|
|
|
JK
|
[NCBI]
|
0.000114199
|
|
|
C3
|
[NCBI]
|
0.000114085
|
|
|
PLP1
|
[NCBI]
|
0.000114085
|
|
|
complement component 2 deficiency
|
[NCBI]
|
0.000113746
|
|
|
GLO1
|
[NCBI]
|
0.000113412
|
|
|
MTM1
|
[NCBI]
|
0.000113412
|
|
|
radial aplasia, x-linked
|
[NCBI]
|
0.000112616
|
|
|
SCRA
|
[NCBI]
|
0.000112616
|
|
|
fucosidase regulator
|
[NCBI]
|
0.000112616
|
|
|
alzheimer disease without neurofibrillary tangles
|
[NCBI]
|
0.000112616
|
|
|
corpus callosum, agenesis of, with abnormal genitalia
|
[NCBI]
|
0.000112616
|
|
|
spinocerebellar ataxia, x-linked 3
|
[NCBI]
|
0.000112616
|
|
|
spondyloepimetaphyseal dysplasia, x-linked
|
[NCBI]
|
0.000112616
|
|
|
CMH8
|
[NCBI]
|
0.000112616
|
|
|
MCDR1
|
[NCBI]
|
0.000111667
|
|
|
MHS1
|
[NCBI]
|
0.000111632
|
|
|
myoclonic dystonia
|
[NCBI]
|
0.000111204
|
|
|
PRKCG
|
[NCBI]
|
0.000111167
|
|
|
PMC
|
[NCBI]
|
0.00011052
|
|
|
CFEOM1
|
[NCBI]
|
0.000109945
|
|
|
USH1C
|
[NCBI]
|
0.000109945
|
|
|
OPD2
|
[NCBI]
|
0.000109945
|
|
|
HMN5
|
[NCBI]
|
0.000109945
|
|
|
trichoepithelioma, multiple familial
|
[NCBI]
|
0.000109605
|
|
|
PFHB1B
|
[NCBI]
|
0.000109605
|
|
|
hereditary motor and sensory neuropathy v
|
[NCBI]
|
0.000109605
|
|
|
HPC10
|
[NCBI]
|
0.000109605
|
|
|
PGL2
|
[NCBI]
|
0.000109605
|
|
|
diabetes mellitus, noninsulin-dependent, 3
|
[NCBI]
|
0.000109605
|
|
|
keratosis palmoplantaris papulosa
|
[NCBI]
|
0.000109605
|
|
|
OSCS
|
[NCBI]
|
0.000109605
|
|
|
panbronchiolitis, diffuse
|
[NCBI]
|
0.000109605
|
|
|
ehlers-danlos syndrome, type viii
|
[NCBI]
|
0.000109605
|
|
|
stature as a quantitative trait
|
[NCBI]
|
0.000109605
|
|
|
SCZD10
|
[NCBI]
|
0.000109605
|
|
|
FHM1
|
[NCBI]
|
0.000109502
|
|
|
XG
|
[NCBI]
|
0.000109215
|
|
|
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency
|
[NCBI]
|
0.000109103
|
|
|
WS1
|
[NCBI]
|
0.000108453
|
|
|
CMH4
|
[NCBI]
|
0.000107595
|
|
|
RHO
|
[NCBI]
|
0.000107363
|
|
|
XK
|
[NCBI]
|
0.000105675
|
|
|
SPDA1
|
[NCBI]
|
0.000104858
|
|
|
CDPX1
|
[NCBI]
|
0.000104823
|
|
|
IDDM10
|
[NCBI]
|
0.000103998
|
|
|
MRX21
|
[NCBI]
|
0.000103998
|
|
|
epidermolysis bullosa of hands and feet
|
[NCBI]
|
0.000103998
|
|
|
STL3
|
[NCBI]
|
0.000103998
|
|
|
dentinogenesis imperfecta, shields type iii
|
[NCBI]
|
0.000103998
|
|
|
CMH3
|
[NCBI]
|
0.000103998
|
|
|
SCZD8
|
[NCBI]
|
0.000103998
|
|
|
asthma-related traits, susceptibility to, 1
|
[NCBI]
|
0.000103998
|
|
|
retinitis pigmentosa, x-linked, with recurrent respiratory infections
|
[NCBI]
|
0.000103998
|
|
|
hypophosphatemic rickets, x-linked recessive
|
[NCBI]
|
0.000103998
|
|
|
EDM3
|
[NCBI]
|
0.000103998
|
|
|
CAT
|
[NCBI]
|
0.000103797
|
|
|
CFB
|
[NCBI]
|
0.000103525
|
|
|
FMF
|
[NCBI]
|
0.000103479
|
|
|
complement component 8 deficiency, type i
|
[NCBI]
|
0.000103172
|
|
|
EBP
|
[NCBI]
|
0.000103172
|
|
|
CD40LG
|
[NCBI]
|
0.000103102
|
|
|
COL4A5
|
[NCBI]
|
0.000103102
|
|
|
CHE2
|
[NCBI]
|
0.000102715
|
|
|
myotonia congenita, autosomal dominant
|
[NCBI]
|
0.000102711
|
|
|
PDHA1
|
[NCBI]
|
0.000102322
|
|
|
PFC
|
[NCBI]
|
0.000101935
|
|
|
AK1
|
[NCBI]
|
0.000101283
|
|
|
MECP2
|
[NCBI]
|
0.000101209
|
|
|
DYT1
|
[NCBI]
|
0.000100458
|
|
|
MN
|
[NCBI]
|
9.95328e-05
|
|
|
sialuria, finnish type
|
[NCBI]
|
9.95078e-05
|
|
|
LPA
|
[NCBI]
|
9.94754e-05
|
|
|
NPPA
|
[NCBI]
|
9.87925e-05
|
|
|
hydrocephalus
|
[NCBI]
|
9.78692e-05
|
|
|
SXI1
|
[NCBI]
|
9.78692e-05
|
|
|
LISX1
|
[NCBI]
|
9.78692e-05
|
|
|
spinocerebellar ataxia, 16q22-linked
|
[NCBI]
|
9.78692e-05
|
|
|
MCPH5
|
[NCBI]
|
9.78692e-05
|
|
|
CMT4C
|
[NCBI]
|
9.78692e-05
|
|
|
polycystic kidneys
|
[NCBI]
|
9.77185e-05
|
|
|
SLOS
|
[NCBI]
|
9.68286e-05
|
|
|
MCOPS7
|
[NCBI]
|
9.62668e-05
|
|
|
graves disease
|
[NCBI]
|
9.62668e-05
|
|
|
NPS
|
[NCBI]
|
9.4216e-05
|
|
|
loc387715 gene
|
[NCBI]
|
9.36092e-05
|
|
|
POU3F4
|
[NCBI]
|
9.36092e-05
|
|
|
diabetes mellitus, transient neonatal, 1
|
[NCBI]
|
9.33248e-05
|
|
|
GDI1
|
[NCBI]
|
9.31116e-05
|
|
|
ESD
|
[NCBI]
|
9.29296e-05
|
|
|
epilepsy, myoclonic, benign adult familial, type 1
|
[NCBI]
|
9.23101e-05
|
|
|
exostoses, multiple, type i
|
[NCBI]
|
9.22848e-05
|
|
|
RYR1
|
[NCBI]
|
9.21182e-05
|
|
|
APOA1
|
[NCBI]
|
9.21182e-05
|
|
|
alport syndrome, autosomal dominant
|
[NCBI]
|
9.06361e-05
|
|
|
DYT3
|
[NCBI]
|
9.01526e-05
|
|
|
DFNA12
|
[NCBI]
|
8.94915e-05
|
|
|
SPG6
|
[NCBI]
|
8.94915e-05
|
|
|
LGMD1A
|
[NCBI]
|
8.94915e-05
|
|
|
OCD1
|
[NCBI]
|
8.94915e-05
|
|
|
SH2D1A
|
[NCBI]
|
8.94681e-05
|
|
|
CRS2
|
[NCBI]
|
8.93372e-05
|
|
|
STHAG1
|
[NCBI]
|
8.93372e-05
|
|
|
neural tube defects, x-linked
|
[NCBI]
|
8.93372e-05
|
|
|
DFNB10
|
[NCBI]
|
8.93372e-05
|
|
|
stickler syndrome, type i, nonsyndromic ocular
|
[NCBI]
|
8.93372e-05
|
|
|
clark-baraitser syndrome
|
[NCBI]
|
8.93372e-05
|
|
|
ectodermal dysplasia, hypohidrotic, with immune deficiency
|
[NCBI]
|
8.93372e-05
|
|
|
RP17
|
[NCBI]
|
8.93372e-05
|
|
|
TIMP1
|
[NCBI]
|
8.88525e-05
|
|
|
thiourea tasting
|
[NCBI]
|
8.54831e-05
|
|
|
central core disease of muscle
|
[NCBI]
|
8.54831e-05
|
|
|
KSS
|
[NCBI]
|
8.5296e-05
|
|
|
LGMD2A
|
[NCBI]
|
8.48733e-05
|
|
|
ABCD1
|
[NCBI]
|
8.47994e-05
|
|
|
MNS
|
[NCBI]
|
8.46514e-05
|
|
|
GDNF
|
[NCBI]
|
8.44706e-05
|
|
|
PRH1
|
[NCBI]
|
8.33678e-05
|
|
|
ARHGEF6
|
[NCBI]
|
8.23485e-05
|
|
|
CYLD
|
[NCBI]
|
8.2162e-05
|
|
|
HRPT2
|
[NCBI]
|
8.2162e-05
|
|
|
PPD2
|
[NCBI]
|
8.2162e-05
|
|
|
BRCA1
|
[NCBI]
|
8.1681e-05
|
|
|
dyschromatosis symmetrica hereditaria 1
|
[NCBI]
|
8.13499e-05
|
|
|
C4A
|
[NCBI]
|
8.13166e-05
|
|
|
MYBPC3
|
[NCBI]
|
8.05646e-05
|
|
|
C4BPA
|
[NCBI]
|
8.05646e-05
|
|
|
COL2A1
|
[NCBI]
|
8.04149e-05
|
|
|
LI1
|
[NCBI]
|
8.01344e-05
|
|
|
NPHP1
|
[NCBI]
|
7.95791e-05
|
|
|
bethlem myopathy
|
[NCBI]
|
7.95791e-05
|
|
|
EV
|
[NCBI]
|
7.88832e-05
|
|
|
SCA2
|
[NCBI]
|
7.86478e-05
|
|
|
ST3
|
[NCBI]
|
7.85661e-05
|
|
|
HHRH
|
[NCBI]
|
7.8129e-05
|
|
|
CZP3
|
[NCBI]
|
7.8129e-05
|
|
|
ARMD7
|
[NCBI]
|
7.8129e-05
|
|
|
AN1
|
[NCBI]
|
7.8129e-05
|
|
|
lujan-fryns syndrome
|
[NCBI]
|
7.8129e-05
|
|
|
STL2
|
[NCBI]
|
7.8129e-05
|
|
|
MM
|
[NCBI]
|
7.81173e-05
|
|
|
DFNB1
|
[NCBI]
|
7.74481e-05
|
|
|
GRTH
|
[NCBI]
|
7.56718e-05
|
|
|
ED2
|
[NCBI]
|
7.56718e-05
|
|
|
CIDX
|
[NCBI]
|
7.56021e-05
|
|
|
DFNB31
|
[NCBI]
|
7.56021e-05
|
|
|
MRX63
|
[NCBI]
|
7.56021e-05
|
|
|
aortic aneurysm, familial thoracic 4
|
[NCBI]
|
7.56021e-05
|
|
|
cafe-au-lait spots, multiple
|
[NCBI]
|
7.56021e-05
|
|
|
pterygium syndrome, multiple, x-linked
|
[NCBI]
|
7.56021e-05
|
|
|
MRX46
|
[NCBI]
|
7.56021e-05
|
|
|
LCA4
|
[NCBI]
|
7.56021e-05
|
|
|
atkin-flaitz syndrome
|
[NCBI]
|
7.56021e-05
|
|
|
MRX58
|
[NCBI]
|
7.56021e-05
|
|
|
mental retardation, x-linked, snyder-robinson type
|
[NCBI]
|
7.56021e-05
|
|
|
hepatitis b vaccine, response to
|
[NCBI]
|
7.56021e-05
|
|
|
DDU
|
[NCBI]
|
7.56021e-05
|
|
|
DFNB67
|
[NCBI]
|
7.56021e-05
|
|
|
MRT3
|
[NCBI]
|
7.56021e-05
|
|
|
EDM5
|
[NCBI]
|
7.56021e-05
|
|
|
ATOD4
|
[NCBI]
|
7.56021e-05
|
|
|
autism, x-linked, susceptibility to, 2
|
[NCBI]
|
7.56021e-05
|
|
|
FEB4
|
[NCBI]
|
7.56021e-05
|
|
|
ARTS
|
[NCBI]
|
7.56021e-05
|
|
|
LVNCX
|
[NCBI]
|
7.56021e-05
|
|
|
thrombocytopenia, platelet dysfunction, hemolysis, and imbalanced globin synthesis
|
[NCBI]
|
7.56021e-05
|
|
|
CHM
|
[NCBI]
|
7.48269e-05
|
|
|
DHFR
|
[NCBI]
|
7.46577e-05
|
|
|
CFH
|
[NCBI]
|
7.3942e-05
|
|
|
INS
|
[NCBI]
|
7.39162e-05
|
|
|
BOR1
|
[NCBI]
|
7.37586e-05
|
|
|
myoclonic epilepsy of lafora
|
[NCBI]
|
7.37586e-05
|
|
|
SMA1
|
[NCBI]
|
7.26272e-05
|
|
|
MBP
|
[NCBI]
|
7.18253e-05
|
|
|
APS2
|
[NCBI]
|
7.1544e-05
|
|
|
SPG5A
|
[NCBI]
|
7.1544e-05
|
|
|
SHFM2
|
[NCBI]
|
7.1544e-05
|
|
|
BMND3
|
[NCBI]
|
7.1544e-05
|
|
|
AUTS4
|
[NCBI]
|
7.1544e-05
|
|
|
MSSE
|
[NCBI]
|
7.1544e-05
|
|
|
MYMY1
|
[NCBI]
|
7.1544e-05
|
|
|
SLC6A8
|
[NCBI]
|
7.12976e-05
|
|
|
PQBP1
|
[NCBI]
|
7.12976e-05
|
|
|
FUT2
|
[NCBI]
|
7.12976e-05
|
|
|
IGLP1
|
[NCBI]
|
7.12086e-05
|
|
|
IHG
|
[NCBI]
|
7.12086e-05
|
|
|
BFSP2
|
[NCBI]
|
7.09752e-05
|
|
|
PITX3
|
[NCBI]
|
7.09752e-05
|
|
|
KCNQ4
|
[NCBI]
|
7.09752e-05
|
|
|
MS4A2
|
[NCBI]
|
7.09752e-05
|
|
|
OD
|
[NCBI]
|
7.09595e-05
|
|
|
ETM1
|
[NCBI]
|
7.05239e-05
|
|
|
PGM1
|
[NCBI]
|
7.01754e-05
|
|
|
WGN1
|
[NCBI]
|
6.98696e-05
|
|
|
MODY1
|
[NCBI]
|
6.98696e-05
|
|
|
DRD2
|
[NCBI]
|
6.92924e-05
|
|
|
opitz syndrome
|
[NCBI]
|
6.91112e-05
|
|
|
prostate cancer/brain cancer susceptibility
|
[NCBI]
|
6.91112e-05
|
|
|
mal de meleda
|
[NCBI]
|
6.91112e-05
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 3
|
[NCBI]
|
6.91112e-05
|
|
|
AMDM
|
[NCBI]
|
6.91112e-05
|
|
|
MCOPS2
|
[NCBI]
|
6.91112e-05
|
|
|
MCKD2
|
[NCBI]
|
6.91112e-05
|
|
|
ACHM3
|
[NCBI]
|
6.91112e-05
|
|
|
OPLL
|
[NCBI]
|
6.91112e-05
|
|
|
epilepsy, nocturnal frontal lobe, type 1
|
[NCBI]
|
6.91112e-05
|
|
|
SLEB1
|
[NCBI]
|
6.91112e-05
|
|
|
myoclonic epilepsy of unverricht and lundborg
|
[NCBI]
|
6.90375e-05
|
|
|
PDS
|
[NCBI]
|
6.90375e-05
|
|
|
HYPP
|
[NCBI]
|
6.90375e-05
|
|
|
PPARA
|
[NCBI]
|
6.84897e-05
|
|
|
LQT1
|
[NCBI]
|
6.84165e-05
|
|
|
WBS
|
[NCBI]
|
6.83332e-05
|
|
|
CRYGC
|
[NCBI]
|
6.80444e-05
|
|
|
KRT15
|
[NCBI]
|
6.80444e-05
|
|
|
DKC
|
[NCBI]
|
6.69505e-05
|
|
|
HHC1
|
[NCBI]
|
6.69505e-05
|
|
|
PGK1
|
[NCBI]
|
6.675e-05
|
|
|
faciogenital dysplasia
|
[NCBI]
|
6.64621e-05
|
|
|
MDC1A
|
[NCBI]
|
6.64621e-05
|
|
|
KRT1
|
[NCBI]
|
6.57771e-05
|
|
|
TSD
|
[NCBI]
|
6.55332e-05
|
|
|
SHBG
|
[NCBI]
|
6.55225e-05
|
|
|
MTS
|
[NCBI]
|
6.46421e-05
|
|
|
HMS1
|
[NCBI]
|
6.46421e-05
|
|
|
obesity
|
[NCBI]
|
6.45807e-05
|
|
|
HHT
|
[NCBI]
|
6.45807e-05
|
|
|
TCOF
|
[NCBI]
|
6.41431e-05
|
|
|
AHR
|
[NCBI]
|
6.38467e-05
|
|
|
CFTR
|
[NCBI]
|
6.31973e-05
|
|
|
ACO1
|
[NCBI]
|
6.29947e-05
|
|
|
CRYGD
|
[NCBI]
|
6.29947e-05
|
|
|
LU
|
[NCBI]
|
6.29947e-05
|
|
|
CACNA1F
|
[NCBI]
|
6.29947e-05
|
|
|
ELN
|
[NCBI]
|
6.28318e-05
|
|
|
USH2A
|
[NCBI]
|
6.26686e-05
|
|
|
diabetes mellitus, insulin-dependent, 2
|
[NCBI]
|
6.26525e-05
|
|
|
MFN2
|
[NCBI]
|
6.25734e-05
|
|
|
TM4SF2
|
[NCBI]
|
6.24011e-05
|
|
|
APC
|
[NCBI]
|
6.23488e-05
|
|
|
FCMD
|
[NCBI]
|
6.2291e-05
|
|
|
TBG
|
[NCBI]
|
6.19794e-05
|
|
|
wilson disease
|
[NCBI]
|
6.17936e-05
|
|
|
FTD3
|
[NCBI]
|
6.16165e-05
|
|
|
ADHR
|
[NCBI]
|
6.16165e-05
|
|
|
RP12
|
[NCBI]
|
6.16165e-05
|
|
|
RPS6KA3
|
[NCBI]
|
6.16113e-05
|
|
|
ACP1
|
[NCBI]
|
6.16113e-05
|
|
|
TGM1
|
[NCBI]
|
6.10881e-05
|
|
|
FANCA
|
[NCBI]
|
6.05284e-05
|
|
|
SCA7
|
[NCBI]
|
6.00776e-05
|
|
|
CD
|
[NCBI]
|
6.0033e-05
|
|
|
FFI
|
[NCBI]
|
6.0033e-05
|
|
|
severe combined immunodeficiency with sensitivity to ionizing radiation
|
[NCBI]
|
5.99017e-05
|
|
|
exostoses, multiple, type ii
|
[NCBI]
|
5.99017e-05
|
|
|
PARK6
|
[NCBI]
|
5.99017e-05
|
|
|
EXT1
|
[NCBI]
|
5.96716e-05
|
|
|
HAE III
|
[NCBI]
|
5.95543e-05
|
|
|
CORD6
|
[NCBI]
|
5.95543e-05
|
|
|
epidermolysis bullosa simplex, ogna type
|
[NCBI]
|
5.95543e-05
|
|
|
AIS1
|
[NCBI]
|
5.95543e-05
|
|
|
weill-marchesani syndrome, autosomal dominant
|
[NCBI]
|
5.95543e-05
|
|
|
MRT2
|
[NCBI]
|
5.95543e-05
|
|
|
CORDX3
|
[NCBI]
|
5.95543e-05
|
|
|
mental retardation, x-linked, syndromic, jarid1c-related
|
[NCBI]
|
5.95543e-05
|
|
|
FSGS2
|
[NCBI]
|
5.95543e-05
|
|
|
ASAT
|
[NCBI]
|
5.95543e-05
|
|
|
dyserythropoietic anemia with thrombocytopenia
|
[NCBI]
|
5.95543e-05
|
|
|
endocardial fibroelastosis
|
[NCBI]
|
5.95543e-05
|
|
|
MCOP2
|
[NCBI]
|
5.95543e-05
|
|
|
PRTS
|
[NCBI]
|
5.95543e-05
|
|
|
choroideremia with deafness and obesity
|
[NCBI]
|
5.95543e-05
|
|
|
leigh syndrome, x-linked
|
[NCBI]
|
5.95543e-05
|
|
|
SCA15
|
[NCBI]
|
5.95543e-05
|
|
|
bietti crystalline corneoretinal dystrophy
|
[NCBI]
|
5.95543e-05
|
|
|
RP19
|
[NCBI]
|
5.95543e-05
|
|
|
cataract, autosomal dominant, multiple types 1
|
[NCBI]
|
5.95543e-05
|
|
|
CCL
|
[NCBI]
|
5.95543e-05
|
|
|
asthma-related traits, susceptibility to, 2
|
[NCBI]
|
5.95543e-05
|
|
|
EBN2
|
[NCBI]
|
5.95543e-05
|
|
|
HPA1
|
[NCBI]
|
5.95543e-05
|
|
|
complement component 4, partial deficiency of
|
[NCBI]
|
5.95543e-05
|
|
|
MYOC
|
[NCBI]
|
5.93909e-05
|
|
|
CRYBB2
|
[NCBI]
|
5.87497e-05
|
|
|
ATP1A2
|
[NCBI]
|
5.87497e-05
|
|
|
CD99
|
[NCBI]
|
5.87497e-05
|
|
|
AK3
|
[NCBI]
|
5.87196e-05
|
|
|
ARSE
|
[NCBI]
|
5.87196e-05
|
|
|
DFNA5
|
[NCBI]
|
5.87196e-05
|
|
|
PARK2
|
[NCBI]
|
5.79652e-05
|
|
|
SPG3A
|
[NCBI]
|
5.79652e-05
|
|
|
PLEKHG4
|
[NCBI]
|
5.79374e-05
|
|
|
ZNF81
|
[NCBI]
|
5.79374e-05
|
|
|
GRN
|
[NCBI]
|
5.74727e-05
|
|
|
GNRH1
|
[NCBI]
|
5.72857e-05
|
|
|
FBN1
|
[NCBI]
|
5.68843e-05
|
|
|
CRYBA1
|
[NCBI]
|
5.68582e-05
|
|
|
mycobacterium tuberculosis, susceptibility to, x-linked
|
[NCBI]
|
5.63058e-05
|
|
|
hypogonadism, male
|
[NCBI]
|
5.63058e-05
|
|
|
DFNB37
|
[NCBI]
|
5.63058e-05
|
|
|
brachydactyly, mononen type
|
[NCBI]
|
5.63058e-05
|
|
|
nipples inverted
|
[NCBI]
|
5.63058e-05
|
|
|
CATCN3
|
[NCBI]
|
5.63058e-05
|
|
|
USH2D
|
[NCBI]
|
5.63058e-05
|
|
|
CISS1
|
[NCBI]
|
5.63058e-05
|
|
|
mental retardation associated with psoriasis
|
[NCBI]
|
5.63058e-05
|
|
|
HHF5
|
[NCBI]
|
5.63058e-05
|
|
|
barber-say syndrome
|
[NCBI]
|
5.63058e-05
|
|
|
imprinting gene related to retinoblastoma
|
[NCBI]
|
5.63058e-05
|
|
|
male infertility from defect in meiosis
|
[NCBI]
|
5.63058e-05
|
|
|
TSC3
|
[NCBI]
|
5.63058e-05
|
|
|
dermatoglyphics--arch on any digit
|
[NCBI]
|
5.63058e-05
|
|
|
DFNB23
|
[NCBI]
|
5.63058e-05
|
|
|
cerebellar degeneration-related autoantigen 3
|
[NCBI]
|
5.63058e-05
|
|
|
osteoarthritis of distal interphalangeal joints
|
[NCBI]
|
5.63058e-05
|
|
|
MRX14
|
[NCBI]
|
5.63058e-05
|
|
|
hairy nose tip
|
[NCBI]
|
5.63058e-05
|
|
|
dyggve-melchior-clausen syndrome, x-linked
|
[NCBI]
|
5.63058e-05
|
|
|
asperger syndrome, x-linked, susceptibility to, 2
|
[NCBI]
|
5.63058e-05
|
|
|
CMH2
|
[NCBI]
|
5.63058e-05
|
|
|
DFNB22
|
[NCBI]
|
5.63058e-05
|
|
|
NGFA
|
[NCBI]
|
5.63058e-05
|
|
|
microcephaly with digital anomalies
|
[NCBI]
|
5.63058e-05
|
|
|
cerebellar ataxia and hypergonadotropic hypogonadism
|
[NCBI]
|
5.63058e-05
|
|
|
HRX
|
[NCBI]
|
5.63058e-05
|
|
|
homozygous 11p15-p14 deletion syndrome
|
[NCBI]
|
5.63058e-05
|
|
|
keratosis palmoplantaris striata iii
|
[NCBI]
|
5.63058e-05
|
|
|
hemopoietic proliferation
|
[NCBI]
|
5.63058e-05
|
|
|
neuropathy, hereditary sensory, x-linked
|
[NCBI]
|
5.63058e-05
|
|
|
spondyloepimetaphyseal dysplasia, x-linked, with mental deterioration
|
[NCBI]
|
5.63058e-05
|
|
|
peters anomaly with cataract
|
[NCBI]
|
5.63058e-05
|
|
|
myopathy, early-onset, with fatal cardiomyopathy
|
[NCBI]
|
5.63058e-05
|
|
|
membranoproliferative glomerulonephritis, x-linked
|
[NCBI]
|
5.63058e-05
|
|
|
charcot-marie-tooth disease, axonal, type 2h
|
[NCBI]
|
5.63058e-05
|
|
|
systemic lupus erythematosus, susceptibility to, 9
|
[NCBI]
|
5.63058e-05
|
|
|
RESDX
|
[NCBI]
|
5.63058e-05
|
|
|
NEM4
|
[NCBI]
|
5.63058e-05
|
|
|
myopathy, distal, with early respiratory failure, autosomal dominant
|
[NCBI]
|
5.63058e-05
|
|
|
scott craniodigital syndrome with mental retardation
|
[NCBI]
|
5.63058e-05
|
|
|
POF2B
|
[NCBI]
|
5.63058e-05
|
|
|
EDVX
|
[NCBI]
|
5.63058e-05
|
|
|
neuroendocrine carcinoma of salivary glands, sensorineural hearing loss, and enamel hypoplasia
|
[NCBI]
|
5.63058e-05
|
|
|
charcot-marie-tooth peroneal muscular atrophy, x-linked, with aplasia cutis congenita
|
[NCBI]
|
5.63058e-05
|
|
|
NNO2
|
[NCBI]
|
5.63058e-05
|
|
|
osteopathia striata with pigmentary dermopathy including white forelock
|
[NCBI]
|
5.63058e-05
|
|
|
infundibulopelvic dysgenesis
|
[NCBI]
|
5.63058e-05
|
|
|
DFNB24
|
[NCBI]
|
5.63058e-05
|
|
|
pancreatitis, sclerosing cholangitis, and sicca complex
|
[NCBI]
|
5.63058e-05
|
|
|
spinocerebellar ataxia, x-linked 4
|
[NCBI]
|
5.63058e-05
|
|
|
testes, rudimentary
|
[NCBI]
|
5.63058e-05
|
|
|
ataxia-microcephaly-cataract syndrome
|
[NCBI]
|
5.63058e-05
|
|
|
muscular dystrophy, progressive pectorodorsal
|
[NCBI]
|
5.63058e-05
|
|
|
arthrogryposis, ectodermal dysplasia, cleft lip/palate, and developmental delay
|
[NCBI]
|
5.63058e-05
|
|
|
ADCAD2
|
[NCBI]
|
5.63058e-05
|
|
|
symphalangism with multiple anomalies of hands and feet
|
[NCBI]
|
5.63058e-05
|
|
|
lymphedema-hypoparathyroidism syndrome
|
[NCBI]
|
5.63058e-05
|
|
|
cervical ribs, sprengel anomaly, anal atresia, and urethral obstruction
|
[NCBI]
|
5.63058e-05
|
|
|
OLEDAID
|
[NCBI]
|
5.63058e-05
|
|
|
frontonasal dysplasia
|
[NCBI]
|
5.63058e-05
|
|
|
CATCN2
|
[NCBI]
|
5.63058e-05
|
|
|
cone dystrophy, x-linked, with tapetal-like sheen
|
[NCBI]
|
5.63058e-05
|
|
|
epidermolysis bullosa simplex, autosomal recessive
|
[NCBI]
|
5.63058e-05
|
|
|
HYT8
|
[NCBI]
|
5.63058e-05
|
|
|
charcot-marie-tooth disease, dominant intermediate d
|
[NCBI]
|
5.63058e-05
|
|
|
XLN
|
[NCBI]
|
5.63058e-05
|
|
|
patent ductus arteriosus and bicuspid aortic valve with hand anomalies
|
[NCBI]
|
5.63058e-05
|
|
|
pierre robin sequence with facial and digital anomalies
|
[NCBI]
|
5.63058e-05
|
|
|
cataract-ataxia-deafness-retardation syndrome
|
[NCBI]
|
5.63058e-05
|
|
|
DFNA28
|
[NCBI]
|
5.63058e-05
|
|
|
hypersecretion of adrenal androgens, familial
|
[NCBI]
|
5.63058e-05
|
|
|
diamond-blackfan anemia 3
|
[NCBI]
|
5.63058e-05
|
|
|
DFNB53
|
[NCBI]
|
5.63058e-05
|
|
|
mandibulofacial dysostosis with ptosis, autosomal dominant
|
[NCBI]
|
5.63058e-05
|
|
|
asperger syndrome, x-linked, susceptibility to, 1
|
[NCBI]
|
5.63058e-05
|
|
|
mental retardation, x-linked, with craniofacial dysmorphism
|
[NCBI]
|
5.63058e-05
|
|
|
SLSN6
|
[NCBI]
|
5.63058e-05
|
|
|
cataract, cortical, juvenile-onset
|
[NCBI]
|
5.63058e-05
|
|
|
uruguay faciocardiomusculoskeletal syndrome
|
[NCBI]
|
5.63058e-05
|
|
|
dermatoglyphics--finger ridge count
|
[NCBI]
|
5.63058e-05
|
|
|
spastic paraparesis and deafness
|
[NCBI]
|
5.63058e-05
|
|
|
low density lipoprotein cholesterol, mild elevation of
|
[NCBI]
|
5.63058e-05
|
|
|
facial dysmorphism, cleft palate, hearing loss, and camptodactyly
|
[NCBI]
|
5.63058e-05
|
|
|
microcephaly with simplified gyral pattern
|
[NCBI]
|
5.63058e-05
|
|
|
VMD
|
[NCBI]
|
5.62108e-05
|
|
|
MEN1
|
[NCBI]
|
5.61051e-05
|
|
|
CFNS
|
[NCBI]
|
5.5786e-05
|
|
|
TAF1
|
[NCBI]
|
5.57806e-05
|
|
|
EVR1
|
[NCBI]
|
5.55799e-05
|
|
|
dopamine beta-hydroxylase deficiency, congenital
|
[NCBI]
|
5.55799e-05
|
|
|
ANKH
|
[NCBI]
|
5.55736e-05
|
|
|
hematopoietic stem cell kinetics, control of
|
[NCBI]
|
5.52459e-05
|
|
|
CZP1
|
[NCBI]
|
5.52459e-05
|
|
|
hyperostosis corticalis generalisata
|
[NCBI]
|
5.52459e-05
|
|
|
CMT4D
|
[NCBI]
|
5.52459e-05
|
|
|
USH1D
|
[NCBI]
|
5.52459e-05
|
|
|
SPG17
|
[NCBI]
|
5.52459e-05
|
|
|
FMD
|
[NCBI]
|
5.52459e-05
|
|
|
CBP
|
[NCBI]
|
5.50941e-05
|
|
|
mental retardation, congenital heart disease, blepharophimosis, blepharoptosis, and hypoplastic teeth
|
[NCBI]
|
5.47752e-05
|
|
|
SPG16
|
[NCBI]
|
5.47752e-05
|
|
|
pyle disease
|
[NCBI]
|
5.47752e-05
|
|
|
cerebellar hypoplasia, mental retardation, and quadrupedal locomotion
|
[NCBI]
|
5.47752e-05
|
|
|
diaphyseal medullary stenosis with malignant fibrous histiocytoma
|
[NCBI]
|
5.47752e-05
|
|
|
migraine with or without aura, susceptibility to, 3
|
[NCBI]
|
5.47752e-05
|
|
|
cavitary optic disc anomalies
|
[NCBI]
|
5.47752e-05
|
|
|
ATFB1
|
[NCBI]
|
5.47752e-05
|
|
|
OFD9
|
[NCBI]
|
5.47752e-05
|
|
|
schopf-schulz-passarge syndrome
|
[NCBI]
|
5.47752e-05
|
|
|
SPG15
|
[NCBI]
|
5.47752e-05
|
|
|
mesomelic dysplasia, kantaputra type
|
[NCBI]
|
5.47752e-05
|
|
|
koilonychia, hereditary
|
[NCBI]
|
5.47752e-05
|
|
|
bone size quantitative trait locus 1
|
[NCBI]
|
5.47752e-05
|
|
|
graves disease, susceptibility to, x-linked
|
[NCBI]
|
5.47752e-05
|
|
|
transient erythroblastopenia of childhood
|
[NCBI]
|
5.47752e-05
|
|
|
CSE
|
[NCBI]
|
5.47752e-05
|
|
|
leprosy, susceptibility to, 1
|
[NCBI]
|
5.47752e-05
|
|
|
STUT1
|
[NCBI]
|
5.47752e-05
|
|
|
alopecia-mental retardation syndrome 1
|
[NCBI]
|
5.47752e-05
|
|
|
malignant hyperthermia, susceptibility to, 3
|
[NCBI]
|
5.47752e-05
|
|
|
OFC2
|
[NCBI]
|
5.47752e-05
|
|
|
GLC1M
|
[NCBI]
|
5.47752e-05
|
|
|
preauricular fistulae, congenital
|
[NCBI]
|
5.47752e-05
|
|
|
CMD1F
|
[NCBI]
|
5.47752e-05
|
|
|
FGS2
|
[NCBI]
|
5.47752e-05
|
|
|
telangiectasia, hereditary benign
|
[NCBI]
|
5.47752e-05
|
|
|
MHAC
|
[NCBI]
|
5.47752e-05
|
|
|
hip dysplasia, beukes type
|
[NCBI]
|
5.47752e-05
|
|
|
laterality defects, autosomal dominant
|
[NCBI]
|
5.47752e-05
|
|
|
vitreoretinal degeneration, snowflake type
|
[NCBI]
|
5.47752e-05
|
|
|
body mass index quantitative trait locus on chromosome 6
|
[NCBI]
|
5.47752e-05
|
|
|
CMTX3
|
[NCBI]
|
5.47752e-05
|
|
|
alzheimer disease 11
|
[NCBI]
|
5.47752e-05
|
|
|
bruck syndrome 1
|
[NCBI]
|
5.47752e-05
|
|
|
PARK10
|
[NCBI]
|
5.47752e-05
|
|
|
IDDM18
|
[NCBI]
|
5.47752e-05
|
|
|
PSORS5
|
[NCBI]
|
5.47752e-05
|
|
|
WTS
|
[NCBI]
|
5.47752e-05
|
|
|
body mass index quantitative trait locus on chromosome 11
|
[NCBI]
|
5.47752e-05
|
|
|
split-hand/foot malformation with sensorineural hearing loss
|
[NCBI]
|
5.47752e-05
|
|
|
dermal ridges-off-the-end
|
[NCBI]
|
5.47752e-05
|
|
|
macrocephaly with multiple epiphyseal dysplasia and distinctive facies
|
[NCBI]
|
5.47752e-05
|
|
|
patent ductus arteriosus
|
[NCBI]
|
5.47752e-05
|
|
|
IBD9
|
[NCBI]
|
5.47752e-05
|
|
|
microcephaly, autosomal dominant
|
[NCBI]
|
5.43665e-05
|
|
|
marden-walker syndrome
|
[NCBI]
|
5.43665e-05
|
|
|
DYT2
|
[NCBI]
|
5.43665e-05
|
|
|
telomere length, mean leukocyte
|
[NCBI]
|
5.43665e-05
|
|
|
short rib-polydactyly syndrome, type ii
|
[NCBI]
|
5.43665e-05
|
|
|
DM2
|
[NCBI]
|
5.39379e-05
|
|
|
LMX1B
|
[NCBI]
|
5.3442e-05
|
|
|
PGM3
|
[NCBI]
|
5.3442e-05
|
|
|
IRDN
|
[NCBI]
|
5.3442e-05
|
|
|
GUCY2D
|
[NCBI]
|
5.3442e-05
|
|
|
MDM1
|
[NCBI]
|
5.28279e-05
|
|
|
CD3G
|
[NCBI]
|
5.28279e-05
|
|
|
PRB1
|
[NCBI]
|
5.28279e-05
|
|
|
walker-warburg syndrome
|
[NCBI]
|
5.26677e-05
|
|
|
CADASIL
|
[NCBI]
|
5.26677e-05
|
|
|
osteoarthritis
|
[NCBI]
|
5.26553e-05
|
|
|
TNFRSF11B
|
[NCBI]
|
5.25358e-05
|
|
|
SPTA1
|
[NCBI]
|
5.1994e-05
|
|
|
SPP1
|
[NCBI]
|
5.19748e-05
|
|
|
CACNA1S
|
[NCBI]
|
5.18892e-05
|
|
|
NEU1
|
[NCBI]
|
5.18892e-05
|
|
|
GALK1
|
[NCBI]
|
5.18892e-05
|
|
|
PGD
|
[NCBI]
|
5.18892e-05
|
|
|
VUR1
|
[NCBI]
|
5.17642e-05
|
|
|
hemophilia a
|
[NCBI]
|
5.14953e-05
|
|
|
ATHS
|
[NCBI]
|
5.14476e-05
|
|
|
MS4A1
|
[NCBI]
|
5.14107e-05
|
|
|
GANC
|
[NCBI]
|
5.14107e-05
|
|
|
CCM2
|
[NCBI]
|
5.14107e-05
|
|
|
ESX1L
|
[NCBI]
|
5.14107e-05
|
|
|
SAA4
|
[NCBI]
|
5.14107e-05
|
|
|
CLCN5
|
[NCBI]
|
5.04251e-05
|
|
|
MYH6
|
[NCBI]
|
5.04251e-05
|
|
|
ZIC3
|
[NCBI]
|
5.03934e-05
|
|
|
MYO15A
|
[NCBI]
|
5.03934e-05
|
|
|
C10ORF2
|
[NCBI]
|
5.03934e-05
|
|
|
VHL
|
[NCBI]
|
5.00491e-05
|
|
|
ehlers-danlos syndrome, type ii
|
[NCBI]
|
4.97405e-05
|
|
|
DGI1
|
[NCBI]
|
4.97405e-05
|
|
|
CDL1
|
[NCBI]
|
4.97405e-05
|
|
|
GVM
|
[NCBI]
|
4.97405e-05
|
|
|
SCA14
|
[NCBI]
|
4.97405e-05
|
|
|
MODY3
|
[NCBI]
|
4.97405e-05
|
|
|
GINGF
|
[NCBI]
|
4.97405e-05
|
|
|
ichthyosis vulgaris
|
[NCBI]
|
4.97405e-05
|
|
|
PXE
|
[NCBI]
|
4.97354e-05
|
|
|
SCA6
|
[NCBI]
|
4.96465e-05
|
|
|
LWD
|
[NCBI]
|
4.96465e-05
|
|
|
SPG4
|
[NCBI]
|
4.92591e-05
|
|
|
CBD
|
[NCBI]
|
4.92591e-05
|
|
|
FOXC2
|
[NCBI]
|
4.90407e-05
|
|
|
CACNA1A
|
[NCBI]
|
4.89453e-05
|
|
|
EDM2
|
[NCBI]
|
4.89275e-05
|
|
|
vohwinkel syndrome, variant form
|
[NCBI]
|
4.89275e-05
|
|
|
anderson disease
|
[NCBI]
|
4.89275e-05
|
|
|
RP7
|
[NCBI]
|
4.89275e-05
|
|
|
PGL3
|
[NCBI]
|
4.89275e-05
|
|
|
myopathy, centronuclear, autosomal recessive
|
[NCBI]
|
4.89275e-05
|
|
|
AH
|
[NCBI]
|
4.89275e-05
|
|
|
GDD
|
[NCBI]
|
4.89275e-05
|
|
|
PDB1
|
[NCBI]
|
4.89275e-05
|
|
|
IDDM12
|
[NCBI]
|
4.89275e-05
|
|
|
NEM1
|
[NCBI]
|
4.89275e-05
|
|
|
RTADR
|
[NCBI]
|
4.89275e-05
|
|
|
watson syndrome
|
[NCBI]
|
4.89275e-05
|
|
|
HCHOLA3
|
[NCBI]
|
4.89275e-05
|
|
|
neurofibromatosis, familial spinal
|
[NCBI]
|
4.89275e-05
|
|
|
mental retardation, x-linked, with cerebellar hypoplasia and distinctive facial appearance
|
[NCBI]
|
4.89275e-05
|
|
|
DFNA13
|
[NCBI]
|
4.89275e-05
|
|
|
LI2
|
[NCBI]
|
4.89275e-05
|
|
|
keratosis palmoplantaris striata i
|
[NCBI]
|
4.89275e-05
|
|
|
MRX59
|
[NCBI]
|
4.89275e-05
|
|
|
NRG1
|
[NCBI]
|
4.82361e-05
|
|
|
PAK3
|
[NCBI]
|
4.82081e-05
|
|
|
SOX3
|
[NCBI]
|
4.82081e-05
|
|
|
CLN2
|
[NCBI]
|
4.7982e-05
|
|
|
osteogenesis imperfecta, type iv
|
[NCBI]
|
4.7982e-05
|
|
|
HRPT1
|
[NCBI]
|
4.7982e-05
|
|
|
SHH
|
[NCBI]
|
4.78605e-05
|
|
|
CAPN10
|
[NCBI]
|
4.77282e-05
|
|
|
TCOF1
|
[NCBI]
|
4.77282e-05
|
|
|
PAX3
|
[NCBI]
|
4.75939e-05
|
|
|
GABRG1
|
[NCBI]
|
4.74711e-05
|
|
|
MMP23B
|
[NCBI]
|
4.74711e-05
|
|
|
OTOA
|
[NCBI]
|
4.74711e-05
|
|
|
ZNF261
|
[NCBI]
|
4.74711e-05
|
|
|
ZNF33B
|
[NCBI]
|
4.74711e-05
|
|
|
MMP23A
|
[NCBI]
|
4.74711e-05
|
|
|
UBL4A
|
[NCBI]
|
4.74711e-05
|
|
|
cytochrome p450, family 4, subfamily v, polypeptide 2
|
[NCBI]
|
4.74711e-05
|
|
|
DAR
|
[NCBI]
|
4.69299e-05
|
|
|
CBBM
|
[NCBI]
|
4.68722e-05
|
|
|
ATP1A3
|
[NCBI]
|
4.6799e-05
|
|
|
LW
|
[NCBI]
|
4.6799e-05
|
|
|
IGHD
|
[NCBI]
|
4.6799e-05
|
|
|
PRKAR2B
|
[NCBI]
|
4.6799e-05
|
|
|
SOAT2
|
[NCBI]
|
4.6799e-05
|
|
|
SMS
|
[NCBI]
|
4.6799e-05
|
|
|
C8G
|
[NCBI]
|
4.6799e-05
|
|
|
BMP3
|
[NCBI]
|
4.6799e-05
|
|
|
AGT
|
[NCBI]
|
4.67747e-05
|
|
|
FLNA
|
[NCBI]
|
4.67747e-05
|
|
|
SMS
|
[NCBI]
|
4.66968e-05
|
|
|
CDH23
|
[NCBI]
|
4.6481e-05
|
|
|
GARS
|
[NCBI]
|
4.62272e-05
|
|
|
HCRTR2
|
[NCBI]
|
4.62272e-05
|
|
|
FCGR2A
|
[NCBI]
|
4.62272e-05
|
|
|
PRPS1
|
[NCBI]
|
4.62272e-05
|
|
|
MPI
|
[NCBI]
|
4.62272e-05
|
|
|
MPZ
|
[NCBI]
|
4.56157e-05
|
|
|
OTC
|
[NCBI]
|
4.54077e-05
|
|
|
FKRP
|
[NCBI]
|
4.52934e-05
|
|
|
THC1
|
[NCBI]
|
4.49221e-05
|
|
|
DFNA6
|
[NCBI]
|
4.49221e-05
|
|
|
CDA
|
[NCBI]
|
4.49221e-05
|
|
|
SACS
|
[NCBI]
|
4.49221e-05
|
|
|
LGMD2D
|
[NCBI]
|
4.49221e-05
|
|
|
amyloidosis, primary cutaneous
|
[NCBI]
|
4.49221e-05
|
|
|
hyperlipoproteinemia, type ii
|
[NCBI]
|
4.49221e-05
|
|
|
ALUNC
|
[NCBI]
|
4.49221e-05
|
|
|
IHPS1
|
[NCBI]
|
4.49221e-05
|
|
|
thrombasthenia of glanzmann and naegeli
|
[NCBI]
|
4.49051e-05
|
|
|
RTT
|
[NCBI]
|
4.48818e-05
|
|
|
NOD2
|
[NCBI]
|
4.47661e-05
|
|
|
PARK8
|
[NCBI]
|
4.4624e-05
|
|
|
MEN2B
|
[NCBI]
|
4.4624e-05
|
|
|
MSS
|
[NCBI]
|
4.4624e-05
|
|
|
PSACH
|
[NCBI]
|
4.45927e-05
|
|
|
ANON1
|
[NCBI]
|
4.45856e-05
|
|
|
gastroesophageal reflux
|
[NCBI]
|
4.45856e-05
|
|
|
pulmonary disease, chronic obstructive
|
[NCBI]
|
4.45856e-05
|
|
|
PGP
|
[NCBI]
|
4.41603e-05
|
|
|
GALC
|
[NCBI]
|
4.41603e-05
|
|
|
FY
|
[NCBI]
|
4.3948e-05
|
|
|
NF2
|
[NCBI]
|
4.37877e-05
|
|
|
PRB2
|
[NCBI]
|
4.32127e-05
|
|
|
HLA-F
|
[NCBI]
|
4.32127e-05
|
|
|
MDH2
|
[NCBI]
|
4.32127e-05
|
|
|
myofibrillogenesis regulator 1
|
[NCBI]
|
4.32127e-05
|
|
|
NHS
|
[NCBI]
|
4.32127e-05
|
|
|
POU2F1
|
[NCBI]
|
4.32127e-05
|
|
|
FANCB
|
[NCBI]
|
4.32127e-05
|
|
|
CHMP4B
|
[NCBI]
|
4.32127e-05
|
|
|
IL1RAPL1
|
[NCBI]
|
4.32127e-05
|
|
|
IL4R
|
[NCBI]
|
4.30773e-05
|
|
|
APOA4
|
[NCBI]
|
4.27513e-05
|
|
|
PGK2
|
[NCBI]
|
4.27513e-05
|
|
|
KCNQ1
|
[NCBI]
|
4.2237e-05
|
|
|
GJA8
|
[NCBI]
|
4.20406e-05
|
|
|
AHO
|
[NCBI]
|
4.1962e-05
|
|
|
cutis laxa, x-linked
|
[NCBI]
|
4.15169e-05
|
|
|
CCAL2
|
[NCBI]
|
4.15169e-05
|
|
|
POAG
|
[NCBI]
|
4.13836e-05
|
|
|
COL5A1
|
[NCBI]
|
4.12099e-05
|
|
|
ectopia lentis, isolated
|
[NCBI]
|
4.10744e-05
|
|
|
whim syndrome
|
[NCBI]
|
4.10744e-05
|
|
|
DFNA4
|
[NCBI]
|
4.10744e-05
|
|
|
scapuloperoneal syndrome, neurogenic, kaeser type
|
[NCBI]
|
4.10744e-05
|
|
|
ceroid lipofuscinosis, neuronal, 8, northern epilepsy variant
|
[NCBI]
|
4.10744e-05
|
|
|
DFNA11
|
[NCBI]
|
4.10744e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-negative
|
[NCBI]
|
4.10744e-05
|
|
|
EVR4
|
[NCBI]
|
4.10744e-05
|
|
|
DFNA5
|
[NCBI]
|
4.10744e-05
|
|
|
bartter syndrome, infantile, with sensorineural deafness
|
[NCBI]
|
4.10744e-05
|
|
|
DFNB7
|
[NCBI]
|
4.10744e-05
|
|
|
OCA1B
|
[NCBI]
|
4.10744e-05
|
|
|
DFNB8
|
[NCBI]
|
4.10744e-05
|
|
|
ATCAY
|
[NCBI]
|
4.10744e-05
|
|
|
MRT1
|
[NCBI]
|
4.10744e-05
|
|
|
CNA2
|
[NCBI]
|
4.10744e-05
|
|
|
RP14
|
[NCBI]
|
4.10744e-05
|
|
|
nasopharyngeal carcinoma
|
[NCBI]
|
4.10744e-05
|
|
|
hairy ears, y-linked
|
[NCBI]
|
4.10744e-05
|
|
|
TLR4
|
[NCBI]
|
4.10357e-05
|
|
|
HPS
|
[NCBI]
|
4.09757e-05
|
|
|
THC2
|
[NCBI]
|
4.06628e-05
|
|
|
CMT2A1
|
[NCBI]
|
4.06628e-05
|
|
|
SHEP1
|
[NCBI]
|
4.06628e-05
|
|
|
wolff-parkinson-white syndrome
|
[NCBI]
|
4.06628e-05
|
|
|
CDGG1
|
[NCBI]
|
4.06628e-05
|
|
|
NM
|
[NCBI]
|
4.06628e-05
|
|
|
synovitis, granulomatous, with uveitis and cranial neuropathies
|
[NCBI]
|
4.06628e-05
|
|
|
WS2A
|
[NCBI]
|
4.06628e-05
|
|
|
COL9A3
|
[NCBI]
|
4.02768e-05
|
|
|
TMC1
|
[NCBI]
|
4.02768e-05
|
|
|
PTPRG
|
[NCBI]
|
4.02768e-05
|
|
|
DISC1
|
[NCBI]
|
4.00923e-05
|
|
|
C7
|
[NCBI]
|
3.97765e-05
|
|
|
PG
|
[NCBI]
|
3.95409e-05
|
|
|
FPLD2
|
[NCBI]
|
3.94839e-05
|
|
|
pygmy
|
[NCBI]
|
3.9233e-05
|
|
|
PPH1
|
[NCBI]
|
3.86347e-05
|
|
|
ARPKD
|
[NCBI]
|
3.85437e-05
|
|
|
CGB
|
[NCBI]
|
3.84377e-05
|
|
|
FOXC1
|
[NCBI]
|
3.84377e-05
|
|
|
GLUD1
|
[NCBI]
|
3.84377e-05
|
|
|
GJA3
|
[NCBI]
|
3.84377e-05
|
|
|
HBZ
|
[NCBI]
|
3.84377e-05
|
|
|
MTRNR1
|
[NCBI]
|
3.8292e-05
|
|
|
CNTF
|
[NCBI]
|
3.82264e-05
|
|
|
TH
|
[NCBI]
|
3.80109e-05
|
|
|
VIL
|
[NCBI]
|
3.77932e-05
|
|
|
PRH2
|
[NCBI]
|
3.77932e-05
|
|
|
TEK
|
[NCBI]
|
3.77932e-05
|
|
|
GCKR
|
[NCBI]
|
3.77932e-05
|
|
|
PSG2
|
[NCBI]
|
3.77932e-05
|
|
|
CD244
|
[NCBI]
|
3.77932e-05
|
|
|
OPHN1
|
[NCBI]
|
3.77932e-05
|
|
|
DYSF
|
[NCBI]
|
3.74413e-05
|
|
|
CTGF
|
[NCBI]
|
3.73315e-05
|
|
|
CD
|
[NCBI]
|
3.72256e-05
|
|
|
ACTC1
|
[NCBI]
|
3.71826e-05
|
|
|
COL11A2
|
[NCBI]
|
3.71826e-05
|
|
|
ENO1
|
[NCBI]
|
3.71826e-05
|
|
|
NFNS
|
[NCBI]
|
3.68678e-05
|
|
|
PPS
|
[NCBI]
|
3.68678e-05
|
|
|
DRPLA
|
[NCBI]
|
3.66334e-05
|
|
|
CYBB
|
[NCBI]
|
3.66208e-05
|
|
|
IGHJ
|
[NCBI]
|
3.62216e-05
|
|
|
LHFPL5
|
[NCBI]
|
3.62216e-05
|
|
|
XLRL
|
[NCBI]
|
3.62216e-05
|
|
|
LARS
|
[NCBI]
|
3.62216e-05
|
|
|
HSPA1B
|
[NCBI]
|
3.62216e-05
|
|
|
GABRG3
|
[NCBI]
|
3.62216e-05
|
|
|
ATP6V0A4
|
[NCBI]
|
3.62216e-05
|
|
|
DYM
|
[NCBI]
|
3.62216e-05
|
|
|
PPEF1
|
[NCBI]
|
3.62216e-05
|
|
|
IGHV
|
[NCBI]
|
3.60019e-05
|
|
|
DRD
|
[NCBI]
|
3.5955e-05
|
|
|
EKV
|
[NCBI]
|
3.5955e-05
|
|
|
diastrophic dysplasia
|
[NCBI]
|
3.5955e-05
|
|
|
GAPDH
|
[NCBI]
|
3.58962e-05
|
|
|
PEPD
|
[NCBI]
|
3.58286e-05
|
|
|
F13A1
|
[NCBI]
|
3.56898e-05
|
|
|
PSG3
|
[NCBI]
|
3.56434e-05
|
|
|
IGHE
|
[NCBI]
|
3.56434e-05
|
|
|
RP1
|
[NCBI]
|
3.56434e-05
|
|
|
ELOVL4
|
[NCBI]
|
3.56434e-05
|
|
|
ALMS1
|
[NCBI]
|
3.56434e-05
|
|
|
LMAN1
|
[NCBI]
|
3.56434e-05
|
|
|
B2M
|
[NCBI]
|
3.51069e-05
|
|
|
CYP2A6
|
[NCBI]
|
3.50631e-05
|
|
|
STHAG3
|
[NCBI]
|
3.49287e-05
|
|
|
cardiomyopathy, familial hypertrophic, with wolff-parkinson-white syndrome
|
[NCBI]
|
3.49287e-05
|
|
|
SCA5
|
[NCBI]
|
3.49287e-05
|
|
|
F5F8D
|
[NCBI]
|
3.49287e-05
|
|
|
NEM2
|
[NCBI]
|
3.49287e-05
|
|
|
AEXS
|
[NCBI]
|
3.49287e-05
|
|
|
LGMD2J
|
[NCBI]
|
3.49287e-05
|
|
|
amme complex
|
[NCBI]
|
3.49287e-05
|
|
|
vacterl association with hydrocephalus
|
[NCBI]
|
3.49287e-05
|
|
|
body mass index
|
[NCBI]
|
3.49287e-05
|
|
|
CO
|
[NCBI]
|
3.49287e-05
|
|
|
FSGS1
|
[NCBI]
|
3.49287e-05
|
|
|
FHL2
|
[NCBI]
|
3.49287e-05
|
|
|
weill-marchesani syndrome, autosomal recessive
|
[NCBI]
|
3.49287e-05
|
|
|
agammaglobulinemia, non-bruton type, autosomal recessive
|
[NCBI]
|
3.49287e-05
|
|
|
atrial septal defect with atrioventricular conduction defects
|
[NCBI]
|
3.49287e-05
|
|
|
deafness, congenital, with keratopachydermia and constrictions of fingers and toes
|
[NCBI]
|
3.49287e-05
|
|
|
HPRT1
|
[NCBI]
|
3.47585e-05
|
|
|
FGF7
|
[NCBI]
|
3.47474e-05
|
|
|
XDH
|
[NCBI]
|
3.47453e-05
|
|
|
MYO7A
|
[NCBI]
|
3.43228e-05
|
|
|
GATA1
|
[NCBI]
|
3.43228e-05
|
|
|
GTS
|
[NCBI]
|
3.42142e-05
|
|
|
MYH7
|
[NCBI]
|
3.39803e-05
|
|
|
TFPI
|
[NCBI]
|
3.3889e-05
|
|
|
PEPC
|
[NCBI]
|
3.37506e-05
|
|
|
KERA
|
[NCBI]
|
3.37506e-05
|
|
|
COL5A2
|
[NCBI]
|
3.37506e-05
|
|
|
CSN2
|
[NCBI]
|
3.37506e-05
|
|
|
NID
|
[NCBI]
|
3.37506e-05
|
|
|
SLC26A4
|
[NCBI]
|
3.36061e-05
|
|
|
tibial muscular dystrophy, tardive
|
[NCBI]
|
3.34644e-05
|
|
|
heterotopia, periventricular, x-linked dominant
|
[NCBI]
|
3.34644e-05
|
|
|
vitamin d-dependent rickets, type i
|
[NCBI]
|
3.34644e-05
|
|
|
BHC
|
[NCBI]
|
3.34644e-05
|
|
|
MCPH1
|
[NCBI]
|
3.34644e-05
|
|
|
lymphedema-distichiasis syndrome
|
[NCBI]
|
3.34644e-05
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 1
|
[NCBI]
|
3.34644e-05
|
|
|
JH
|
[NCBI]
|
3.34644e-05
|
|
|
OPTN
|
[NCBI]
|
3.2912e-05
|
|
|
HSPA1A
|
[NCBI]
|
3.28351e-05
|
|
|
WFS1
|
[NCBI]
|
3.28351e-05
|
|
|
CA1
|
[NCBI]
|
3.28351e-05
|
|
|
GJB3
|
[NCBI]
|
3.28351e-05
|
|
|
LPL
|
[NCBI]
|
3.2367e-05
|
|
|
CDLS1
|
[NCBI]
|
3.2329e-05
|
|
|
RHCE
|
[NCBI]
|
3.2239e-05
|
|
|
transcobalamin ii deficiency
|
[NCBI]
|
3.2239e-05
|
|
|
JARID1C
|
[NCBI]
|
3.20617e-05
|
|
|
UBQLN1
|
[NCBI]
|
3.20617e-05
|
|
|
RAB7
|
[NCBI]
|
3.20617e-05
|
|
|
IRF5
|
[NCBI]
|
3.20617e-05
|
|
|
SOST
|
[NCBI]
|
3.20617e-05
|
|
|
HEMB
|
[NCBI]
|
3.2036e-05
|
|
|
COL4A1
|
[NCBI]
|
3.18856e-05
|
|
|
EDA
|
[NCBI]
|
3.18856e-05
|
|
|
MSX1
|
[NCBI]
|
3.18856e-05
|
|
|
GPI
|
[NCBI]
|
3.17354e-05
|
|
|
fucosidosis
|
[NCBI]
|
3.15862e-05
|
|
|
DES
|
[NCBI]
|
3.15862e-05
|
|
|
BWS
|
[NCBI]
|
3.15549e-05
|
|
|
MUC1
|
[NCBI]
|
3.15246e-05
|
|
|
WT1
|
[NCBI]
|
3.15222e-05
|
|
|
PCTT
|
[NCBI]
|
3.12687e-05
|
|
|
OCA2
|
[NCBI]
|
3.12687e-05
|
|
|
FCAS
|
[NCBI]
|
3.12687e-05
|
|
|
MYP2
|
[NCBI]
|
3.12626e-05
|
|
|
NONO
|
[NCBI]
|
3.11981e-05
|
|
|
TRSP
|
[NCBI]
|
3.11981e-05
|
|
|
GZMH
|
[NCBI]
|
3.11981e-05
|
|
|
PRPF8
|
[NCBI]
|
3.11981e-05
|
|
|
PRB4
|
[NCBI]
|
3.11981e-05
|
|
|
LY9
|
[NCBI]
|
3.11981e-05
|
|
|
PSME2
|
[NCBI]
|
3.11981e-05
|
|
|
SPANXB1
|
[NCBI]
|
3.11981e-05
|
|
|
SLC34A3
|
[NCBI]
|
3.11981e-05
|
|
|
TAL2
|
[NCBI]
|
3.11981e-05
|
|
|
PLEKHA1
|
[NCBI]
|
3.11981e-05
|
|
|
EFHC1
|
[NCBI]
|
3.11981e-05
|
|
|
KRT13
|
[NCBI]
|
3.11981e-05
|
|
|
SNX15
|
[NCBI]
|
3.11981e-05
|
|
|
MEP1A
|
[NCBI]
|
3.11981e-05
|
|
|
CHRM2
|
[NCBI]
|
3.11981e-05
|
|
|
BBS
|
[NCBI]
|
3.11512e-05
|
|
|
POMC
|
[NCBI]
|
3.10873e-05
|
|
|
MIP
|
[NCBI]
|
3.09814e-05
|
|
|
MATN3
|
[NCBI]
|
3.05389e-05
|
|
|
IDH1
|
[NCBI]
|
3.05389e-05
|
|
|
F13B
|
[NCBI]
|
3.05389e-05
|
|
|
TNP2
|
[NCBI]
|
3.05389e-05
|
|
|
PKM2
|
[NCBI]
|
3.05389e-05
|
|
|
ART4
|
[NCBI]
|
3.05389e-05
|
|
|
APOC1
|
[NCBI]
|
3.05389e-05
|
|
|
ADD1
|
[NCBI]
|
3.05389e-05
|
|
|
ITGB3
|
[NCBI]
|
3.04026e-05
|
|
|
CMDD
|
[NCBI]
|
3.03959e-05
|
|
|
PFM
|
[NCBI]
|
3.03959e-05
|
|
|
PFIC1
|
[NCBI]
|
3.03959e-05
|
|
|
infantile sialic acid storage disorder
|
[NCBI]
|
3.03959e-05
|
|
|
PPAC
|
[NCBI]
|
3.03959e-05
|
|
|
HLA-DRA
|
[NCBI]
|
3.03372e-05
|
|
|
ASS
|
[NCBI]
|
3.01816e-05
|
|
|
RBP3
|
[NCBI]
|
3.01188e-05
|
|
|
CHED2
|
[NCBI]
|
2.99452e-05
|
|
|
takayasu arteritis
|
[NCBI]
|
2.99452e-05
|
|
|
vitiligo
|
[NCBI]
|
2.99452e-05
|
|
|
CMT4B1
|
[NCBI]
|
2.99452e-05
|
|
|
MFS2
|
[NCBI]
|
2.99452e-05
|
|
|
IBM3
|
[NCBI]
|
2.99452e-05
|
|
|
ODG2
|
[NCBI]
|
2.99452e-05
|
|
|
hypertriglyceridemia, familial
|
[NCBI]
|
2.99452e-05
|
|
|
EPPK
|
[NCBI]
|
2.99452e-05
|
|
|
NPHP2
|
[NCBI]
|
2.99452e-05
|
|
|
PHA2
|
[NCBI]
|
2.99452e-05
|
|
|
JBTS3
|
[NCBI]
|
2.99452e-05
|
|
|
GS1
|
[NCBI]
|
2.99452e-05
|
|
|
proteinuria, low molecular weight, with hypercalciuria and nephrocalcinosis
|
[NCBI]
|
2.99452e-05
|
|
|
HYR
|
[NCBI]
|
2.99452e-05
|
|
|
AIH2
|
[NCBI]
|
2.99452e-05
|
|
|
RP10
|
[NCBI]
|
2.99452e-05
|
|
|
congenital hemidysplasia with ichthyosiform erythroderma and limb defects
|
[NCBI]
|
2.99452e-05
|
|
|
PARK4
|
[NCBI]
|
2.99452e-05
|
|
|
DFNB3
|
[NCBI]
|
2.99452e-05
|
|
|
filaminopathy, autosomal dominant
|
[NCBI]
|
2.97753e-05
|
|
|
leg ulcers, familial, of juvenile onset
|
[NCBI]
|
2.97753e-05
|
|
|
CDD
|
[NCBI]
|
2.97753e-05
|
|
|
immunoglobulin switch sequences
|
[NCBI]
|
2.97753e-05
|
|
|
alopecia-contractures-dwarfism mental retardation syndrome
|
[NCBI]
|
2.97753e-05
|
|
|
scapuloperoneal myopathy, x-linked dominant
|
[NCBI]
|
2.97753e-05
|
|
|
testicular torsion
|
[NCBI]
|
2.97753e-05
|
|
|
aortic aneurysm, familial thoracic 3
|
[NCBI]
|
2.97753e-05
|
|
|
velofacioskeletal syndrome
|
[NCBI]
|
2.97753e-05
|
|
|
S PEAK SYNDROME
|
[NCBI]
|
2.97753e-05
|
|
|
malignant hyperthermia, susceptibility to, 5
|
[NCBI]
|
2.97753e-05
|
|
|
obesity, susceptibility to, x-linked
|
[NCBI]
|
2.97753e-05
|
|
|
LCCS2
|
[NCBI]
|
2.97753e-05
|
|
|
urticaria, familial localized heat
|
[NCBI]
|
2.97753e-05
|
|
|
epiphyseal dysplasia, multiple, with myopia and conductive deafness
|
[NCBI]
|
2.97753e-05
|
|
|
myocardial infarction, susceptibility to, 1
|
[NCBI]
|
2.97753e-05
|
|
|
peeling skin syndrome, acral type
|
[NCBI]
|
2.97753e-05
|
|
|
RP31
|
[NCBI]
|
2.97753e-05
|
|
|
microphthalmia, isolated, with cataract 4
|
[NCBI]
|
2.97753e-05
|
|
|
IS3
|
[NCBI]
|
2.97753e-05
|
|
|
MRXS14
|
[NCBI]
|
2.97753e-05
|
|
|
CLSD
|
[NCBI]
|
2.97753e-05
|
|
|
buerger disease
|
[NCBI]
|
2.97753e-05
|
|
|
glutamyl ribose-5-phosphate storage disease
|
[NCBI]
|
2.97753e-05
|
|
|
CMH10
|
[NCBI]
|
2.97753e-05
|
|
|
MCOPS5
|
[NCBI]
|
2.97753e-05
|
|
|
PROA
|
[NCBI]
|
2.97753e-05
|
|
|
MRX45
|
[NCBI]
|
2.97753e-05
|
|
|
holoprosencephaly with fetal akinesia/hypokinesia sequence
|
[NCBI]
|
2.97753e-05
|
|
|
mental retardation, x-linked, with brachydactyly and macroglossia
|
[NCBI]
|
2.97753e-05
|
|
|
muscular dystrophy, scapulohumeral
|
[NCBI]
|
2.97753e-05
|
|
|
MRX93
|
[NCBI]
|
2.97753e-05
|
|
|
radial-renal syndrome
|
[NCBI]
|
2.97753e-05
|
|
|
DFNB28
|
[NCBI]
|
2.97753e-05
|
|
|
neuronal intestinal dysplasia, type b
|
[NCBI]
|
2.97753e-05
|
|
|
LOCS
|
[NCBI]
|
2.97753e-05
|
|
|
AGS2
|
[NCBI]
|
2.97753e-05
|
|
|
acrofacial dysostosis, catania type
|
[NCBI]
|
2.97753e-05
|
|
|
WD
|
[NCBI]
|
2.97753e-05
|
|
|
retinopathy, pigmentary, and mental retardation
|
[NCBI]
|
2.97753e-05
|
|
|
SAL-I
|
[NCBI]
|
2.97753e-05
|
|
|
radiation sensitivity of natural killer activity
|
[NCBI]
|
2.97753e-05
|
|
|
dermal ridges, nelson syndrome
|
[NCBI]
|
2.97753e-05
|
|
|
OASD
|
[NCBI]
|
2.97753e-05
|
|
|
cerebellotrigeminal dermal dysplasia
|
[NCBI]
|
2.97753e-05
|
|
|
ichthyosis hystrix gravior
|
[NCBI]
|
2.97753e-05
|
|
|
epilepsy, myoclonic, x-linked, with mental retardation and spasticity
|
[NCBI]
|
2.97753e-05
|
|
|
heterotopia, periventricular, autosomal recessive
|
[NCBI]
|
2.97753e-05
|
|
|
ear pits, posterior helical
|
[NCBI]
|
2.97753e-05
|
|
|
brain small vessel disease with hemorrhage
|
[NCBI]
|
2.97753e-05
|
|
|
cataract, nonnuclear polymorphic congenital, autosomal dominant
|
[NCBI]
|
2.97753e-05
|
|
|
bothnia retinal dystrophy
|
[NCBI]
|
2.97753e-05
|
|
|
DSMA4
|
[NCBI]
|
2.97753e-05
|
|
|
mental retardation, x-linked, with short stature, small testes, muscle wasting, and tremor
|
[NCBI]
|
2.97753e-05
|
|
|
tyrosine aminotransferase, regulator of
|
[NCBI]
|
2.97753e-05
|
|
|
bruck syndrome 2
|
[NCBI]
|
2.97753e-05
|
|
|
MCOP3
|
[NCBI]
|
2.97753e-05
|
|
|
LGMD2G
|
[NCBI]
|
2.97753e-05
|
|
|
ataxia-deafness-retardation syndrome
|
[NCBI]
|
2.97753e-05
|
|
|
HMPS2
|
[NCBI]
|
2.97753e-05
|
|
|
paine syndrome
|
[NCBI]
|
2.97753e-05
|
|
|
cataract, crystalline aculeiform
|
[NCBI]
|
2.97753e-05
|
|
|
SPG5B
|
[NCBI]
|
2.97753e-05
|
|
|
angioma serpiginosum, autosomal dominant
|
[NCBI]
|
2.97753e-05
|
|
|
stocco dos santos x-linked mental retardation syndrome
|
[NCBI]
|
2.97753e-05
|
|
|
DHS
|
[NCBI]
|
2.97753e-05
|
|
|
FIM1
|
[NCBI]
|
2.97753e-05
|
|
|
uric acid nephrolithiasis, susceptibility to
|
[NCBI]
|
2.97753e-05
|
|
|
NEPPK
|
[NCBI]
|
2.97753e-05
|
|
|
body length, mouse, human homolog
|
[NCBI]
|
2.97753e-05
|
|
|
laryngeal web, familial
|
[NCBI]
|
2.97753e-05
|
|
|
PPCD2
|
[NCBI]
|
2.97753e-05
|
|
|
CCA3
|
[NCBI]
|
2.97753e-05
|
|
|
MRXS10
|
[NCBI]
|
2.97753e-05
|
|
|
prader-willi habitus, osteopenia, and camptodactyly
|
[NCBI]
|
2.97753e-05
|
|
|
HMN7B
|
[NCBI]
|
2.97753e-05
|
|
|
IL2
|
[NCBI]
|
2.97229e-05
|
|
|
HGPS
|
[NCBI]
|
2.96249e-05
|
|
|
WFS1
|
[NCBI]
|
2.94698e-05
|
|
|
IGAN1
|
[NCBI]
|
2.92566e-05
|
|
|
abdominal obesity-metabolic syndrome
|
[NCBI]
|
2.92566e-05
|
|
|
CDAN2
|
[NCBI]
|
2.92566e-05
|
|
|
ENG
|
[NCBI]
|
2.91576e-05
|
|
|
TPM1
|
[NCBI]
|
2.9154e-05
|
|
|
PEPA
|
[NCBI]
|
2.9154e-05
|
|
|
SFTPA1
|
[NCBI]
|
2.9154e-05
|
|
|
KRT9
|
[NCBI]
|
2.9154e-05
|
|
|
APS1
|
[NCBI]
|
2.91316e-05
|
|
|
ZS
|
[NCBI]
|
2.91316e-05
|
|
|
diabetes insipidus, nephrogenic, x-linked
|
[NCBI]
|
2.89541e-05
|
|
|
LCA1
|
[NCBI]
|
2.89541e-05
|
|
|
TNNT2
|
[NCBI]
|
2.85058e-05
|
|
|
contractural arachnodactyly, congenital
|
[NCBI]
|
2.85058e-05
|
|
|
GPT
|
[NCBI]
|
2.81436e-05
|
|
|
FUT1
|
[NCBI]
|
2.78853e-05
|
|
|
EFNB1
|
[NCBI]
|
2.78853e-05
|
|
|
AHCY
|
[NCBI]
|
2.78853e-05
|
|
|
TECTA
|
[NCBI]
|
2.78853e-05
|
|
|
DNAH11
|
[NCBI]
|
2.78853e-05
|
|
|
CES
|
[NCBI]
|
2.77984e-05
|
|
|
MAGEB1
|
[NCBI]
|
2.77843e-05
|
|
|
homeobox protein, pepp subfamily, 2
|
[NCBI]
|
2.77843e-05
|
|
|
NYX
|
[NCBI]
|
2.77843e-05
|
|
|
ZNF33A
|
[NCBI]
|
2.77843e-05
|
|
|
SLC25A12
|
[NCBI]
|
2.77843e-05
|
|
|
minor histocompatibility antigen ha-1
|
[NCBI]
|
2.77843e-05
|
|
|
UBE2A
|
[NCBI]
|
2.77843e-05
|
|
|
PPAT
|
[NCBI]
|
2.77843e-05
|
|
|
PRKAR1B
|
[NCBI]
|
2.77843e-05
|
|
|
BFSP1
|
[NCBI]
|
2.77843e-05
|
|
|
EPRS
|
[NCBI]
|
2.77843e-05
|
|
|
LAP3
|
[NCBI]
|
2.77843e-05
|
|
|
KNSL2
|
[NCBI]
|
2.77843e-05
|
|
|
FABP2
|
[NCBI]
|
2.77499e-05
|
|
|
KRT14
|
[NCBI]
|
2.77499e-05
|
|
|
HLA-DQA1
|
[NCBI]
|
2.77499e-05
|
|
|
refsum disease
|
[NCBI]
|
2.7617e-05
|
|
|
DHRD
|
[NCBI]
|
2.7617e-05
|
|
|
blood group, p system
|
[NCBI]
|
2.7617e-05
|
|
|
hydatidiform mole
|
[NCBI]
|
2.7617e-05
|
|
|
SPCH1
|
[NCBI]
|
2.7617e-05
|
|
|
EEC3
|
[NCBI]
|
2.7617e-05
|
|
|
ICP
|
[NCBI]
|
2.7617e-05
|
|
|
thyroid hormonogenesis, genetic defect in, 2a
|
[NCBI]
|
2.7617e-05
|
|
|
EDC
|
[NCBI]
|
2.7617e-05
|
|
|
HBFQTL1
|
[NCBI]
|
2.69183e-05
|
|
|
PCD
|
[NCBI]
|
2.67595e-05
|
|
|
LOR
|
[NCBI]
|
2.6716e-05
|
|
|
ATM
|
[NCBI]
|
2.66019e-05
|
|
|
RB1
|
[NCBI]
|
2.65505e-05
|
|
|
APP
|
[NCBI]
|
2.65009e-05
|
|
|
GPC3
|
[NCBI]
|
2.63276e-05
|
|
|
JBTS1
|
[NCBI]
|
2.5881e-05
|
|
|
PARK3
|
[NCBI]
|
2.58515e-05
|
|
|
microcephalic osteodysplastic primordial dwarfism, type i
|
[NCBI]
|
2.58515e-05
|
|
|
NIDDM
|
[NCBI]
|
2.58192e-05
|
|
|
PLSJ
|
[NCBI]
|
2.58056e-05
|
|
|
HFE3
|
[NCBI]
|
2.58056e-05
|
|
|
CMT4B2
|
[NCBI]
|
2.58056e-05
|
|
|
renal cell carcinoma, papillary
|
[NCBI]
|
2.58056e-05
|
|
|
dyskeratosis congenita, autosomal dominant
|
[NCBI]
|
2.58056e-05
|
|
|
reifenstein syndrome
|
[NCBI]
|
2.58056e-05
|
|
|
HHF6
|
[NCBI]
|
2.58056e-05
|
|
|
GS2
|
[NCBI]
|
2.58056e-05
|
|
|
EDM4
|
[NCBI]
|
2.58056e-05
|
|
|
DMC
|
[NCBI]
|
2.58056e-05
|
|
|
NIDDM1
|
[NCBI]
|
2.58056e-05
|
|
|
SPG10
|
[NCBI]
|
2.58056e-05
|
|
|
elliptocytosis, rhesus-unlinked type
|
[NCBI]
|
2.58056e-05
|
|
|
tobacco addiction, susceptibility to
|
[NCBI]
|
2.58056e-05
|
|
|
MODY2
|
[NCBI]
|
2.58056e-05
|
|
|
CGF1
|
[NCBI]
|
2.56899e-05
|
|
|
ADFN
|
[NCBI]
|
2.56899e-05
|
|
|
hypertension with brachydactyly
|
[NCBI]
|
2.56899e-05
|
|
|
FTL
|
[NCBI]
|
2.56572e-05
|
|
|
GLI3
|
[NCBI]
|
2.56572e-05
|
|
|
AMY2A
|
[NCBI]
|
2.56328e-05
|
|
|
ELAC2
|
[NCBI]
|
2.56328e-05
|
|
|
FLG
|
[NCBI]
|
2.56328e-05
|
|
|
HLA-DPA1
|
[NCBI]
|
2.56328e-05
|
|
|
LYST
|
[NCBI]
|
2.56328e-05
|
|
|
SGCA
|
[NCBI]
|
2.56328e-05
|
|
|
HS
|
[NCBI]
|
2.54922e-05
|
|
|
CDC2L2
|
[NCBI]
|
2.51943e-05
|
|
|
HSN2
|
[NCBI]
|
2.51943e-05
|
|
|
MYL3
|
[NCBI]
|
2.51943e-05
|
|
|
SLC4A3
|
[NCBI]
|
2.51943e-05
|
|
|
PLA2G1B
|
[NCBI]
|
2.51943e-05
|
|
|
NIPA1
|
[NCBI]
|
2.51943e-05
|
|
|
ABCG1
|
[NCBI]
|
2.51943e-05
|
|
|
TEAD1
|
[NCBI]
|
2.51943e-05
|
|
|
NLGN4
|
[NCBI]
|
2.51943e-05
|
|
|
FTSJ1
|
[NCBI]
|
2.51943e-05
|
|
|
PSME1
|
[NCBI]
|
2.51943e-05
|
|
|
3-@beta-hydroxysteroid dehydrogenase/delta-isomerase, type i
|
[NCBI]
|
2.51943e-05
|
|
|
ARL6
|
[NCBI]
|
2.51943e-05
|
|
|
SEC23A
|
[NCBI]
|
2.51943e-05
|
|
|
SLC7A1
|
[NCBI]
|
2.51943e-05
|
|
|
ATP1B1
|
[NCBI]
|
2.51943e-05
|
|
|
FCGR1A
|
[NCBI]
|
2.51943e-05
|
|
|
CSN10
|
[NCBI]
|
2.51943e-05
|
|
|
ovary-, testis-, and epididymis-expressed gene
|
[NCBI]
|
2.51943e-05
|
|
|
MTMR1
|
[NCBI]
|
2.51943e-05
|
|
|
HSPA1L
|
[NCBI]
|
2.51943e-05
|
|
|
CRYBB3
|
[NCBI]
|
2.51943e-05
|
|
|
MIC2Y
|
[NCBI]
|
2.51943e-05
|
|
|
g72 gene
|
[NCBI]
|
2.51943e-05
|
|
|
ANKK1
|
[NCBI]
|
2.51943e-05
|
|
|
OFD1
|
[NCBI]
|
2.50912e-05
|
|
|
camurati-engelmann disease
|
[NCBI]
|
2.50912e-05
|
|
|
EAOH
|
[NCBI]
|
2.50912e-05
|
|
|
MAG
|
[NCBI]
|
2.50876e-05
|
|
|
von willebrand disease
|
[NCBI]
|
2.46576e-05
|
|
|
KEL
|
[NCBI]
|
2.46247e-05
|
|
|
IL7R
|
[NCBI]
|
2.46247e-05
|
|
|
RPS14
|
[NCBI]
|
2.46247e-05
|
|
|
COL11A1
|
[NCBI]
|
2.46247e-05
|
|
|
CYP11A1
|
[NCBI]
|
2.46247e-05
|
|
|
HHF1
|
[NCBI]
|
2.4592e-05
|
|
|
HMI
|
[NCBI]
|
2.43896e-05
|
|
|
SOD2
|
[NCBI]
|
2.39462e-05
|
|
|
GJB2
|
[NCBI]
|
2.38861e-05
|
|
|
GSN
|
[NCBI]
|
2.37894e-05
|
|
|
IKBKG
|
[NCBI]
|
2.37894e-05
|
|
|
CYP4F22
|
[NCBI]
|
2.37349e-05
|
|
|
GABRR1
|
[NCBI]
|
2.37349e-05
|
|
|
RNF17
|
[NCBI]
|
2.37349e-05
|
|
|
ZNF109
|
[NCBI]
|
2.37349e-05
|
|
|
FTHL17
|
[NCBI]
|
2.37349e-05
|
|
|
RBP2
|
[NCBI]
|
2.37349e-05
|
|
|
ZNF122
|
[NCBI]
|
2.37349e-05
|
|
|
TAF7L
|
[NCBI]
|
2.37349e-05
|
|
|
HSPB2
|
[NCBI]
|
2.37349e-05
|
|
|
TEX13A
|
[NCBI]
|
2.37349e-05
|
|
|
TCP11
|
[NCBI]
|
2.37349e-05
|
|
|
ZNF110
|
[NCBI]
|
2.37349e-05
|
|
|
ZNF102
|
[NCBI]
|
2.37349e-05
|
|
|
ZFP3
|
[NCBI]
|
2.37349e-05
|
|
|
ARSC2
|
[NCBI]
|
2.37349e-05
|
|
|
INE1
|
[NCBI]
|
2.37349e-05
|
|
|
ZNF100
|
[NCBI]
|
2.37349e-05
|
|
|
TARS
|
[NCBI]
|
2.37349e-05
|
|
|
ZNF112
|
[NCBI]
|
2.37349e-05
|
|
|
COL5A3
|
[NCBI]
|
2.37349e-05
|
|
|
IL3RA
|
[NCBI]
|
2.37349e-05
|
|
|
MS4A4E
|
[NCBI]
|
2.37349e-05
|
|
|
TEX13B
|
[NCBI]
|
2.37349e-05
|
|
|
TEX11
|
[NCBI]
|
2.37349e-05
|
|
|
ZNF103
|
[NCBI]
|
2.37349e-05
|
|
|
ESAT
|
[NCBI]
|
2.37349e-05
|
|
|
mental retardation, x-linked, south african type
|
[NCBI]
|
2.37349e-05
|
|
|
ZNF111
|
[NCBI]
|
2.37349e-05
|
|
|
RPL36AL
|
[NCBI]
|
2.37349e-05
|
|
|
immunoglobulin: d (diversity) region of heavy chain
|
[NCBI]
|
2.37349e-05
|
|
|
FRMD7
|
[NCBI]
|
2.37349e-05
|
|
|
RPS20A
|
[NCBI]
|
2.37349e-05
|
|
|
TEX12
|
[NCBI]
|
2.37349e-05
|
|
|
BAT4
|
[NCBI]
|
2.37349e-05
|
|
|
thrombocytosis, familial x-linked
|
[NCBI]
|
2.37349e-05
|
|
|
ZNF119
|
[NCBI]
|
2.37349e-05
|
|
|
GRHL2
|
[NCBI]
|
2.37349e-05
|
|
|
mental retardation, x-linked, with short stature
|
[NCBI]
|
2.37349e-05
|
|
|
heterogeneous nuclear ribonucleoprotein g-t
|
[NCBI]
|
2.37349e-05
|
|
|
EML1
|
[NCBI]
|
2.37349e-05
|
|
|
twirler mutation, murine, human homolog of
|
[NCBI]
|
2.37349e-05
|
|
|
KLHL4
|
[NCBI]
|
2.37349e-05
|
|
|
ZNF120
|
[NCBI]
|
2.37349e-05
|
|
|
CRYGB
|
[NCBI]
|
2.37349e-05
|
|
|
REL
|
[NCBI]
|
2.37349e-05
|
|
|
GAGEC1
|
[NCBI]
|
2.37349e-05
|
|
|
ZNF101
|
[NCBI]
|
2.37349e-05
|
|
|
TCTE1
|
[NCBI]
|
2.37349e-05
|
|
|
ZNF108
|
[NCBI]
|
2.37349e-05
|
|
|
ZNF98
|
[NCBI]
|
2.37349e-05
|
|
|
GJB5
|
[NCBI]
|
2.37349e-05
|
|
|
BAT5
|
[NCBI]
|
2.37349e-05
|
|
|
MS4A10
|
[NCBI]
|
2.37349e-05
|
|
|
ZNF114
|
[NCBI]
|
2.37349e-05
|
|
|
GABRR2
|
[NCBI]
|
2.37349e-05
|
|
|
DPEP2
|
[NCBI]
|
2.37349e-05
|
|
|
KLC3
|
[NCBI]
|
2.37349e-05
|
|
|
asthma-associated alternatively spliced gene 1
|
[NCBI]
|
2.37349e-05
|
|
|
STK31
|
[NCBI]
|
2.37349e-05
|
|
|
PSMB2
|
[NCBI]
|
2.37349e-05
|
|
|
ACTN1
|
[NCBI]
|
2.37349e-05
|
|
|
ZNF106
|
[NCBI]
|
2.37349e-05
|
|
|
ZNF99
|
[NCBI]
|
2.37349e-05
|
|
|
ZNF97
|
[NCBI]
|
2.37349e-05
|
|
|
MS4A6E
|
[NCBI]
|
2.37349e-05
|
|
|
ZNF118
|
[NCBI]
|
2.37349e-05
|
|
|
UBE2G1
|
[NCBI]
|
2.37349e-05
|
|
|
GTF2E2
|
[NCBI]
|
2.37349e-05
|
|
|
DPEP3
|
[NCBI]
|
2.37349e-05
|
|
|
RPS20B
|
[NCBI]
|
2.37349e-05
|
|
|
MPZL3
|
[NCBI]
|
2.37349e-05
|
|
|
EVX1
|
[NCBI]
|
2.37349e-05
|
|
|
ZNF25
|
[NCBI]
|
2.37349e-05
|
|
|
IGKDEL
|
[NCBI]
|
2.37349e-05
|
|
|
ZNF94
|
[NCBI]
|
2.37349e-05
|
|
|
INE2
|
[NCBI]
|
2.37349e-05
|
|
|
fetal and adult testis-expressed gene
|
[NCBI]
|
2.37349e-05
|
|
|
PPKB
|
[NCBI]
|
2.37349e-05
|
|
|
PSMB3
|
[NCBI]
|
2.37349e-05
|
|
|
NDRG3
|
[NCBI]
|
2.37349e-05
|
|
|
IGAT
|
[NCBI]
|
2.37349e-05
|
|
|
PSMB4
|
[NCBI]
|
2.37349e-05
|
|
|
ZNF113
|
[NCBI]
|
2.37349e-05
|
|
|
radial ray deficiency, x-linked
|
[NCBI]
|
2.37349e-05
|
|
|
BMND8
|
[NCBI]
|
2.37349e-05
|
|
|
TEX15
|
[NCBI]
|
2.37349e-05
|
|
|
IPHEG
|
[NCBI]
|
2.37349e-05
|
|
|
GOLGA6
|
[NCBI]
|
2.37349e-05
|
|
|
ZNF95
|
[NCBI]
|
2.37349e-05
|
|
|
ATP11C
|
[NCBI]
|
2.37349e-05
|
|
|
hairy palms and soles
|
[NCBI]
|
2.37349e-05
|
|
|
ZNF105
|
[NCBI]
|
2.37349e-05
|
|
|
mov10-like 1
|
[NCBI]
|
2.37349e-05
|
|
|
HNRPA3
|
[NCBI]
|
2.37349e-05
|
|
|
hypertelorism with esophageal abnormality and hypospadias
|
[NCBI]
|
2.3723e-05
|
|
|
EXT2
|
[NCBI]
|
2.36829e-05
|
|
|
ACY1
|
[NCBI]
|
2.36829e-05
|
|
|
TSHB
|
[NCBI]
|
2.36829e-05
|
|
|
SPG7
|
[NCBI]
|
2.36829e-05
|
|
|
KIT
|
[NCBI]
|
2.36672e-05
|
|
|
TTR
|
[NCBI]
|
2.3563e-05
|
|
|
ornithine transcarbamylase deficiency, hyperammonemia due to
|
[NCBI]
|
2.35037e-05
|
|
|
OSM
|
[NCBI]
|
2.34642e-05
|
|
|
pyruvate decarboxylase deficiency
|
[NCBI]
|
2.32244e-05
|
|
|
STGD1
|
[NCBI]
|
2.32244e-05
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type i
|
[NCBI]
|
2.32244e-05
|
|
|
IGKC
|
[NCBI]
|
2.32099e-05
|
|
|
CTNNA2
|
[NCBI]
|
2.31112e-05
|
|
|
NSDHL
|
[NCBI]
|
2.31112e-05
|
|
|
CRYM
|
[NCBI]
|
2.31112e-05
|
|
|
ISGF3G
|
[NCBI]
|
2.31112e-05
|
|
|
HSF4
|
[NCBI]
|
2.31112e-05
|
|
|
GLP1R
|
[NCBI]
|
2.31112e-05
|
|
|
COL4A2
|
[NCBI]
|
2.31112e-05
|
|
|
IL1R1
|
[NCBI]
|
2.31112e-05
|
|
|
TPM2
|
[NCBI]
|
2.31112e-05
|
|
|
CTRB1
|
[NCBI]
|
2.31112e-05
|
|
|
SLURP1
|
[NCBI]
|
2.31112e-05
|
|
|
WHRN
|
[NCBI]
|
2.31112e-05
|
|
|
TBX22
|
[NCBI]
|
2.31112e-05
|
|
|
XPNPEP2
|
[NCBI]
|
2.31112e-05
|
|
|
KLRA1
|
[NCBI]
|
2.31112e-05
|
|
|
restless legs syndrome, susceptibility to, 1
|
[NCBI]
|
2.31078e-05
|
|
|
BRCA2
|
[NCBI]
|
2.28607e-05
|
|
|
PCDH15
|
[NCBI]
|
2.27999e-05
|
|
|
ADRB3
|
[NCBI]
|
2.27999e-05
|
|
|
PCLD
|
[NCBI]
|
2.27885e-05
|
|
|
HIDS
|
[NCBI]
|
2.27885e-05
|
|
|
GEFS+
|
[NCBI]
|
2.27885e-05
|
|
|
HNA
|
[NCBI]
|
2.27885e-05
|
|
|
CHS
|
[NCBI]
|
2.26891e-05
|
|
|
PF4
|
[NCBI]
|
2.26887e-05
|
|
|
phenylketonuria
|
[NCBI]
|
2.26397e-05
|
|
|
APOB
|
[NCBI]
|
2.24981e-05
|
|
|
hurler syndrome
|
[NCBI]
|
2.2462e-05
|
|
|
CDB1
|
[NCBI]
|
2.23072e-05
|
|
|
renal tubular acidosis, distal, autosomal dominant
|
[NCBI]
|
2.23072e-05
|
|
|
BRIC1
|
[NCBI]
|
2.23072e-05
|
|
|
spondyloepimetaphyseal dysplasia, strudwick type
|
[NCBI]
|
2.23072e-05
|
|
|
PBT
|
[NCBI]
|
2.23072e-05
|
|
|
renal tubular acidosis, distal, with progressive nerve deafness
|
[NCBI]
|
2.23072e-05
|
|
|
HFE4
|
[NCBI]
|
2.23072e-05
|
|
|
epstein syndrome
|
[NCBI]
|
2.23072e-05
|
|
|
CLN8
|
[NCBI]
|
2.23072e-05
|
|
|
DFNB9
|
[NCBI]
|
2.23072e-05
|
|
|
stuve-wiedemann syndrome
|
[NCBI]
|
2.23072e-05
|
|
|
keratolytic winter erythema
|
[NCBI]
|
2.22793e-05
|
|
|
cholesterol level quantitative trait locus 1
|
[NCBI]
|
2.22793e-05
|
|
|
HBFQTL3
|
[NCBI]
|
2.22793e-05
|
|
|
stature quantitative trait locus 3
|
[NCBI]
|
2.22793e-05
|
|
|
opioid dependence, susceptibility to, 1
|
[NCBI]
|
2.22793e-05
|
|
|
autoimmune thyroid disease, susceptibility to, 1
|
[NCBI]
|
2.22793e-05
|
|
|
migraine with or without aura, susceptibility to, 6
|
[NCBI]
|
2.22793e-05
|
|
|
endometriosis, susceptibility to, 1
|
[NCBI]
|
2.22793e-05
|
|
|
gout susceptibility 1
|
[NCBI]
|
2.22793e-05
|
|
|
SCAR2
|
[NCBI]
|
2.22793e-05
|
|
|
PPPP
|
[NCBI]
|
2.22793e-05
|
|
|
PSNP2
|
[NCBI]
|
2.22793e-05
|
|
|
DYX5
|
[NCBI]
|
2.22793e-05
|
|
|
ALS5
|
[NCBI]
|
2.22793e-05
|
|
|
epilepsy, nocturnal frontal lobe, type 2
|
[NCBI]
|
2.22793e-05
|
|
|
OSCS
|
[NCBI]
|
2.22793e-05
|
|
|
hypobetalipoproteinemia, familial, 2
|
[NCBI]
|
2.22793e-05
|
|
|
dyschromatosis universalis hereditaria
|
[NCBI]
|
2.22793e-05
|
|
|
speech-sound disorder
|
[NCBI]
|
2.22793e-05
|
|
|
autism, susceptibility to, 3
|
[NCBI]
|
2.22793e-05
|
|
|
ARVD4
|
[NCBI]
|
2.22793e-05
|
|
|
MPD2
|
[NCBI]
|
2.22793e-05
|
|
|
ichthyosis follicularis, atrichia, and photophobia syndrome
|
[NCBI]
|
2.22793e-05
|
|
|
sclerotylosis
|
[NCBI]
|
2.22793e-05
|
|
|
charcot-marie-tooth disease, dominant intermediate a
|
[NCBI]
|
2.22793e-05
|
|
|
laryngeal abductor paralysis
|
[NCBI]
|
2.22793e-05
|
|
|
DFNB15
|
[NCBI]
|
2.22793e-05
|
|
|
otitis media, susceptibility to
|
[NCBI]
|
2.22793e-05
|
|
|
FPLD1
|
[NCBI]
|
2.22793e-05
|
|
|
TKCR
|
[NCBI]
|
2.22793e-05
|
|
|
GSM1
|
[NCBI]
|
2.22793e-05
|
|
|
DYX6
|
[NCBI]
|
2.22793e-05
|
|
|
EVR3
|
[NCBI]
|
2.22793e-05
|
|
|
PN
|
[NCBI]
|
2.22793e-05
|
|
|
BRCA3
|
[NCBI]
|
2.22793e-05
|
|
|
LTA
|
[NCBI]
|
2.21083e-05
|
|
|
APOC2
|
[NCBI]
|
2.21083e-05
|
|
|
FN1
|
[NCBI]
|
2.21083e-05
|
|
|
CHRNA4
|
[NCBI]
|
2.19694e-05
|
|
|
TG
|
[NCBI]
|
2.19208e-05
|
|
|
PMP22
|
[NCBI]
|
2.18961e-05
|
|
|
SLC11A1
|
[NCBI]
|
2.16098e-05
|
|
|
PDE6B
|
[NCBI]
|
2.15841e-05
|
|
|
RPS17
|
[NCBI]
|
2.13733e-05
|
|
|
PTGFR
|
[NCBI]
|
2.13733e-05
|
|
|
ACP2
|
[NCBI]
|
2.13733e-05
|
|
|
PSG4
|
[NCBI]
|
2.13733e-05
|
|
|
SLC9A1
|
[NCBI]
|
2.13733e-05
|
|
|
PPP1R2
|
[NCBI]
|
2.13733e-05
|
|
|
PSG9
|
[NCBI]
|
2.13733e-05
|
|
|
CLCN2
|
[NCBI]
|
2.13733e-05
|
|
|
TAPBP
|
[NCBI]
|
2.13733e-05
|
|
|
PSG10
|
[NCBI]
|
2.13733e-05
|
|
|
CNGA3
|
[NCBI]
|
2.13733e-05
|
|
|
GNAT2
|
[NCBI]
|
2.13733e-05
|
|
|
NIPBL
|
[NCBI]
|
2.13733e-05
|
|
|
RNU2
|
[NCBI]
|
2.13733e-05
|
|
|
USH3A
|
[NCBI]
|
2.13733e-05
|
|
|
TMPRSS3
|
[NCBI]
|
2.13733e-05
|
|
|
CLDN14
|
[NCBI]
|
2.13733e-05
|
|
|
COL4A6
|
[NCBI]
|
2.13733e-05
|
|
|
EVPL
|
[NCBI]
|
2.13733e-05
|
|
|
CUL4B
|
[NCBI]
|
2.13733e-05
|
|
|
PSG7
|
[NCBI]
|
2.13733e-05
|
|
|
GPR154
|
[NCBI]
|
2.13733e-05
|
|
|
PSG5
|
[NCBI]
|
2.13733e-05
|
|
|
BCYRN1
|
[NCBI]
|
2.13733e-05
|
|
|
PRPF31
|
[NCBI]
|
2.13733e-05
|
|
|
glycogen storage disease vi
|
[NCBI]
|
2.13733e-05
|
|
|
PSG8
|
[NCBI]
|
2.13733e-05
|
|
|
PSG11
|
[NCBI]
|
2.13733e-05
|
|
|
PSG6
|
[NCBI]
|
2.13733e-05
|
|
|
MAOA
|
[NCBI]
|
2.12423e-05
|
|
|
DCX
|
[NCBI]
|
2.11862e-05
|
|
|
PLOSL
|
[NCBI]
|
2.06839e-05
|
|
|
LIF
|
[NCBI]
|
2.05846e-05
|
|
|
MCPH6
|
[NCBI]
|
2.05355e-05
|
|
|
steatocystoma multiplex
|
[NCBI]
|
2.05355e-05
|
|
|
BDD
|
[NCBI]
|
2.05355e-05
|
|
|
SCA11
|
[NCBI]
|
2.05355e-05
|
|
|
epilepsy, nocturnal frontal lobe, type 3
|
[NCBI]
|
2.05355e-05
|
|
|
CSCI
|
[NCBI]
|
2.05355e-05
|
|
|
slowed nerve conduction velocity, autosomal dominant
|
[NCBI]
|
2.05355e-05
|
|
|
CSNBAD2
|
[NCBI]
|
2.05355e-05
|
|
|
fetal akinesia syndrome, x-linked
|
[NCBI]
|
2.05355e-05
|
|
|
PEOA4
|
[NCBI]
|
2.05355e-05
|
|
|
chromosome xp11.3 deletion syndrome
|
[NCBI]
|
2.05355e-05
|
|
|
ADCAD1
|
[NCBI]
|
2.05355e-05
|
|
|
DFNA36
|
[NCBI]
|
2.05355e-05
|
|
|
retinohepatoendocrinologic syndrome
|
[NCBI]
|
2.05355e-05
|
|
|
glycogen storage disease 0, liver
|
[NCBI]
|
2.05355e-05
|
|
|
osteoarthritis with mild chondrodysplasia
|
[NCBI]
|
2.05355e-05
|
|
|
CMD1J
|
[NCBI]
|
2.05355e-05
|
|
|
CMD1L
|
[NCBI]
|
2.05355e-05
|
|
|
ALS8
|
[NCBI]
|
2.05355e-05
|
|
|
egasyn
|
[NCBI]
|
2.05355e-05
|
|
|
DFNA15
|
[NCBI]
|
2.05355e-05
|
|
|
MCOPCB3
|
[NCBI]
|
2.05355e-05
|
|
|
lathosterolosis
|
[NCBI]
|
2.05355e-05
|
|
|
otofaciocervical syndrome
|
[NCBI]
|
2.05355e-05
|
|
|
bernard-soulier syndrome, benign autosomal dominant
|
[NCBI]
|
2.05355e-05
|
|
|
brunner syndrome
|
[NCBI]
|
2.05355e-05
|
|
|
retinitis pigmentosa, late-adult onset
|
[NCBI]
|
2.05355e-05
|
|
|
CVT
|
[NCBI]
|
2.05355e-05
|
|
|
YT
|
[NCBI]
|
2.05355e-05
|
|
|
siderius x-linked mental retardation syndrome
|
[NCBI]
|
2.05355e-05
|
|
|
HMERF
|
[NCBI]
|
2.05355e-05
|
|
|
SMC
|
[NCBI]
|
2.05355e-05
|
|
|
epidermolysis bullosa with congenital localized absence of skin and deformity of nails
|
[NCBI]
|
2.05355e-05
|
|
|
brugada syndrome 2
|
[NCBI]
|
2.05355e-05
|
|
|
brachydactyly, preaxial, with hallux varus and thumb abduction
|
[NCBI]
|
2.05355e-05
|
|
|
leprosy, susceptibility to, 4
|
[NCBI]
|
2.05355e-05
|
|
|
charcot-marie-tooth disease, axonal, type 2e
|
[NCBI]
|
2.05355e-05
|
|
|
parotid proline-rich salivary protein pc
|
[NCBI]
|
2.05355e-05
|
|
|
haw river syndrome
|
[NCBI]
|
2.05355e-05
|
|
|
DFNB21
|
[NCBI]
|
2.05355e-05
|
|
|
encephalopathy, ethylmalonic
|
[NCBI]
|
2.05355e-05
|
|
|
dyskeratosis congenita, autosomal recessive
|
[NCBI]
|
2.05355e-05
|
|
|
charcot-marie-tooth disease, axonal, type 2i
|
[NCBI]
|
2.05355e-05
|
|
|
spondyloepiphyseal dysplasia, kimberley type
|
[NCBI]
|
2.05355e-05
|
|
|
myotubular myopathy with abnormal genital development
|
[NCBI]
|
2.05355e-05
|
|
|
HOMG4
|
[NCBI]
|
2.05355e-05
|
|
|
urticaria, aquagenic
|
[NCBI]
|
2.05355e-05
|
|
|
glomerulocystic kidney disease with hyperuricemia and isosthenuria
|
[NCBI]
|
2.05355e-05
|
|
|
genitopalatocardiac syndrome
|
[NCBI]
|
2.05355e-05
|
|
|
LBSL
|
[NCBI]
|
2.05355e-05
|
|
|
ARMD10
|
[NCBI]
|
2.05355e-05
|
|
|
epidermolysis bullosa, pretibial
|
[NCBI]
|
2.05355e-05
|
|
|
MODY4
|
[NCBI]
|
2.05355e-05
|
|
|
SRN1
|
[NCBI]
|
2.05355e-05
|
|
|
diabetic nephropathy, susceptibility to
|
[NCBI]
|
2.05355e-05
|
|
|
meniere disease
|
[NCBI]
|
2.05355e-05
|
|
|
ABSD
|
[NCBI]
|
2.05355e-05
|
|
|
FECD1
|
[NCBI]
|
2.05355e-05
|
|
|
catel-manzke syndrome
|
[NCBI]
|
2.05355e-05
|
|
|
tuberous sclerosis 4
|
[NCBI]
|
2.05355e-05
|
|
|
SPS
|
[NCBI]
|
2.05355e-05
|
|
|
EDMD3
|
[NCBI]
|
2.05355e-05
|
|
|
diabetes mellitus, permanent neonatal, with cerebellar agenesis
|
[NCBI]
|
2.05355e-05
|
|
|
roifman syndrome
|
[NCBI]
|
2.05355e-05
|
|
|
FEB3
|
[NCBI]
|
2.05355e-05
|
|
|
majeed syndrome
|
[NCBI]
|
2.05355e-05
|
|
|
CMD3A
|
[NCBI]
|
2.05355e-05
|
|
|
advanced sleep-phase syndrome, familial
|
[NCBI]
|
2.05355e-05
|
|
|
autism, x-linked, susceptibility to, 1
|
[NCBI]
|
2.05355e-05
|
|
|
hydrocephalus due to congenital stenosis of aqueduct of sylvius
|
[NCBI]
|
2.05355e-05
|
|
|
SLEB2
|
[NCBI]
|
2.05355e-05
|
|
|
RP26
|
[NCBI]
|
2.05355e-05
|
|
|
DBH
|
[NCBI]
|
2.04458e-05
|
|
|
MYB
|
[NCBI]
|
2.04458e-05
|
|
|
PDGFRA
|
[NCBI]
|
2.04458e-05
|
|
|
DKC1
|
[NCBI]
|
2.04458e-05
|
|
|
PDGFRB
|
[NCBI]
|
2.04458e-05
|
|
|
CMH
|
[NCBI]
|
2.04086e-05
|
|
|
PEPB
|
[NCBI]
|
1.9886e-05
|
|
|
SACS
|
[NCBI]
|
1.9886e-05
|
|
|
RPL19
|
[NCBI]
|
1.9886e-05
|
|
|
BSCL2
|
[NCBI]
|
1.9886e-05
|
|
|
FRZB
|
[NCBI]
|
1.9886e-05
|
|
|
CCKBR
|
[NCBI]
|
1.9886e-05
|
|
|
TGFB2
|
[NCBI]
|
1.9886e-05
|
|
|
PVALB
|
[NCBI]
|
1.9886e-05
|
|
|
COL9A2
|
[NCBI]
|
1.9886e-05
|
|
|
RCV1
|
[NCBI]
|
1.9886e-05
|
|
|
NRG2
|
[NCBI]
|
1.9886e-05
|
|
|
GNAI1
|
[NCBI]
|
1.9886e-05
|
|
|
HBQ1
|
[NCBI]
|
1.9886e-05
|
|
|
PTF1A
|
[NCBI]
|
1.9886e-05
|
|
|
OPRD1
|
[NCBI]
|
1.9886e-05
|
|
|
CD3D
|
[NCBI]
|
1.9886e-05
|
|
|
FOXP3
|
[NCBI]
|
1.97636e-05
|
|
|
SDHD
|
[NCBI]
|
1.97442e-05
|
|
|
NR3C2
|
[NCBI]
|
1.97442e-05
|
|
|
CYP1B1
|
[NCBI]
|
1.97442e-05
|
|
|
STAR
|
[NCBI]
|
1.96977e-05
|
|
|
DURS1
|
[NCBI]
|
1.93969e-05
|
|
|
ATS
|
[NCBI]
|
1.93129e-05
|
|
|
IRID2
|
[NCBI]
|
1.93129e-05
|
|
|
IRID1
|
[NCBI]
|
1.93129e-05
|
|
|
BDA1
|
[NCBI]
|
1.93129e-05
|
|
|
WS3
|
[NCBI]
|
1.93129e-05
|
|
|
ASMD
|
[NCBI]
|
1.93129e-05
|
|
|
HNPCC2
|
[NCBI]
|
1.93129e-05
|
|
|
cirrhosis, familial
|
[NCBI]
|
1.93129e-05
|
|
|
PHA1
|
[NCBI]
|
1.93129e-05
|
|
|
SCAR1
|
[NCBI]
|
1.93129e-05
|
|
|
BDB1
|
[NCBI]
|
1.93129e-05
|
|
|
OSMED
|
[NCBI]
|
1.93129e-05
|
|
|
SCN4A
|
[NCBI]
|
1.91954e-05
|
|
|
TGFBI
|
[NCBI]
|
1.90781e-05
|
|
|
TK1
|
[NCBI]
|
1.90781e-05
|
|
|
CYP1A1
|
[NCBI]
|
1.90513e-05
|
|
|
antithrombin iii deficiency
|
[NCBI]
|
1.8894e-05
|
|
|
EDMD2
|
[NCBI]
|
1.87563e-05
|
|
|
pfeiffer syndrome
|
[NCBI]
|
1.87563e-05
|
|
|
GLC3A
|
[NCBI]
|
1.87563e-05
|
|
|
CGL2
|
[NCBI]
|
1.87563e-05
|
|
|
UCMD
|
[NCBI]
|
1.87563e-05
|
|
|
LMBR1
|
[NCBI]
|
1.85891e-05
|
|
|
DIO1
|
[NCBI]
|
1.85891e-05
|
|
|
TNNI2
|
[NCBI]
|
1.85891e-05
|
|
|
SCNN1G
|
[NCBI]
|
1.85891e-05
|
|
|
GCNT2
|
[NCBI]
|
1.85891e-05
|
|
|
IGKV
|
[NCBI]
|
1.85891e-05
|
|
|
EYA4
|
[NCBI]
|
1.85891e-05
|
|
|
NCAM1
|
[NCBI]
|
1.85891e-05
|
|
|
SCN1B
|
[NCBI]
|
1.85891e-05
|
|
|
SETX
|
[NCBI]
|
1.85891e-05
|
|
|
BBS4
|
[NCBI]
|
1.85891e-05
|
|
|
CR2
|
[NCBI]
|
1.85891e-05
|
|
|
CD28
|
[NCBI]
|
1.85891e-05
|
|
|
RPS4X
|
[NCBI]
|
1.85891e-05
|
|
|
CNGB3
|
[NCBI]
|
1.85891e-05
|
|
|
ITIH1
|
[NCBI]
|
1.85891e-05
|
|
|
cystinuria
|
[NCBI]
|
1.84959e-05
|
|
|
LRP5
|
[NCBI]
|
1.84444e-05
|
|
|
MYO5A
|
[NCBI]
|
1.84444e-05
|
|
|
GZMB
|
[NCBI]
|
1.84444e-05
|
|
|
GRA
|
[NCBI]
|
1.82066e-05
|
|
|
BPES
|
[NCBI]
|
1.79994e-05
|
|
|
SCN1A
|
[NCBI]
|
1.78407e-05
|
|
|
NRAS
|
[NCBI]
|
1.78407e-05
|
|
|
ELA2
|
[NCBI]
|
1.78407e-05
|
|
|
LEPR
|
[NCBI]
|
1.78345e-05
|
|
|
giant platelet syndrome
|
[NCBI]
|
1.77389e-05
|
|
|
DBA
|
[NCBI]
|
1.77389e-05
|
|
|
TSC2
|
[NCBI]
|
1.74748e-05
|
|
|
WARS
|
[NCBI]
|
1.74418e-05
|
|
|
GRIA3
|
[NCBI]
|
1.74418e-05
|
|
|
FACL4
|
[NCBI]
|
1.74418e-05
|
|
|
PRM1
|
[NCBI]
|
1.74418e-05
|
|
|
IGHM
|
[NCBI]
|
1.74418e-05
|
|
|
MDH1
|
[NCBI]
|
1.74418e-05
|
|
|
SAA2
|
[NCBI]
|
1.74418e-05
|
|
|
NPPB
|
[NCBI]
|
1.74418e-05
|
|
|
LMNB1
|
[NCBI]
|
1.74418e-05
|
|
|
CYLD1
|
[NCBI]
|
1.74418e-05
|
|
|
HSD17B10
|
[NCBI]
|
1.74418e-05
|
|
|
VANGL2
|
[NCBI]
|
1.74418e-05
|
|
|
LAMC1
|
[NCBI]
|
1.74418e-05
|
|
|
HK2
|
[NCBI]
|
1.74418e-05
|
|
|
glioma of brain, familial
|
[NCBI]
|
1.73799e-05
|
|
|
galactosemia
|
[NCBI]
|
1.73799e-05
|
|
|
CRYAB
|
[NCBI]
|
1.72645e-05
|
|
|
COL7A1
|
[NCBI]
|
1.71314e-05
|
|
|
ARMD1
|
[NCBI]
|
1.6993e-05
|
|
|
ehlers-danlos syndrome, type i
|
[NCBI]
|
1.69879e-05
|
|
|
SCS
|
[NCBI]
|
1.67832e-05
|
|
|
COL3A1
|
[NCBI]
|
1.67515e-05
|
|
|
MTC
|
[NCBI]
|
1.67255e-05
|
|
|
HOMG
|
[NCBI]
|
1.67255e-05
|
|
|
SNDI
|
[NCBI]
|
1.67255e-05
|
|
|
SFD
|
[NCBI]
|
1.67255e-05
|
|
|
encephalopathy, neonatal severe, due to mecp2 mutations
|
[NCBI]
|
1.67255e-05
|
|
|
congenital cataracts, facial dysmorphism, and neuropathy
|
[NCBI]
|
1.67255e-05
|
|
|
LGMD2H
|
[NCBI]
|
1.67255e-05
|
|
|
ITGA2B
|
[NCBI]
|
1.67138e-05
|
|
|
SDS
|
[NCBI]
|
1.65774e-05
|
|
|
neuroblastoma
|
[NCBI]
|
1.6562e-05
|
|
|
CD1A
|
[NCBI]
|
1.64154e-05
|
|
|
SAG
|
[NCBI]
|
1.64154e-05
|
|
|
CKM
|
[NCBI]
|
1.64154e-05
|
|
|
GLUL
|
[NCBI]
|
1.64154e-05
|
|
|
TIMM8A
|
[NCBI]
|
1.64154e-05
|
|
|
CXORF5
|
[NCBI]
|
1.64154e-05
|
|
|
ORM2
|
[NCBI]
|
1.64154e-05
|
|
|
TGFB3
|
[NCBI]
|
1.64154e-05
|
|
|
FUR
|
[NCBI]
|
1.64154e-05
|
|
|
AL-A1
|
[NCBI]
|
1.64154e-05
|
|
|
MYH1
|
[NCBI]
|
1.64154e-05
|
|
|
TFAP2B
|
[NCBI]
|
1.64154e-05
|
|
|
tritanopia
|
[NCBI]
|
1.64154e-05
|
|
|
ASPM
|
[NCBI]
|
1.64154e-05
|
|
|
HPS1
|
[NCBI]
|
1.64154e-05
|
|
|
COL4A4
|
[NCBI]
|
1.64154e-05
|
|
|
PTGDS
|
[NCBI]
|
1.64154e-05
|
|
|
FUT3
|
[NCBI]
|
1.64154e-05
|
|
|
CHRNA3
|
[NCBI]
|
1.64154e-05
|
|
|
SPTB
|
[NCBI]
|
1.61867e-05
|
|
|
SLC25A4
|
[NCBI]
|
1.61867e-05
|
|
|
CMD1A
|
[NCBI]
|
1.58027e-05
|
|
|
GP1BA
|
[NCBI]
|
1.56818e-05
|
|
|
TP73L
|
[NCBI]
|
1.56818e-05
|
|
|
TTN
|
[NCBI]
|
1.56818e-05
|
|
|
GSTP1
|
[NCBI]
|
1.56818e-05
|
|
|
CYP2D6
|
[NCBI]
|
1.56699e-05
|
|
|
EVI2A
|
[NCBI]
|
1.55984e-05
|
|
|
CFHR2
|
[NCBI]
|
1.55984e-05
|
|
|
ASMT
|
[NCBI]
|
1.55984e-05
|
|
|
S100A5
|
[NCBI]
|
1.55984e-05
|
|
|
early lymphoid activation gene
|
[NCBI]
|
1.55984e-05
|
|
|
FABP1
|
[NCBI]
|
1.55984e-05
|
|
|
ZNF92
|
[NCBI]
|
1.55984e-05
|
|
|
ZIC4
|
[NCBI]
|
1.55984e-05
|
|
|
MED12L
|
[NCBI]
|
1.55984e-05
|
|
|
RPL35A
|
[NCBI]
|
1.55984e-05
|
|
|
MEX3C
|
[NCBI]
|
1.55984e-05
|
|
|
TBCD
|
[NCBI]
|
1.55984e-05
|
|
|
ASMT
|
[NCBI]
|
1.55984e-05
|
|
|
LAMA5
|
[NCBI]
|
1.55984e-05
|
|
|
KIF21A
|
[NCBI]
|
1.55984e-05
|
|
|
CTPP4
|
[NCBI]
|
1.55984e-05
|
|
|
MASTL
|
[NCBI]
|
1.55984e-05
|
|
|
C11ORF9
|
[NCBI]
|
1.55984e-05
|
|
|
GLY B+
|
[NCBI]
|
1.55984e-05
|
|
|
NGFG
|
[NCBI]
|
1.55984e-05
|
|
|
HIST1H2AM
|
[NCBI]
|
1.55984e-05
|
|
|
MAGEB5
|
[NCBI]
|
1.55984e-05
|
|
|
yeast factor
|
[NCBI]
|
1.55984e-05
|
|
|
ZNF93
|
[NCBI]
|
1.55984e-05
|
|
|
SSBP1
|
[NCBI]
|
1.55984e-05
|
|
|
MPP4
|
[NCBI]
|
1.55984e-05
|
|
|
dynein, axonemal, intermediate chain 2
|
[NCBI]
|
1.55984e-05
|
|
|
GPR19
|
[NCBI]
|
1.55984e-05
|
|
|
CA7
|
[NCBI]
|
1.55984e-05
|
|
|
SRPX2
|
[NCBI]
|
1.55984e-05
|
|
|
S100A2
|
[NCBI]
|
1.55984e-05
|
|
|
HIST1H2BO
|
[NCBI]
|
1.55984e-05
|
|
|
MRX49
|
[NCBI]
|
1.55984e-05
|
|
|
DOCK8
|
[NCBI]
|
1.55984e-05
|
|
|
SNRPE
|
[NCBI]
|
1.55984e-05
|
|
|
SRPX
|
[NCBI]
|
1.55984e-05
|
|
|
FBXL16
|
[NCBI]
|
1.55984e-05
|
|
|
S100A3
|
[NCBI]
|
1.55984e-05
|
|
|
ATP6V1E
|
[NCBI]
|
1.55984e-05
|
|
|
abl interactor 2
|
[NCBI]
|
1.55984e-05
|
|
|
TRP1
|
[NCBI]
|
1.55984e-05
|
|
|
rlf protein involved in activation of lmyc
|
[NCBI]
|
1.55984e-05
|
|
|
cd163 antigen b
|
[NCBI]
|
1.55984e-05
|
|
|
DUSP12
|
[NCBI]
|
1.55984e-05
|
|
|
SAGE1
|
[NCBI]
|
1.55984e-05
|
|
|
ZNF90
|
[NCBI]
|
1.55984e-05
|
|
|
CORO1B
|
[NCBI]
|
1.55984e-05
|
|
|
TOR1B
|
[NCBI]
|
1.55984e-05
|
|
|
RALA
|
[NCBI]
|
1.55984e-05
|
|
|
MAGEC3
|
[NCBI]
|
1.55984e-05
|
|
|
DARS2
|
[NCBI]
|
1.55984e-05
|
|
|
LIPB
|
[NCBI]
|
1.55984e-05
|
|
|
ZNF107
|
[NCBI]
|
1.55984e-05
|
|
|
ZSCAN12
|
[NCBI]
|
1.55984e-05
|
|
|
DISC2
|
[NCBI]
|
1.55984e-05
|
|
|
GPRK7
|
[NCBI]
|
1.55984e-05
|
|
|
UBE2E3
|
[NCBI]
|
1.55984e-05
|
|
|
ZNF91
|
[NCBI]
|
1.55984e-05
|
|
|
ZFAT1
|
[NCBI]
|
1.55984e-05
|
|
|
TRP2
|
[NCBI]
|
1.55984e-05
|
|
|
NDUFV3
|
[NCBI]
|
1.55984e-05
|
|
|
respiratory rhythmicity in sleep
|
[NCBI]
|
1.55984e-05
|
|
|
TAF1A
|
[NCBI]
|
1.55984e-05
|
|
|
ZNF76
|
[NCBI]
|
1.55984e-05
|
|
|
B3GALT4
|
[NCBI]
|
1.55984e-05
|
|
|
MAGEB4
|
[NCBI]
|
1.55984e-05
|
|
|
TOR2A
|
[NCBI]
|
1.55984e-05
|
|
|
TRL1
|
[NCBI]
|
1.55984e-05
|
|
|
SFTPA2
|
[NCBI]
|
1.55984e-05
|
|
|
PCDH9
|
[NCBI]
|
1.55984e-05
|
|
|
TDRD1
|
[NCBI]
|
1.55984e-05
|
|
|
ARID1A
|
[NCBI]
|
1.55984e-05
|
|
|
TRT2
|
[NCBI]
|
1.55984e-05
|
|
|
ZC3H12D
|
[NCBI]
|
1.55984e-05
|
|
|
TMEM30C
|
[NCBI]
|
1.55984e-05
|
|
|
IFNB3
|
[NCBI]
|
1.55984e-05
|
|
|
PPBPL1
|
[NCBI]
|
1.55984e-05
|
|
|
S5
|
[NCBI]
|
1.55984e-05
|
|
|
PSMB1
|
[NCBI]
|
1.55984e-05
|
|
|
HMX1
|
[NCBI]
|
1.55984e-05
|
|
|
SPRY3
|
[NCBI]
|
1.55984e-05
|
|
|
TMIE
|
[NCBI]
|
1.55984e-05
|
|
|
IFNW1
|
[NCBI]
|
1.55984e-05
|
|
|
PRCD
|
[NCBI]
|
1.55984e-05
|
|
|
PACE4
|
[NCBI]
|
1.55984e-05
|
|
|
ZNF1
|
[NCBI]
|
1.55984e-05
|
|
|
hypertension-related calcium-regulated gene
|
[NCBI]
|
1.55984e-05
|
|
|
TAS2R38
|
[NCBI]
|
1.55984e-05
|
|
|
MAGEB3
|
[NCBI]
|
1.55984e-05
|
|
|
SPG11
|
[NCBI]
|
1.55984e-05
|
|
|
TPM4
|
[NCBI]
|
1.55984e-05
|
|
|
TAF1C
|
[NCBI]
|
1.55984e-05
|
|
|
TBL1Y
|
[NCBI]
|
1.55984e-05
|
|
|
ZNF674
|
[NCBI]
|
1.55984e-05
|
|
|
GALNT4
|
[NCBI]
|
1.55984e-05
|
|
|
DSPG3
|
[NCBI]
|
1.55984e-05
|
|
|
ADAM19
|
[NCBI]
|
1.55984e-05
|
|
|
MAGEB6
|
[NCBI]
|
1.55984e-05
|
|
|
TAF1B
|
[NCBI]
|
1.55984e-05
|
|
|
INPP5A
|
[NCBI]
|
1.55984e-05
|
|
|
ZNF22
|
[NCBI]
|
1.55984e-05
|
|
|
ZNF34
|
[NCBI]
|
1.55984e-05
|
|
|
NDRG1
|
[NCBI]
|
1.54886e-05
|
|
|
LGI1
|
[NCBI]
|
1.54886e-05
|
|
|
PAPSS2
|
[NCBI]
|
1.54886e-05
|
|
|
SGCD
|
[NCBI]
|
1.54886e-05
|
|
|
COL6A3
|
[NCBI]
|
1.54886e-05
|
|
|
EMX2
|
[NCBI]
|
1.54886e-05
|
|
|
TP53
|
[NCBI]
|
1.54792e-05
|
|
|
TGD
|
[NCBI]
|
1.53635e-05
|
|
|
FXN
|
[NCBI]
|
1.53275e-05
|
|
|
NPC1
|
[NCBI]
|
1.51974e-05
|
|
|
CST3
|
[NCBI]
|
1.51974e-05
|
|
|
MFS
|
[NCBI]
|
1.51805e-05
|
|
|
AMH
|
[NCBI]
|
1.50295e-05
|
|
|
LAH
|
[NCBI]
|
1.49712e-05
|
|
|
leprosy, susceptibility to, 2
|
[NCBI]
|
1.49712e-05
|
|
|
MLASA
|
[NCBI]
|
1.49712e-05
|
|
|
SPG8
|
[NCBI]
|
1.49712e-05
|
|
|
retinitis pigmentosa-deafness syndrome
|
[NCBI]
|
1.49712e-05
|
|
|
VAMAS1
|
[NCBI]
|
1.49712e-05
|
|
|
USH1G
|
[NCBI]
|
1.49712e-05
|
|
|
hair whorl
|
[NCBI]
|
1.49712e-05
|
|
|
TS
|
[NCBI]
|
1.49712e-05
|
|
|
allergic rhinitis
|
[NCBI]
|
1.49712e-05
|
|
|
LCA5
|
[NCBI]
|
1.49712e-05
|
|
|
alpha-b crystallinopathy
|
[NCBI]
|
1.49712e-05
|
|
|
SPG7
|
[NCBI]
|
1.49712e-05
|
|
|
sick sinus syndrome, autosomal dominant
|
[NCBI]
|
1.49712e-05
|
|
|
corneal dystrophy and perceptive deafness
|
[NCBI]
|
1.49712e-05
|
|
|
microcephaly with chemotactic defect and transient hypogammaglobulinemia
|
[NCBI]
|
1.49712e-05
|
|
|
cardiac arrhythmia, ankyrin-b-related
|
[NCBI]
|
1.49712e-05
|
|
|
corpus callosum, partial agenesis of, x-linked
|
[NCBI]
|
1.49712e-05
|
|
|
branchial arch syndrome, x-linked
|
[NCBI]
|
1.49712e-05
|
|
|
resting heart rate
|
[NCBI]
|
1.49712e-05
|
|
|
ruvalcaba syndrome
|
[NCBI]
|
1.49712e-05
|
|
|
varicose veins
|
[NCBI]
|
1.49712e-05
|
|
|
lactase deficiency, congenital
|
[NCBI]
|
1.49712e-05
|
|
|
pars planitis
|
[NCBI]
|
1.49712e-05
|
|
|
charcot-marie-tooth disease, recessive intermediate a
|
[NCBI]
|
1.49712e-05
|
|
|
CMD1G
|
[NCBI]
|
1.49712e-05
|
|
|
dna, satellite, alpha type
|
[NCBI]
|
1.49712e-05
|
|
|
CFEOM2
|
[NCBI]
|
1.49712e-05
|
|
|
CELIAC4
|
[NCBI]
|
1.49712e-05
|
|
|
RP18
|
[NCBI]
|
1.49712e-05
|
|
|
JBTS5
|
[NCBI]
|
1.49712e-05
|
|
|
CMD1C
|
[NCBI]
|
1.49712e-05
|
|
|
cryohydrocytosis, stomatin-deficient, with mental retardation, seizures, cataracts, and massive hepatosplenomegaly
|
[NCBI]
|
1.49712e-05
|
|
|
RCM1
|
[NCBI]
|
1.49712e-05
|
|
|
acth deficiency
|
[NCBI]
|
1.49712e-05
|
|
|
DI
|
[NCBI]
|
1.49712e-05
|
|
|
segawa syndrome, autosomal recessive
|
[NCBI]
|
1.49712e-05
|
|
|
orofacial cleft 5
|
[NCBI]
|
1.49712e-05
|
|
|
corneal fleck dystrophy
|
[NCBI]
|
1.49712e-05
|
|
|
immunodeficiency with hyper-igm, type 3
|
[NCBI]
|
1.49712e-05
|
|
|
laurence-moon syndrome
|
[NCBI]
|
1.49712e-05
|
|
|
rheumatic fever-related antigen
|
[NCBI]
|
1.49712e-05
|
|
|
FHL4
|
[NCBI]
|
1.49712e-05
|
|
|
tietz syndrome
|
[NCBI]
|
1.49712e-05
|
|
|
FHCA
|
[NCBI]
|
1.49712e-05
|
|
|
SCA13
|
[NCBI]
|
1.49712e-05
|
|
|
HHF3
|
[NCBI]
|
1.49712e-05
|
|
|
thyroid hormonogenesis, genetic defect in, 5
|
[NCBI]
|
1.49712e-05
|
|
|
leber congenital amaurosis, type iii
|
[NCBI]
|
1.49712e-05
|
|
|
ectopia lentis
|
[NCBI]
|
1.49712e-05
|
|
|
USH1F
|
[NCBI]
|
1.49712e-05
|
|
|
LI3
|
[NCBI]
|
1.49712e-05
|
|
|
DFNB59
|
[NCBI]
|
1.49712e-05
|
|
|
CMT1C
|
[NCBI]
|
1.49712e-05
|
|
|
oculopalatoskeletal syndrome
|
[NCBI]
|
1.49712e-05
|
|
|
IL1A
|
[NCBI]
|
1.47323e-05
|
|
|
DCN
|
[NCBI]
|
1.47323e-05
|
|
|
HDC
|
[NCBI]
|
1.46711e-05
|
|
|
MSH2
|
[NCBI]
|
1.46678e-05
|
|
|
C5R1
|
[NCBI]
|
1.46453e-05
|
|
|
PIM1
|
[NCBI]
|
1.46453e-05
|
|
|
CRYGA
|
[NCBI]
|
1.46453e-05
|
|
|
MTHFD1
|
[NCBI]
|
1.46453e-05
|
|
|
MCF2
|
[NCBI]
|
1.46453e-05
|
|
|
ATP1A1
|
[NCBI]
|
1.46453e-05
|
|
|
MED12
|
[NCBI]
|
1.46453e-05
|
|
|
CA4
|
[NCBI]
|
1.46453e-05
|
|
|
MSR1
|
[NCBI]
|
1.46453e-05
|
|
|
MYF6
|
[NCBI]
|
1.46453e-05
|
|
|
COL9A1
|
[NCBI]
|
1.46453e-05
|
|
|
DRD1
|
[NCBI]
|
1.46453e-05
|
|
|
SFTPC
|
[NCBI]
|
1.46453e-05
|
|
|
TCIRG1
|
[NCBI]
|
1.46453e-05
|
|
|
TFF2
|
[NCBI]
|
1.46453e-05
|
|
|
prekallikrein deficiency
|
[NCBI]
|
1.46453e-05
|
|
|
WNK4
|
[NCBI]
|
1.46453e-05
|
|
|
HOXB5
|
[NCBI]
|
1.46453e-05
|
|
|
MSX2
|
[NCBI]
|
1.46453e-05
|
|
|
alsin
|
[NCBI]
|
1.46453e-05
|
|
|
spinocerebellar ataxia 29
|
[NCBI]
|
1.46123e-05
|
|
|
SJS1
|
[NCBI]
|
1.45766e-05
|
|
|
ARH
|
[NCBI]
|
1.44734e-05
|
|
|
adrenal hyperplasia, congenital, due to 17-alpha-hydroxylase deficiency
|
[NCBI]
|
1.44734e-05
|
|
|
erythrocytosis, familial, 1
|
[NCBI]
|
1.44734e-05
|
|
|
monilethrix
|
[NCBI]
|
1.44734e-05
|
|
|
USH3
|
[NCBI]
|
1.44734e-05
|
|
|
adult syndrome
|
[NCBI]
|
1.44734e-05
|
|
|
FTNS
|
[NCBI]
|
1.44734e-05
|
|
|
multiple pterygium syndrome, lethal type
|
[NCBI]
|
1.44734e-05
|
|
|
adrenal hyperplasia, congenital, due to steroid 11-beta-hydroxylase deficiency
|
[NCBI]
|
1.44734e-05
|
|
|
autoimmune disease
|
[NCBI]
|
1.44734e-05
|
|
|
NCIE1
|
[NCBI]
|
1.44734e-05
|
|
|
A2M
|
[NCBI]
|
1.43499e-05
|
|
|
ENPP1
|
[NCBI]
|
1.42851e-05
|
|
|
KRT5
|
[NCBI]
|
1.42851e-05
|
|
|
MTND6
|
[NCBI]
|
1.42851e-05
|
|
|
HLA-B
|
[NCBI]
|
1.42851e-05
|
|
|
MAOB
|
[NCBI]
|
1.42851e-05
|
|
|
PRNP
|
[NCBI]
|
1.41982e-05
|
|
|
spermatogenic failure, nonobstructive, y-linked
|
[NCBI]
|
1.41658e-05
|
|
|
PCCA
|
[NCBI]
|
1.3873e-05
|
|
|
TNNI3
|
[NCBI]
|
1.3873e-05
|
|
|
DCTN1
|
[NCBI]
|
1.3873e-05
|
|
|
AGTR2
|
[NCBI]
|
1.3873e-05
|
|
|
NEFH
|
[NCBI]
|
1.3873e-05
|
|
|
PLA2G7
|
[NCBI]
|
1.3873e-05
|
|
|
CCL3
|
[NCBI]
|
1.3873e-05
|
|
|
RMD
|
[NCBI]
|
1.38699e-05
|
|
|
hyperglycerolemia
|
[NCBI]
|
1.38699e-05
|
|
|
MB
|
[NCBI]
|
1.36938e-05
|
|
|
ABCC8
|
[NCBI]
|
1.35578e-05
|
|
|
SLC6A3
|
[NCBI]
|
1.34997e-05
|
|
|
PI
|
[NCBI]
|
1.34437e-05
|
|
|
FIH
|
[NCBI]
|
1.34245e-05
|
|
|
MEB
|
[NCBI]
|
1.34245e-05
|
|
|
malaria, susceptibility to
|
[NCBI]
|
1.34245e-05
|
|
|
XPA
|
[NCBI]
|
1.33877e-05
|
|
|
ACPP
|
[NCBI]
|
1.3339e-05
|
|
|
hypogonadotropic hypogonadism
|
[NCBI]
|
1.32823e-05
|
|
|
GDAP1
|
[NCBI]
|
1.31618e-05
|
|
|
DTNBP1
|
[NCBI]
|
1.31618e-05
|
|
|
PLAU
|
[NCBI]
|
1.31618e-05
|
|
|
POMT1
|
[NCBI]
|
1.31618e-05
|
|
|
TNFRSF11A
|
[NCBI]
|
1.31618e-05
|
|
|
MTND4L
|
[NCBI]
|
1.31618e-05
|
|
|
TULP1
|
[NCBI]
|
1.31618e-05
|
|
|
PIK3R1
|
[NCBI]
|
1.31618e-05
|
|
|
CCKAR
|
[NCBI]
|
1.31618e-05
|
|
|
ME2
|
[NCBI]
|
1.31618e-05
|
|
|
MOS
|
[NCBI]
|
1.31618e-05
|
|
|
DRD5
|
[NCBI]
|
1.31618e-05
|
|
|
KCNQ2
|
[NCBI]
|
1.31618e-05
|
|
|
BMPR2
|
[NCBI]
|
1.31618e-05
|
|
|
APOA2
|
[NCBI]
|
1.31618e-05
|
|
|
RAB27A
|
[NCBI]
|
1.31618e-05
|
|
|
TAP1
|
[NCBI]
|
1.31618e-05
|
|
|
OTOF
|
[NCBI]
|
1.31618e-05
|
|
|
ENAM
|
[NCBI]
|
1.31618e-05
|
|
|
HEPH
|
[NCBI]
|
1.31618e-05
|
|
|
COCH
|
[NCBI]
|
1.31618e-05
|
|
|
FOXP2
|
[NCBI]
|
1.31618e-05
|
|
|
IGF1
|
[NCBI]
|
1.31517e-05
|
|
|
HBB
|
[NCBI]
|
1.30668e-05
|
|
|
RASA1
|
[NCBI]
|
1.30029e-05
|
|
|
AMCN
|
[NCBI]
|
1.29221e-05
|
|
|
SHFLD1
|
[NCBI]
|
1.29221e-05
|
|
|
gonadal dysgenesis, xy type
|
[NCBI]
|
1.29221e-05
|
|
|
centralopathic epilepsy
|
[NCBI]
|
1.29221e-05
|
|
|
BULN1
|
[NCBI]
|
1.29221e-05
|
|
|
PRPH2
|
[NCBI]
|
1.26566e-05
|
|
|
adrenoleukodystrophy, autosomal neonatal form
|
[NCBI]
|
1.26206e-05
|
|
|
PCOS1
|
[NCBI]
|
1.26098e-05
|
|
|
GZMM
|
[NCBI]
|
1.25965e-05
|
|
|
UBQLN2
|
[NCBI]
|
1.25965e-05
|
|
|
NLGN4Y
|
[NCBI]
|
1.25965e-05
|
|
|
ATP2B4
|
[NCBI]
|
1.25965e-05
|
|
|
MAGEA12
|
[NCBI]
|
1.25965e-05
|
|
|
ZNF21
|
[NCBI]
|
1.25965e-05
|
|
|
lymphocyte cytosol polypeptide, 20-kd
|
[NCBI]
|
1.25965e-05
|
|
|
CLEC4C
|
[NCBI]
|
1.25965e-05
|
|
|
KLRC3
|
[NCBI]
|
1.25965e-05
|
|
|
GNPTG
|
[NCBI]
|
1.25965e-05
|
|
|
MAGED2
|
[NCBI]
|
1.25965e-05
|
|
|
NKX2-4
|
[NCBI]
|
1.25965e-05
|
|
|
PLEKHG5
|
[NCBI]
|
1.25965e-05
|
|
|
HLA-DNA
|
[NCBI]
|
1.25965e-05
|
|
|
SLC25A18
|
[NCBI]
|
1.25965e-05
|
|
|
ADAT1
|
[NCBI]
|
1.25965e-05
|
|
|
RRH
|
[NCBI]
|
1.25965e-05
|
|
|
MFAP2
|
[NCBI]
|
1.25965e-05
|
|
|
GNA15
|
[NCBI]
|
1.25965e-05
|
|
|
CLDN5
|
[NCBI]
|
1.25965e-05
|
|
|
DNAI1
|
[NCBI]
|
1.25965e-05
|
|
|
NDUFA7
|
[NCBI]
|
1.25965e-05
|
|
|
GUCY2C
|
[NCBI]
|
1.25965e-05
|
|
|
MAGEA10
|
[NCBI]
|
1.25965e-05
|
|
|
TEX14
|
[NCBI]
|
1.25965e-05
|
|
|
PCSK4
|
[NCBI]
|
1.25965e-05
|
|
|
SNRPA
|
[NCBI]
|
1.25965e-05
|
|
|
RECQL
|
[NCBI]
|
1.25965e-05
|
|
|
DPYSL4
|
[NCBI]
|
1.25965e-05
|
|
|
MAGEA9
|
[NCBI]
|
1.25965e-05
|
|
|
MAGEA4
|
[NCBI]
|
1.25965e-05
|
|
|
ANXA11
|
[NCBI]
|
1.25965e-05
|
|
|
P2RX5
|
[NCBI]
|
1.25965e-05
|
|
|
C20ORF41
|
[NCBI]
|
1.25965e-05
|
|
|
ABHD5
|
[NCBI]
|
1.25965e-05
|
|
|
ZNF43
|
[NCBI]
|
1.25965e-05
|
|
|
GCNT1
|
[NCBI]
|
1.25965e-05
|
|
|
TRAM2
|
[NCBI]
|
1.25965e-05
|
|
|
PSMA5
|
[NCBI]
|
1.25965e-05
|
|
|
ETFDH
|
[NCBI]
|
1.25965e-05
|
|
|
TMEM16E
|
[NCBI]
|
1.25965e-05
|
|
|
GRM3
|
[NCBI]
|
1.25965e-05
|
|
|
PAICS
|
[NCBI]
|
1.25965e-05
|
|
|
SPANXA1
|
[NCBI]
|
1.25965e-05
|
|
|
IFI16
|
[NCBI]
|
1.25965e-05
|
|
|
EMX1
|
[NCBI]
|
1.25965e-05
|
|
|
LCA5
|
[NCBI]
|
1.25965e-05
|
|
|
EDG6
|
[NCBI]
|
1.25965e-05
|
|
|
androgen-induced prostate proliferative shutoff-associated protein
|
[NCBI]
|
1.25965e-05
|
|
|
SH3BP2
|
[NCBI]
|
1.25965e-05
|
|
|
NDUFA6
|
[NCBI]
|
1.25965e-05
|
|
|
CDH7
|
[NCBI]
|
1.25965e-05
|
|
|
PNPLA4
|
[NCBI]
|
1.25965e-05
|
|
|
TIMM8B
|
[NCBI]
|
1.25965e-05
|
|
|
MAGEC1
|
[NCBI]
|
1.25965e-05
|
|
|
LXN
|
[NCBI]
|
1.25965e-05
|
|
|
SPTAN1
|
[NCBI]
|
1.25965e-05
|
|
|
GAS7
|
[NCBI]
|
1.25965e-05
|
|
|
DRG2
|
[NCBI]
|
1.25965e-05
|
|
|
NDUFB8
|
[NCBI]
|
1.25965e-05
|
|
|
VAX1
|
[NCBI]
|
1.25965e-05
|
|
|
MLN
|
[NCBI]
|
1.25965e-05
|
|
|
ARHGAP4
|
[NCBI]
|
1.25965e-05
|
|
|
SCN3A
|
[NCBI]
|
1.25965e-05
|
|
|
TTBK2
|
[NCBI]
|
1.25965e-05
|
|
|
VPREB1
|
[NCBI]
|
1.25965e-05
|
|
|
DDX4
|
[NCBI]
|
1.25965e-05
|
|
|
CCNF
|
[NCBI]
|
1.25965e-05
|
|
|
MDFI
|
[NCBI]
|
1.25965e-05
|
|
|
TLL1
|
[NCBI]
|
1.25965e-05
|
|
|
MAGEA3
|
[NCBI]
|
1.25965e-05
|
|
|
KCNJ16
|
[NCBI]
|
1.25965e-05
|
|
|
MN1
|
[NCBI]
|
1.25965e-05
|
|
|
KCNJ10
|
[NCBI]
|
1.25965e-05
|
|
|
ETHE1
|
[NCBI]
|
1.25965e-05
|
|
|
SEA
|
[NCBI]
|
1.25965e-05
|
|
|
UCK2
|
[NCBI]
|
1.25965e-05
|
|
|
SIGLEC8
|
[NCBI]
|
1.25965e-05
|
|
|
PYGB
|
[NCBI]
|
1.25965e-05
|
|
|
TLL2
|
[NCBI]
|
1.25965e-05
|
|
|
EVER2
|
[NCBI]
|
1.25965e-05
|
|
|
CD1E
|
[NCBI]
|
1.25965e-05
|
|
|
KRT6B
|
[NCBI]
|
1.25965e-05
|
|
|
USP14
|
[NCBI]
|
1.25965e-05
|
|
|
CRBN
|
[NCBI]
|
1.25965e-05
|
|
|
MAGEA6
|
[NCBI]
|
1.25965e-05
|
|
|
OTOG
|
[NCBI]
|
1.25965e-05
|
|
|
SULT1B1
|
[NCBI]
|
1.25965e-05
|
|
|
RFX2
|
[NCBI]
|
1.25965e-05
|
|
|
PBX3
|
[NCBI]
|
1.25965e-05
|
|
|
ATP1AL1
|
[NCBI]
|
1.25965e-05
|
|
|
MAGEA11
|
[NCBI]
|
1.25965e-05
|
|
|
RAC3
|
[NCBI]
|
1.25965e-05
|
|
|
ALG9
|
[NCBI]
|
1.25965e-05
|
|
|
CYP2F1
|
[NCBI]
|
1.25965e-05
|
|
|
actin-binding protein, 34-kd
|
[NCBI]
|
1.25965e-05
|
|
|
PSMB5
|
[NCBI]
|
1.25965e-05
|
|
|
CERKL
|
[NCBI]
|
1.25965e-05
|
|
|
GUK1
|
[NCBI]
|
1.25965e-05
|
|
|
PPP2CB
|
[NCBI]
|
1.25965e-05
|
|
|
IGHG4
|
[NCBI]
|
1.25965e-05
|
|
|
RBM10
|
[NCBI]
|
1.25965e-05
|
|
|
IDH3G
|
[NCBI]
|
1.25965e-05
|
|
|
USP26
|
[NCBI]
|
1.25965e-05
|
|
|
CACNG1
|
[NCBI]
|
1.25965e-05
|
|
|
MUC3B
|
[NCBI]
|
1.25965e-05
|
|
|
NUP62
|
[NCBI]
|
1.25965e-05
|
|
|
SLC20A2
|
[NCBI]
|
1.25965e-05
|
|
|
NDRG2
|
[NCBI]
|
1.25965e-05
|
|
|
ATP11A
|
[NCBI]
|
1.25965e-05
|
|
|
ASMTL
|
[NCBI]
|
1.25965e-05
|
|
|
CSN1
|
[NCBI]
|
1.25965e-05
|
|
|
CACNA2D4
|
[NCBI]
|
1.25965e-05
|
|
|
ESA4
|
[NCBI]
|
1.25965e-05
|
|
|
CD48
|
[NCBI]
|
1.25965e-05
|
|
|
RPL30
|
[NCBI]
|
1.25965e-05
|
|
|
MTTS2
|
[NCBI]
|
1.25965e-05
|
|
|
USP24
|
[NCBI]
|
1.25965e-05
|
|
|
HEXA
|
[NCBI]
|
1.25731e-05
|
|
|
SVAS
|
[NCBI]
|
1.25526e-05
|
|
|
GABRB3
|
[NCBI]
|
1.2504e-05
|
|
|
PRTN3
|
[NCBI]
|
1.2504e-05
|
|
|
SLC26A2
|
[NCBI]
|
1.2504e-05
|
|
|
LAMP2
|
[NCBI]
|
1.2504e-05
|
|
|
SELE
|
[NCBI]
|
1.2504e-05
|
|
|
LAMA2
|
[NCBI]
|
1.2504e-05
|
|
|
CYBA
|
[NCBI]
|
1.2504e-05
|
|
|
PLA2G2A
|
[NCBI]
|
1.2504e-05
|
|
|
CPS1
|
[NCBI]
|
1.2504e-05
|
|
|
complement component 7 deficiency
|
[NCBI]
|
1.25025e-05
|
|
|
LGMD2I
|
[NCBI]
|
1.25025e-05
|
|
|
JLNS1
|
[NCBI]
|
1.25025e-05
|
|
|
ACHM2
|
[NCBI]
|
1.25025e-05
|
|
|
EA1
|
[NCBI]
|
1.25025e-05
|
|
|
SPD1
|
[NCBI]
|
1.25025e-05
|
|
|
GCCD1
|
[NCBI]
|
1.25025e-05
|
|
|
BHD
|
[NCBI]
|
1.25025e-05
|
|
|
ARVD1
|
[NCBI]
|
1.25025e-05
|
|
|
citrullinemia, classic
|
[NCBI]
|
1.24957e-05
|
|
|
FDH
|
[NCBI]
|
1.24957e-05
|
|
|
NEM3
|
[NCBI]
|
1.24957e-05
|
|
|
BCR
|
[NCBI]
|
1.2462e-05
|
|
|
SDC2
|
[NCBI]
|
1.23749e-05
|
|
|
LFS1
|
[NCBI]
|
1.23419e-05
|
|
|
OCA1A
|
[NCBI]
|
1.23419e-05
|
|
|
MTCO1
|
[NCBI]
|
1.2285e-05
|
|
|
GK
|
[NCBI]
|
1.2285e-05
|
|
|
MAPT
|
[NCBI]
|
1.20652e-05
|
|
|
PMCH
|
[NCBI]
|
1.20054e-05
|
|
|
ALB
|
[NCBI]
|
1.19546e-05
|
|
|
H4FN
|
[NCBI]
|
1.18928e-05
|
|
|
MIF
|
[NCBI]
|
1.18928e-05
|
|
|
CAST
|
[NCBI]
|
1.18928e-05
|
|
|
DLL3
|
[NCBI]
|
1.18928e-05
|
|
|
SLC16A2
|
[NCBI]
|
1.18928e-05
|
|
|
ROR2
|
[NCBI]
|
1.18928e-05
|
|
|
SCNN1A
|
[NCBI]
|
1.18928e-05
|
|
|
GCG
|
[NCBI]
|
1.18928e-05
|
|
|
GABRG2
|
[NCBI]
|
1.18928e-05
|
|
|
MYO6
|
[NCBI]
|
1.18928e-05
|
|
|
THY1
|
[NCBI]
|
1.18928e-05
|
|
|
SCNN1B
|
[NCBI]
|
1.18928e-05
|
|
|
RSTS
|
[NCBI]
|
1.18653e-05
|
|
|
VDR
|
[NCBI]
|
1.18093e-05
|
|
|
LPI
|
[NCBI]
|
1.14139e-05
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
1.14115e-05
|
|
|
HP
|
[NCBI]
|
1.13306e-05
|
|
|
C5
|
[NCBI]
|
1.13231e-05
|
|
|
UCHL1
|
[NCBI]
|
1.13231e-05
|
|
|
IL6R
|
[NCBI]
|
1.13231e-05
|
|
|
TPM3
|
[NCBI]
|
1.13231e-05
|
|
|
ALDOA
|
[NCBI]
|
1.13231e-05
|
|
|
USH1C
|
[NCBI]
|
1.13231e-05
|
|
|
HBA1
|
[NCBI]
|
1.12445e-05
|
|
|
TNFRSF1B
|
[NCBI]
|
1.1244e-05
|
|
|
UMOD
|
[NCBI]
|
1.1244e-05
|
|
|
ATP7B
|
[NCBI]
|
1.1244e-05
|
|
|
NS1
|
[NCBI]
|
1.12403e-05
|
|
|
SMA2
|
[NCBI]
|
1.1231e-05
|
|
|
ALMS
|
[NCBI]
|
1.1231e-05
|
|
|
PFIC2
|
[NCBI]
|
1.11524e-05
|
|
|
lymphedema, hereditary, ii
|
[NCBI]
|
1.11524e-05
|
|
|
DFNA10
|
[NCBI]
|
1.11524e-05
|
|
|
CSCD
|
[NCBI]
|
1.11524e-05
|
|
|
witkop syndrome
|
[NCBI]
|
1.11524e-05
|
|
|
TINU
|
[NCBI]
|
1.11524e-05
|
|
|
MKS3
|
[NCBI]
|
1.11524e-05
|
|
|
DFNB2
|
[NCBI]
|
1.11524e-05
|
|
|
paroxysmal extreme pain disorder
|
[NCBI]
|
1.11524e-05
|
|
|
wildervanck syndrome
|
[NCBI]
|
1.11524e-05
|
|
|
vasculopathy, retinal, with cerebral leukodystrophy
|
[NCBI]
|
1.11524e-05
|
|
|
JAE
|
[NCBI]
|
1.11524e-05
|
|
|
NN
|
[NCBI]
|
1.11524e-05
|
|
|
ED3
|
[NCBI]
|
1.11524e-05
|
|
|
hunter-mcalpine craniosynostosis syndrome
|
[NCBI]
|
1.11524e-05
|
|
|
white sponge nevus of cannon
|
[NCBI]
|
1.11524e-05
|
|
|
PC2
|
[NCBI]
|
1.11524e-05
|
|
|
dentin dysplasia, type ii
|
[NCBI]
|
1.11524e-05
|
|
|
peroxisomal acyl-coa oxidase deficiency
|
[NCBI]
|
1.11524e-05
|
|
|
CACP
|
[NCBI]
|
1.11524e-05
|
|
|
subglottic bar
|
[NCBI]
|
1.11524e-05
|
|
|
PFM2
|
[NCBI]
|
1.11524e-05
|
|
|
OPTB5
|
[NCBI]
|
1.11524e-05
|
|
|
hydroxyacyl-coa dehydrogenase ii deficiency
|
[NCBI]
|
1.11524e-05
|
|
|
carpenter syndrome
|
[NCBI]
|
1.11524e-05
|
|
|
microcephaly with spastic quadriplegia
|
[NCBI]
|
1.11524e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive
|
[NCBI]
|
1.11524e-05
|
|
|
seizures, benign familial neonatal-infantile
|
[NCBI]
|
1.11524e-05
|
|
|
cystinosis, late-onset juvenile or adolescent nephropathic type
|
[NCBI]
|
1.11524e-05
|
|
|
hairy ears
|
[NCBI]
|
1.11524e-05
|
|
|
insulin-like growth factor i deficiency
|
[NCBI]
|
1.11524e-05
|
|
|
niemann-pick disease, type c2
|
[NCBI]
|
1.11524e-05
|
|
|
porencephaly, familial
|
[NCBI]
|
1.11524e-05
|
|
|
CMD1D
|
[NCBI]
|
1.11524e-05
|
|
|
DFNB6
|
[NCBI]
|
1.11524e-05
|
|
|
trismus-pseudocamptodactyly syndrome
|
[NCBI]
|
1.11524e-05
|
|
|
ramon syndrome
|
[NCBI]
|
1.11524e-05
|
|
|
eunuchoidism, familial hypogonadotropic
|
[NCBI]
|
1.11524e-05
|
|
|
DFNA17
|
[NCBI]
|
1.11524e-05
|
|
|
osteogenesis imperfecta, type viii
|
[NCBI]
|
1.11524e-05
|
|
|
SMEI
|
[NCBI]
|
1.11221e-05
|
|
|
CSF2
|
[NCBI]
|
1.09196e-05
|
|
|
TLR2
|
[NCBI]
|
1.09087e-05
|
|
|
KCNJ2
|
[NCBI]
|
1.07903e-05
|
|
|
KRIT1
|
[NCBI]
|
1.07903e-05
|
|
|
CSF1R
|
[NCBI]
|
1.07903e-05
|
|
|
IL9
|
[NCBI]
|
1.07903e-05
|
|
|
GAN1
|
[NCBI]
|
1.07709e-05
|
|
|
CDG2C
|
[NCBI]
|
1.07709e-05
|
|
|
leprosy, susceptibility to
|
[NCBI]
|
1.07709e-05
|
|
|
PALS
|
[NCBI]
|
1.07709e-05
|
|
|
CHNG1
|
[NCBI]
|
1.07709e-05
|
|
|
SOST
|
[NCBI]
|
1.07709e-05
|
|
|
LMS
|
[NCBI]
|
1.07709e-05
|
|
|
waardenburg-shah syndrome
|
[NCBI]
|
1.07709e-05
|
|
|
danon disease
|
[NCBI]
|
1.07709e-05
|
|
|
IGAD1
|
[NCBI]
|
1.07336e-05
|
|
|
CRYZ
|
[NCBI]
|
1.06861e-05
|
|
|
PPP5C
|
[NCBI]
|
1.06861e-05
|
|
|
GNAZ
|
[NCBI]
|
1.06861e-05
|
|
|
ABCA7
|
[NCBI]
|
1.06861e-05
|
|
|
IGLV
|
[NCBI]
|
1.06861e-05
|
|
|
PLCG2
|
[NCBI]
|
1.06861e-05
|
|
|
AOC2
|
[NCBI]
|
1.06861e-05
|
|
|
CRTL1
|
[NCBI]
|
1.06861e-05
|
|
|
FDFT1
|
[NCBI]
|
1.06861e-05
|
|
|
RGS5
|
[NCBI]
|
1.06861e-05
|
|
|
pejvakin
|
[NCBI]
|
1.06861e-05
|
|
|
PCSK5
|
[NCBI]
|
1.06861e-05
|
|
|
NAP1L2
|
[NCBI]
|
1.06861e-05
|
|
|
HCCS
|
[NCBI]
|
1.06861e-05
|
|
|
SLC6A14
|
[NCBI]
|
1.06861e-05
|
|
|
GUCY2F
|
[NCBI]
|
1.06861e-05
|
|
|
BBS2
|
[NCBI]
|
1.06861e-05
|
|
|
CGB8
|
[NCBI]
|
1.06861e-05
|
|
|
OSR2
|
[NCBI]
|
1.06861e-05
|
|
|
MAGEA8
|
[NCBI]
|
1.06861e-05
|
|
|
MEP1B
|
[NCBI]
|
1.06861e-05
|
|
|
RAB23
|
[NCBI]
|
1.06861e-05
|
|
|
THH
|
[NCBI]
|
1.06861e-05
|
|
|
F8A
|
[NCBI]
|
1.06861e-05
|
|
|
ATP2B3
|
[NCBI]
|
1.06861e-05
|
|
|
KLRC4
|
[NCBI]
|
1.06861e-05
|
|
|
RBBP4
|
[NCBI]
|
1.06861e-05
|
|
|
PHF11
|
[NCBI]
|
1.06861e-05
|
|
|
BST1
|
[NCBI]
|
1.06861e-05
|
|
|
GAPDHS
|
[NCBI]
|
1.06861e-05
|
|
|
SOX18
|
[NCBI]
|
1.06861e-05
|
|
|
ELAVL2
|
[NCBI]
|
1.06861e-05
|
|
|
ITPKC
|
[NCBI]
|
1.06861e-05
|
|
|
EXTL1
|
[NCBI]
|
1.06861e-05
|
|
|
CTNNA3
|
[NCBI]
|
1.06861e-05
|
|
|
CGB5
|
[NCBI]
|
1.06861e-05
|
|
|
GATA5
|
[NCBI]
|
1.06861e-05
|
|
|
ZIC1
|
[NCBI]
|
1.06861e-05
|
|
|
GAS2
|
[NCBI]
|
1.06861e-05
|
|
|
DPP6
|
[NCBI]
|
1.06861e-05
|
|
|
ST5
|
[NCBI]
|
1.06861e-05
|
|
|
ZNF85
|
[NCBI]
|
1.06861e-05
|
|
|
HPS3
|
[NCBI]
|
1.06861e-05
|
|
|
GYS2
|
[NCBI]
|
1.06861e-05
|
|
|
BZRP
|
[NCBI]
|
1.06861e-05
|
|
|
PAXIP1
|
[NCBI]
|
1.06861e-05
|
|
|
ETFB
|
[NCBI]
|
1.06861e-05
|
|
|
CSH2
|
[NCBI]
|
1.06861e-05
|
|
|
PRKCI
|
[NCBI]
|
1.06861e-05
|
|
|
IGKV1OR2108
|
[NCBI]
|
1.06861e-05
|
|
|
MAGEA5
|
[NCBI]
|
1.06861e-05
|
|
|
RPL28
|
[NCBI]
|
1.06861e-05
|
|
|
GPR34
|
[NCBI]
|
1.06861e-05
|
|
|
NAZC
|
[NCBI]
|
1.06861e-05
|
|
|
ADRBK2
|
[NCBI]
|
1.06861e-05
|
|
|
NXF2
|
[NCBI]
|
1.06861e-05
|
|
|
RNU3
|
[NCBI]
|
1.06861e-05
|
|
|
ICA1
|
[NCBI]
|
1.06861e-05
|
|
|
CDR2
|
[NCBI]
|
1.06861e-05
|
|
|
neutrophil-specific antigen 1
|
[NCBI]
|
1.06861e-05
|
|
|
KLRG1
|
[NCBI]
|
1.06861e-05
|
|
|
LIPH
|
[NCBI]
|
1.06861e-05
|
|
|
OCM
|
[NCBI]
|
1.06861e-05
|
|
|
RHCG
|
[NCBI]
|
1.06861e-05
|
|
|
CDC37
|
[NCBI]
|
1.06861e-05
|
|
|
TAGLN2
|
[NCBI]
|
1.06861e-05
|
|
|
EVER1
|
[NCBI]
|
1.06861e-05
|
|
|
COL8A2
|
[NCBI]
|
1.06861e-05
|
|
|
MIPEP
|
[NCBI]
|
1.06861e-05
|
|
|
EVX2
|
[NCBI]
|
1.06861e-05
|
|
|
CECR2
|
[NCBI]
|
1.06861e-05
|
|
|
CHRNA5
|
[NCBI]
|
1.06861e-05
|
|
|
MAGEA2
|
[NCBI]
|
1.06861e-05
|
|
|
MFAP1
|
[NCBI]
|
1.06861e-05
|
|
|
PFN2
|
[NCBI]
|
1.06861e-05
|
|
|
JRK
|
[NCBI]
|
1.06861e-05
|
|
|
kindlin 1
|
[NCBI]
|
1.06861e-05
|
|
|
HDLBP
|
[NCBI]
|
1.06861e-05
|
|
|
CENPI
|
[NCBI]
|
1.06861e-05
|
|
|
ITGA7
|
[NCBI]
|
1.06861e-05
|
|
|
SLITRK1
|
[NCBI]
|
1.06861e-05
|
|
|
hemoglobin--alpha locus 3
|
[NCBI]
|
1.06861e-05
|
|
|
EGR4
|
[NCBI]
|
1.06861e-05
|
|
|
CTSH
|
[NCBI]
|
1.06861e-05
|
|
|
TRIOBP
|
[NCBI]
|
1.06861e-05
|
|
|
ACTN2
|
[NCBI]
|
1.06861e-05
|
|
|
GNAI3
|
[NCBI]
|
1.06861e-05
|
|
|
minor histocompatibility antigen ha-2
|
[NCBI]
|
1.06861e-05
|
|
|
GPR48
|
[NCBI]
|
1.06861e-05
|
|
|
ARFGEF2
|
[NCBI]
|
1.06861e-05
|
|
|
GPD1L
|
[NCBI]
|
1.06861e-05
|
|
|
HSPCB
|
[NCBI]
|
1.06861e-05
|
|
|
SIRT5
|
[NCBI]
|
1.06861e-05
|
|
|
GSTM3
|
[NCBI]
|
1.06861e-05
|
|
|
IGHA1
|
[NCBI]
|
1.06861e-05
|
|
|
NEF3
|
[NCBI]
|
1.06861e-05
|
|
|
TRPM6
|
[NCBI]
|
1.06861e-05
|
|
|
MAGEB2
|
[NCBI]
|
1.06861e-05
|
|
|
CGB7
|
[NCBI]
|
1.06861e-05
|
|
|
TRMI1
|
[NCBI]
|
1.06861e-05
|
|
|
BAT3
|
[NCBI]
|
1.06861e-05
|
|
|
ATP11B
|
[NCBI]
|
1.06861e-05
|
|
|
GABRB1
|
[NCBI]
|
1.06861e-05
|
|
|
CTLA4
|
[NCBI]
|
1.06056e-05
|
|
|
growth hormone insensitivity syndrome
|
[NCBI]
|
1.03919e-05
|
|
|
AMY1A
|
[NCBI]
|
1.02905e-05
|
|
|
udp-n-acetylglucosamine 2-epimerase/n-acetylmannosamine kinase
|
[NCBI]
|
1.02905e-05
|
|
|
WNK1
|
[NCBI]
|
1.02905e-05
|
|
|
CSF1
|
[NCBI]
|
1.02905e-05
|
|
|
PHB
|
[NCBI]
|
1.02905e-05
|
|
|
PHOX2B
|
[NCBI]
|
1.02905e-05
|
|
|
C9
|
[NCBI]
|
1.02905e-05
|
|
|
bullous erythroderma ichthyosiformis congenita of brocq
|
[NCBI]
|
1.01957e-05
|
|
|
OPTB1
|
[NCBI]
|
1.00668e-05
|
|
|
apc gene
|
[NCBI]
|
9.97083e-06
|
|
|
THRB
|
[NCBI]
|
9.92752e-06
|
|
|
FSHR
|
[NCBI]
|
9.92752e-06
|
|
|
NRL
|
[NCBI]
|
9.82064e-06
|
|
|
CHRNA1
|
[NCBI]
|
9.82064e-06
|
|
|
HLA-G
|
[NCBI]
|
9.82064e-06
|
|
|
PEX7
|
[NCBI]
|
9.82064e-06
|
|
|
HR
|
[NCBI]
|
9.82064e-06
|
|
|
TCRA
|
[NCBI]
|
9.72104e-06
|
|
|
homocystinuria due to deficiency of n(5,10)-methylenetetrahydrofolate reductase activity
|
[NCBI]
|
9.67516e-06
|
|
|
mucolipidosis ii
|
[NCBI]
|
9.67516e-06
|
|
|
VLDLR
|
[NCBI]
|
9.444e-06
|
|
|
FAAH
|
[NCBI]
|
9.39226e-06
|
|
|
HLA-DQB1
|
[NCBI]
|
9.37784e-06
|
|
|
SYP
|
[NCBI]
|
9.37784e-06
|
|
|
HOXD13
|
[NCBI]
|
9.37784e-06
|
|
|
IL1RN
|
[NCBI]
|
9.37784e-06
|
|
|
CEBPD
|
[NCBI]
|
9.29398e-06
|
|
|
IL3RA
|
[NCBI]
|
9.29398e-06
|
|
|
GPR44
|
[NCBI]
|
9.29398e-06
|
|
|
COL13A1
|
[NCBI]
|
9.29398e-06
|
|
|
AARS
|
[NCBI]
|
9.29398e-06
|
|
|
GLMN
|
[NCBI]
|
9.29398e-06
|
|
|
KARS
|
[NCBI]
|
9.29398e-06
|
|
|
CLCNKA
|
[NCBI]
|
9.29398e-06
|
|
|
MTMR3
|
[NCBI]
|
9.29398e-06
|
|
|
g30 gene
|
[NCBI]
|
9.29398e-06
|
|
|
NFKBIL1
|
[NCBI]
|
9.29398e-06
|
|
|
SQLE
|
[NCBI]
|
9.29398e-06
|
|
|
EHF
|
[NCBI]
|
9.29398e-06
|
|
|
STRC
|
[NCBI]
|
9.29398e-06
|
|
|
ABCA12
|
[NCBI]
|
9.29398e-06
|
|
|
CD84
|
[NCBI]
|
9.29398e-06
|
|
|
PLOD2
|
[NCBI]
|
9.29398e-06
|
|
|
saitohin
|
[NCBI]
|
9.29398e-06
|
|
|
AP1S2
|
[NCBI]
|
9.29398e-06
|
|
|
C1S
|
[NCBI]
|
9.29398e-06
|
|
|
CGB2
|
[NCBI]
|
9.29398e-06
|
|
|
GABRA3
|
[NCBI]
|
9.29398e-06
|
|
|
CLTCL1
|
[NCBI]
|
9.29398e-06
|
|
|
MANBA
|
[NCBI]
|
9.29398e-06
|
|
|
CPA4
|
[NCBI]
|
9.29398e-06
|
|
|
MX1
|
[NCBI]
|
9.29398e-06
|
|
|
ATP5A1
|
[NCBI]
|
9.29398e-06
|
|
|
DNAH5
|
[NCBI]
|
9.29398e-06
|
|
|
PIP5K3
|
[NCBI]
|
9.29398e-06
|
|
|
FOXE3
|
[NCBI]
|
9.29398e-06
|
|
|
SIRT4
|
[NCBI]
|
9.29398e-06
|
|
|
OSTM1
|
[NCBI]
|
9.29398e-06
|
|
|
HSPA6
|
[NCBI]
|
9.29398e-06
|
|
|
NBL1
|
[NCBI]
|
9.29398e-06
|
|
|
piwi-like 2: piwil2
|
[NCBI]
|
9.29398e-06
|
|
|
GRM7
|
[NCBI]
|
9.29398e-06
|
|
|
GABRA6
|
[NCBI]
|
9.29398e-06
|
|
|
CCT
|
[NCBI]
|
9.29398e-06
|
|
|
TNS1
|
[NCBI]
|
9.29398e-06
|
|
|
MAGED1
|
[NCBI]
|
9.29398e-06
|
|
|
pepsinogen c
|
[NCBI]
|
9.29398e-06
|
|
|
DUSP2
|
[NCBI]
|
9.29398e-06
|
|
|
CRYGS
|
[NCBI]
|
9.29398e-06
|
|
|
neuroblastoma stage 4s gene
|
[NCBI]
|
9.29398e-06
|
|
|
SSPN
|
[NCBI]
|
9.29398e-06
|
|
|
U2AF1
|
[NCBI]
|
9.29398e-06
|
|
|
EFEMP1
|
[NCBI]
|
9.29398e-06
|
|
|
PCTK1
|
[NCBI]
|
9.29398e-06
|
|
|
EDARADD
|
[NCBI]
|
9.29398e-06
|
|
|
ASGR1
|
[NCBI]
|
9.29398e-06
|
|
|
VAPB
|
[NCBI]
|
9.29398e-06
|
|
|
RPS24
|
[NCBI]
|
9.29398e-06
|
|
|
ROBO3
|
[NCBI]
|
9.29398e-06
|
|
|
HMGN1
|
[NCBI]
|
9.29398e-06
|
|
|
DCAMKL1
|
[NCBI]
|
9.29398e-06
|
|
|
SLC7A2
|
[NCBI]
|
9.29398e-06
|
|
|
FBP1
|
[NCBI]
|
9.29398e-06
|
|
|
ITIH3
|
[NCBI]
|
9.29398e-06
|
|
|
FLOT2
|
[NCBI]
|
9.29398e-06
|
|
|
NDUFA2
|
[NCBI]
|
9.29398e-06
|
|
|
TBC1D25
|
[NCBI]
|
9.29398e-06
|
|
|
SLC20A1
|
[NCBI]
|
9.29398e-06
|
|
|
THOP1
|
[NCBI]
|
9.29398e-06
|
|
|
MAGEE1
|
[NCBI]
|
9.29398e-06
|
|
|
RPS11
|
[NCBI]
|
9.29398e-06
|
|
|
PRKCSH
|
[NCBI]
|
9.29398e-06
|
|
|
A1BG
|
[NCBI]
|
9.29398e-06
|
|
|
RPL21
|
[NCBI]
|
9.29398e-06
|
|
|
ATP6AP2
|
[NCBI]
|
9.29398e-06
|
|
|
ABCC11
|
[NCBI]
|
9.29398e-06
|
|
|
TGFA
|
[NCBI]
|
9.29398e-06
|
|
|
TGM5
|
[NCBI]
|
9.29398e-06
|
|
|
EDG2
|
[NCBI]
|
9.29398e-06
|
|
|
TSTA3
|
[NCBI]
|
9.29398e-06
|
|
|
ETFA
|
[NCBI]
|
9.29398e-06
|
|
|
RPL23
|
[NCBI]
|
9.29398e-06
|
|
|
CD53
|
[NCBI]
|
9.29398e-06
|
|
|
VAX2
|
[NCBI]
|
9.29398e-06
|
|
|
MCC
|
[NCBI]
|
9.29398e-06
|
|
|
PHF8
|
[NCBI]
|
9.29398e-06
|
|
|
ACLY
|
[NCBI]
|
9.29398e-06
|
|
|
KCNC3
|
[NCBI]
|
9.29398e-06
|
|
|
ITGB7
|
[NCBI]
|
9.29398e-06
|
|
|
LILRB2
|
[NCBI]
|
9.29398e-06
|
|
|
PUS1
|
[NCBI]
|
9.29398e-06
|
|
|
BAPX1
|
[NCBI]
|
9.29398e-06
|
|
|
MTX1
|
[NCBI]
|
9.29398e-06
|
|
|
PRM2
|
[NCBI]
|
9.29398e-06
|
|
|
VCX3A
|
[NCBI]
|
9.29398e-06
|
|
|
CGB1
|
[NCBI]
|
9.29398e-06
|
|
|
HLA-E
|
[NCBI]
|
9.29398e-06
|
|
|
PDGFC
|
[NCBI]
|
9.29398e-06
|
|
|
DDT
|
[NCBI]
|
9.29398e-06
|
|
|
IRAK3
|
[NCBI]
|
9.29398e-06
|
|
|
GBP1
|
[NCBI]
|
9.29398e-06
|
|
|
ERMAP
|
[NCBI]
|
9.29398e-06
|
|
|
NCK1
|
[NCBI]
|
9.29398e-06
|
|
|
multiple coagulation factor deficiency protein 2
|
[NCBI]
|
9.29398e-06
|
|
|
NPY2R
|
[NCBI]
|
9.29398e-06
|
|
|
MEA1
|
[NCBI]
|
9.29398e-06
|
|
|
HRC
|
[NCBI]
|
9.29398e-06
|
|
|
KLRC2
|
[NCBI]
|
9.29398e-06
|
|
|
MIRN133A2
|
[NCBI]
|
9.29398e-06
|
|
|
SEC13L1
|
[NCBI]
|
9.29398e-06
|
|
|
MYOG
|
[NCBI]
|
9.29398e-06
|
|
|
UPF3B
|
[NCBI]
|
9.29398e-06
|
|
|
AP3B2
|
[NCBI]
|
9.29398e-06
|
|
|
GPC4
|
[NCBI]
|
9.29398e-06
|
|
|
SH3TC2
|
[NCBI]
|
9.29398e-06
|
|
|
ELAVL3
|
[NCBI]
|
9.29398e-06
|
|
|
AK2
|
[NCBI]
|
9.29398e-06
|
|
|
HLX1
|
[NCBI]
|
9.29398e-06
|
|
|
PYCS
|
[NCBI]
|
9.29398e-06
|
|
|
MIRN133A1
|
[NCBI]
|
9.29398e-06
|
|
|
NLRP1
|
[NCBI]
|
9.29398e-06
|
|
|
STX16
|
[NCBI]
|
9.29398e-06
|
|
|
RFX1
|
[NCBI]
|
9.29398e-06
|
|
|
pseudoxanthoma elasticum, forme fruste
|
[NCBI]
|
9.24529e-06
|
|
|
diabetes insipidus, neurohypophyseal type
|
[NCBI]
|
9.24529e-06
|
|
|
lecithin:cholesterol acyltransferase deficiency
|
[NCBI]
|
9.24529e-06
|
|
|
VED
|
[NCBI]
|
9.24529e-06
|
|
|
hartnup disorder
|
[NCBI]
|
9.24529e-06
|
|
|
HSAN2
|
[NCBI]
|
9.24529e-06
|
|
|
IFNG
|
[NCBI]
|
9.17522e-06
|
|
|
methemoglobinemia due to deficiency of methemoglobin reductase
|
[NCBI]
|
9.17522e-06
|
|
|
PHS
|
[NCBI]
|
8.99547e-06
|
|
|
CVID
|
[NCBI]
|
8.99445e-06
|
|
|
DCK
|
[NCBI]
|
8.97841e-06
|
|
|
neuraminidase deficiency
|
[NCBI]
|
8.97272e-06
|
|
|
lactase persistence
|
[NCBI]
|
8.97272e-06
|
|
|
PLAT
|
[NCBI]
|
8.95969e-06
|
|
|
AACT
|
[NCBI]
|
8.95969e-06
|
|
|
HBEGF
|
[NCBI]
|
8.95969e-06
|
|
|
RHD
|
[NCBI]
|
8.95969e-06
|
|
|
APTX
|
[NCBI]
|
8.95969e-06
|
|
|
ALAD
|
[NCBI]
|
8.91436e-06
|
|
|
HSR
|
[NCBI]
|
8.56411e-06
|
|
|
CDSN
|
[NCBI]
|
8.56411e-06
|
|
|
IRF1
|
[NCBI]
|
8.56411e-06
|
|
|
LDHA
|
[NCBI]
|
8.56411e-06
|
|
|
MTND3
|
[NCBI]
|
8.56411e-06
|
|
|
PINK1
|
[NCBI]
|
8.56411e-06
|
|
|
GRP
|
[NCBI]
|
8.48642e-06
|
|
|
NP
|
[NCBI]
|
8.41513e-06
|
|
|
GC
|
[NCBI]
|
8.4143e-06
|
|
|
LIS2
|
[NCBI]
|
8.36174e-06
|
|
|
LGMD2F
|
[NCBI]
|
8.36174e-06
|
|
|
UL
|
[NCBI]
|
8.36174e-06
|
|
|
CGL1
|
[NCBI]
|
8.36174e-06
|
|
|
polydactyly, preaxial iv
|
[NCBI]
|
8.36174e-06
|
|
|
basal ganglia disease, adult-onset
|
[NCBI]
|
8.36174e-06
|
|
|
DFNA20
|
[NCBI]
|
8.36174e-06
|
|
|
boomerang dysplasia
|
[NCBI]
|
8.36174e-06
|
|
|
hemoglobin--variants for which the chain carrying the mutation is unknown or uncertain
|
[NCBI]
|
8.36174e-06
|
|
|
USH2C
|
[NCBI]
|
8.36174e-06
|
|
|
CMD1E
|
[NCBI]
|
8.36174e-06
|
|
|
intestinal pseudoobstruction, neuronal, chronic idiopathic, x-linked
|
[NCBI]
|
8.36174e-06
|
|
|
oguchi disease
|
[NCBI]
|
8.36174e-06
|
|
|
alternating hemiplegia of childhood
|
[NCBI]
|
8.36174e-06
|
|
|
leukodystrophy, adult-onset, autosomal dominant
|
[NCBI]
|
8.36174e-06
|
|
|
CMRD
|
[NCBI]
|
8.36174e-06
|
|
|
myopathy, centronuclear, autosomal dominant
|
[NCBI]
|
8.36174e-06
|
|
|
MRXSL
|
[NCBI]
|
8.36174e-06
|
|
|
HOA
|
[NCBI]
|
8.36174e-06
|
|
|
SPG13
|
[NCBI]
|
8.36174e-06
|
|
|
leiomyomatosis, esophageal and vulval, with nephropathy
|
[NCBI]
|
8.36174e-06
|
|
|
CCM2
|
[NCBI]
|
8.36174e-06
|
|
|
SHFM4
|
[NCBI]
|
8.36174e-06
|
|
|
amyloidosis vii
|
[NCBI]
|
8.36174e-06
|
|
|
HOMG2
|
[NCBI]
|
8.36174e-06
|
|
|
cherubism
|
[NCBI]
|
8.36174e-06
|
|
|
charcot-marie-tooth disease and deafness
|
[NCBI]
|
8.36174e-06
|
|
|
patterned dystrophy of retinal pigment epithelium
|
[NCBI]
|
8.36174e-06
|
|
|
thyroxine-binding globulin of serum
|
[NCBI]
|
8.36174e-06
|
|
|
fibular aplasia or hypoplasia, femoral bowing and poly-, syn-, and oligodactyly
|
[NCBI]
|
8.36174e-06
|
|
|
HCA2
|
[NCBI]
|
8.36174e-06
|
|
|
PVOD
|
[NCBI]
|
8.36174e-06
|
|
|
azoospermia due to perturbations of meiosis
|
[NCBI]
|
8.36174e-06
|
|
|
myotonia, potassium-aggravated
|
[NCBI]
|
8.36174e-06
|
|
|
SMA3
|
[NCBI]
|
8.28533e-06
|
|
|
HMBS
|
[NCBI]
|
8.28497e-06
|
|
|
FGR
|
[NCBI]
|
8.20718e-06
|
|
|
ITIH4
|
[NCBI]
|
8.20718e-06
|
|
|
ABCB7
|
[NCBI]
|
8.20718e-06
|
|
|
VSX1
|
[NCBI]
|
8.20718e-06
|
|
|
ANXA4
|
[NCBI]
|
8.20718e-06
|
|
|
CHRNB4
|
[NCBI]
|
8.20718e-06
|
|
|
KCNN3
|
[NCBI]
|
8.20718e-06
|
|
|
NLRP7
|
[NCBI]
|
8.20718e-06
|
|
|
DBP
|
[NCBI]
|
8.20718e-06
|
|
|
PDHX
|
[NCBI]
|
8.20718e-06
|
|
|
CDH5
|
[NCBI]
|
8.20718e-06
|
|
|
LSS
|
[NCBI]
|
8.20718e-06
|
|
|
NUP214
|
[NCBI]
|
8.20718e-06
|
|
|
RHOB
|
[NCBI]
|
8.20718e-06
|
|
|
HCN4
|
[NCBI]
|
8.20718e-06
|
|
|
CMA1
|
[NCBI]
|
8.20718e-06
|
|
|
RDX
|
[NCBI]
|
8.20718e-06
|
|
|
CEACAM3
|
[NCBI]
|
8.20718e-06
|
|
|
GRIK2
|
[NCBI]
|
8.20718e-06
|
|
|
bsnd gene
|
[NCBI]
|
8.20718e-06
|
|
|
ANK2
|
[NCBI]
|
8.20718e-06
|
|
|
NPHS2
|
[NCBI]
|
8.20718e-06
|
|
|
THBS3
|
[NCBI]
|
8.20718e-06
|
|
|
CD163
|
[NCBI]
|
8.20718e-06
|
|
|
SBF2
|
[NCBI]
|
8.20718e-06
|
|
|
SULT2A1
|
[NCBI]
|
8.20718e-06
|
|
|
MYCL1
|
[NCBI]
|
8.20718e-06
|
|
|
MAGEA1
|
[NCBI]
|
8.20718e-06
|
|
|
RSPO4
|
[NCBI]
|
8.20718e-06
|
|
|
UGT2B17
|
[NCBI]
|
8.20718e-06
|
|
|
MYL2
|
[NCBI]
|
8.20718e-06
|
|
|
PKD2L1
|
[NCBI]
|
8.20718e-06
|
|
|
CSDE1
|
[NCBI]
|
8.20718e-06
|
|
|
GJB4
|
[NCBI]
|
8.20718e-06
|
|
|
ALOX15
|
[NCBI]
|
8.20718e-06
|
|
|
BCOR
|
[NCBI]
|
8.20718e-06
|
|
|
ATP6V1B1
|
[NCBI]
|
8.20718e-06
|
|
|
S100A6
|
[NCBI]
|
8.20718e-06
|
|
|
TCP1
|
[NCBI]
|
8.20718e-06
|
|
|
SLC2A10
|
[NCBI]
|
8.20718e-06
|
|
|
ANXA8
|
[NCBI]
|
8.20718e-06
|
|
|
SCN2B
|
[NCBI]
|
8.20718e-06
|
|
|
POU2F2
|
[NCBI]
|
8.20718e-06
|
|
|
MALAT1
|
[NCBI]
|
8.20718e-06
|
|
|
PCDH8
|
[NCBI]
|
8.20718e-06
|
|
|
MIRN124A1
|
[NCBI]
|
8.20718e-06
|
|
|
PLEKHC1
|
[NCBI]
|
8.20718e-06
|
|
|
MOCS1
|
[NCBI]
|
8.20718e-06
|
|
|
IL11RA
|
[NCBI]
|
8.20718e-06
|
|
|
NTF5
|
[NCBI]
|
8.20718e-06
|
|
|
RAB8A
|
[NCBI]
|
8.20718e-06
|
|
|
P2RX4
|
[NCBI]
|
8.20718e-06
|
|
|
STX11
|
[NCBI]
|
8.20718e-06
|
|
|
ARF4
|
[NCBI]
|
8.20718e-06
|
|
|
PRB3
|
[NCBI]
|
8.20718e-06
|
|
|
CASQ1
|
[NCBI]
|
8.20718e-06
|
|
|
DLG5
|
[NCBI]
|
8.20718e-06
|
|
|
GPRK2L
|
[NCBI]
|
8.20718e-06
|
|
|
POU4F3
|
[NCBI]
|
8.20718e-06
|
|
|
MFRP
|
[NCBI]
|
8.20718e-06
|
|
|
IL17RA
|
[NCBI]
|
8.20718e-06
|
|
|
SYNJ1
|
[NCBI]
|
8.20718e-06
|
|
|
EHD1
|
[NCBI]
|
8.20718e-06
|
|
|
IGSF1
|
[NCBI]
|
8.20718e-06
|
|
|
regulatory associated protein of mtor
|
[NCBI]
|
8.20718e-06
|
|
|
MAK
|
[NCBI]
|
8.20718e-06
|
|
|
UBE2B
|
[NCBI]
|
8.20718e-06
|
|
|
FANCM
|
[NCBI]
|
8.20718e-06
|
|
|
CASK
|
[NCBI]
|
8.20718e-06
|
|
|
HMCN1
|
[NCBI]
|
8.20718e-06
|
|
|
TOPORS
|
[NCBI]
|
8.20718e-06
|
|
|
FUCA2
|
[NCBI]
|
8.20718e-06
|
|
|
C4BPB
|
[NCBI]
|
8.20718e-06
|
|
|
PI7
|
[NCBI]
|
8.20718e-06
|
|
|
HK3
|
[NCBI]
|
8.20718e-06
|
|
|
KIF11
|
[NCBI]
|
8.20718e-06
|
|
|
E4F1
|
[NCBI]
|
8.20718e-06
|
|
|
AGPAT2
|
[NCBI]
|
8.20718e-06
|
|
|
NKX2E
|
[NCBI]
|
8.18923e-06
|
|
|
MTCO3
|
[NCBI]
|
8.18923e-06
|
|
|
SLC12A3
|
[NCBI]
|
8.18923e-06
|
|
|
MAP1B
|
[NCBI]
|
8.17617e-06
|
|
|
testicular tumors
|
[NCBI]
|
8.01008e-06
|
|
|
TS
|
[NCBI]
|
7.9929e-06
|
|
|
COL1A1
|
[NCBI]
|
7.94759e-06
|
|
|
MKKS
|
[NCBI]
|
7.89899e-06
|
|
|
alkaptonuria
|
[NCBI]
|
7.89899e-06
|
|
|
acromegaly
|
[NCBI]
|
7.89899e-06
|
|
|
CIPA
|
[NCBI]
|
7.89899e-06
|
|
|
RSMD1
|
[NCBI]
|
7.89899e-06
|
|
|
HAE
|
[NCBI]
|
7.84635e-06
|
|
|
HSAN3
|
[NCBI]
|
7.84635e-06
|
|
|
LDHB
|
[NCBI]
|
7.83344e-06
|
|
|
HTR2A
|
[NCBI]
|
7.83344e-06
|
|
|
pta deficiency
|
[NCBI]
|
7.83344e-06
|
|
|
MTND2
|
[NCBI]
|
7.83344e-06
|
|
|
ADA
|
[NCBI]
|
7.75276e-06
|
|
|
CLL
|
[NCBI]
|
7.61387e-06
|
|
|
sandhoff disease
|
[NCBI]
|
7.61387e-06
|
|
|
PLG
|
[NCBI]
|
7.5586e-06
|
|
|
ADH2
|
[NCBI]
|
7.49529e-06
|
|
|
COL4A3
|
[NCBI]
|
7.49529e-06
|
|
|
CDC42
|
[NCBI]
|
7.49529e-06
|
|
|
OPA1
|
[NCBI]
|
7.49529e-06
|
|
|
MKS1
|
[NCBI]
|
7.4251e-06
|
|
|
CDK4
|
[NCBI]
|
7.35982e-06
|
|
|
VNN1
|
[NCBI]
|
7.32211e-06
|
|
|
PRCC
|
[NCBI]
|
7.32211e-06
|
|
|
FBXW4
|
[NCBI]
|
7.32211e-06
|
|
|
SLC25A5
|
[NCBI]
|
7.32211e-06
|
|
|
DLX2
|
[NCBI]
|
7.32211e-06
|
|
|
CHD7
|
[NCBI]
|
7.32211e-06
|
|
|
MUC3A
|
[NCBI]
|
7.32211e-06
|
|
|
CRYBA4
|
[NCBI]
|
7.32211e-06
|
|
|
CLEC4A
|
[NCBI]
|
7.32211e-06
|
|
|
NEGF2
|
[NCBI]
|
7.32211e-06
|
|
|
GNAT1
|
[NCBI]
|
7.32211e-06
|
|
|
PRPS2
|
[NCBI]
|
7.32211e-06
|
|
|
ATP2B1
|
[NCBI]
|
7.32211e-06
|
|
|
GNA11
|
[NCBI]
|
7.32211e-06
|
|
|
ARIX
|
[NCBI]
|
7.32211e-06
|
|
|
KCNQ3
|
[NCBI]
|
7.32211e-06
|
|
|
ANK3
|
[NCBI]
|
7.32211e-06
|
|
|
PRKCB1
|
[NCBI]
|
7.32211e-06
|
|
|
NPAT
|
[NCBI]
|
7.32211e-06
|
|
|
NKX2-2
|
[NCBI]
|
7.32211e-06
|
|
|
MPP1
|
[NCBI]
|
7.32211e-06
|
|
|
PCMT1
|
[NCBI]
|
7.32211e-06
|
|
|
NDUFS8
|
[NCBI]
|
7.32211e-06
|
|
|
WNT2
|
[NCBI]
|
7.32211e-06
|
|
|
LST1
|
[NCBI]
|
7.32211e-06
|
|
|
CD6
|
[NCBI]
|
7.32211e-06
|
|
|
S100A9
|
[NCBI]
|
7.32211e-06
|
|
|
UNC5C
|
[NCBI]
|
7.32211e-06
|
|
|
HOXD10
|
[NCBI]
|
7.32211e-06
|
|
|
SART3
|
[NCBI]
|
7.32211e-06
|
|
|
CAPN1
|
[NCBI]
|
7.32211e-06
|
|
|
RYK
|
[NCBI]
|
7.32211e-06
|
|
|
LHX8
|
[NCBI]
|
7.32211e-06
|
|
|
CACNA2D1
|
[NCBI]
|
7.32211e-06
|
|
|
HRPT2
|
[NCBI]
|
7.32211e-06
|
|
|
DYX1C1
|
[NCBI]
|
7.32211e-06
|
|
|
GREM1
|
[NCBI]
|
7.32211e-06
|
|
|
HLA-DPB1
|
[NCBI]
|
7.32211e-06
|
|
|
PCK1
|
[NCBI]
|
7.32211e-06
|
|
|
SORL1
|
[NCBI]
|
7.32211e-06
|
|
|
PDE6G
|
[NCBI]
|
7.32211e-06
|
|
|
CA3
|
[NCBI]
|
7.32211e-06
|
|
|
VPS13A
|
[NCBI]
|
7.32211e-06
|
|
|
SATB2
|
[NCBI]
|
7.32211e-06
|
|
|
UGT2B4
|
[NCBI]
|
7.32211e-06
|
|
|
UCHL3
|
[NCBI]
|
7.32211e-06
|
|
|
PI6
|
[NCBI]
|
7.32211e-06
|
|
|
LIPE
|
[NCBI]
|
7.32211e-06
|
|
|
IL5RA
|
[NCBI]
|
7.32211e-06
|
|
|
NHLH1
|
[NCBI]
|
7.32211e-06
|
|
|
P4HA1
|
[NCBI]
|
7.32211e-06
|
|
|
AMELY
|
[NCBI]
|
7.32211e-06
|
|
|
S100A1
|
[NCBI]
|
7.32211e-06
|
|
|
NPY1R
|
[NCBI]
|
7.32211e-06
|
|
|
MYH2
|
[NCBI]
|
7.32211e-06
|
|
|
RPL29
|
[NCBI]
|
7.32211e-06
|
|
|
SEMA4A
|
[NCBI]
|
7.32211e-06
|
|
|
GCLC
|
[NCBI]
|
7.32211e-06
|
|
|
PTPNS1
|
[NCBI]
|
7.32211e-06
|
|
|
GTF2I
|
[NCBI]
|
7.32211e-06
|
|
|
IL15RA
|
[NCBI]
|
7.32211e-06
|
|
|
CLN8
|
[NCBI]
|
7.32211e-06
|
|
|
HAGH
|
[NCBI]
|
7.32211e-06
|
|
|
EPHB3
|
[NCBI]
|
7.32211e-06
|
|
|
CKB
|
[NCBI]
|
7.32211e-06
|
|
|
TIMP3
|
[NCBI]
|
7.1735e-06
|
|
|
DYT1
|
[NCBI]
|
7.1735e-06
|
|
|
IFNGR1
|
[NCBI]
|
7.1735e-06
|
|
|
UCP3
|
[NCBI]
|
7.14592e-06
|
|
|
NRCLP1
|
[NCBI]
|
7.10448e-06
|
|
|
DCC
|
[NCBI]
|
6.87545e-06
|
|
|
PSEN2
|
[NCBI]
|
6.87545e-06
|
|
|
PITX2
|
[NCBI]
|
6.86691e-06
|
|
|
THRA
|
[NCBI]
|
6.86691e-06
|
|
|
CALCA
|
[NCBI]
|
6.86691e-06
|
|
|
TCRB
|
[NCBI]
|
6.86691e-06
|
|
|
NOG
|
[NCBI]
|
6.86691e-06
|
|
|
IGF2R
|
[NCBI]
|
6.86691e-06
|
|
|
OPMD
|
[NCBI]
|
6.78344e-06
|
|
|
leopard syndrome 1
|
[NCBI]
|
6.71016e-06
|
|
|
SHEP2
|
[NCBI]
|
6.71016e-06
|
|
|
IGF2
|
[NCBI]
|
6.67876e-06
|
|
|
NLGN3
|
[NCBI]
|
6.58043e-06
|
|
|
LAMB2
|
[NCBI]
|
6.58043e-06
|
|
|
CSRP2
|
[NCBI]
|
6.58043e-06
|
|
|
PAI2
|
[NCBI]
|
6.58043e-06
|
|
|
IL10RB
|
[NCBI]
|
6.58043e-06
|
|
|
TRPM7
|
[NCBI]
|
6.58043e-06
|
|
|
HSD17B1
|
[NCBI]
|
6.58043e-06
|
|
|
DNASE2
|
[NCBI]
|
6.58043e-06
|
|
|
GLRA2
|
[NCBI]
|
6.58043e-06
|
|
|
PDIA3
|
[NCBI]
|
6.58043e-06
|
|
|
MAP2K4
|
[NCBI]
|
6.58043e-06
|
|
|
GRIA4
|
[NCBI]
|
6.58043e-06
|
|
|
GFRA1
|
[NCBI]
|
6.58043e-06
|
|
|
EVC2
|
[NCBI]
|
6.58043e-06
|
|
|
CLCN4
|
[NCBI]
|
6.58043e-06
|
|
|
FLNC
|
[NCBI]
|
6.58043e-06
|
|
|
USP9Y
|
[NCBI]
|
6.58043e-06
|
|
|
GCGR
|
[NCBI]
|
6.58043e-06
|
|
|
RHOC
|
[NCBI]
|
6.58043e-06
|
|
|
ALX4
|
[NCBI]
|
6.58043e-06
|
|
|
NOVA1
|
[NCBI]
|
6.58043e-06
|
|
|
CRYBB1
|
[NCBI]
|
6.58043e-06
|
|
|
PODXL
|
[NCBI]
|
6.58043e-06
|
|
|
GSTA2
|
[NCBI]
|
6.58043e-06
|
|
|
TNFSF14
|
[NCBI]
|
6.58043e-06
|
|
|
SLC22A4
|
[NCBI]
|
6.58043e-06
|
|
|
complement component 8 deficiency, type ii
|
[NCBI]
|
6.58043e-06
|
|
|
LILRB1
|
[NCBI]
|
6.58043e-06
|
|
|
RPL4
|
[NCBI]
|
6.58043e-06
|
|
|
PTGIR
|
[NCBI]
|
6.58043e-06
|
|
|
TBL1X
|
[NCBI]
|
6.58043e-06
|
|
|
LAMP1
|
[NCBI]
|
6.58043e-06
|
|
|
LPIN2
|
[NCBI]
|
6.58043e-06
|
|
|
TBX4
|
[NCBI]
|
6.58043e-06
|
|
|
S100A7
|
[NCBI]
|
6.58043e-06
|
|
|
GNB2L1
|
[NCBI]
|
6.58043e-06
|
|
|
ODF1
|
[NCBI]
|
6.58043e-06
|
|
|
S100A4
|
[NCBI]
|
6.58043e-06
|
|
|
MLLT7
|
[NCBI]
|
6.58043e-06
|
|
|
TAS2R16
|
[NCBI]
|
6.58043e-06
|
|
|
CENPJ
|
[NCBI]
|
6.58043e-06
|
|
|
FSCN2
|
[NCBI]
|
6.58043e-06
|
|
|
PKN1
|
[NCBI]
|
6.58043e-06
|
|
|
OPRK1
|
[NCBI]
|
6.58043e-06
|
|
|
EPB72
|
[NCBI]
|
6.58043e-06
|
|
|
SLC4A7
|
[NCBI]
|
6.58043e-06
|
|
|
BLVRA
|
[NCBI]
|
6.58043e-06
|
|
|
CD86
|
[NCBI]
|
6.58043e-06
|
|
|
ISL1
|
[NCBI]
|
6.58043e-06
|
|
|
CCL4L1
|
[NCBI]
|
6.58043e-06
|
|
|
ROM1
|
[NCBI]
|
6.58043e-06
|
|
|
LOXL1
|
[NCBI]
|
6.58043e-06
|
|
|
BAT1
|
[NCBI]
|
6.58043e-06
|
|
|
GIPR
|
[NCBI]
|
6.58043e-06
|
|
|
CHRNG
|
[NCBI]
|
6.58043e-06
|
|
|
PLCG1
|
[NCBI]
|
6.58043e-06
|
|
|
CHMP2B
|
[NCBI]
|
6.58043e-06
|
|
|
KIF1B
|
[NCBI]
|
6.58043e-06
|
|
|
BCS1L
|
[NCBI]
|
6.58043e-06
|
|
|
ATP10A
|
[NCBI]
|
6.58043e-06
|
|
|
AREG
|
[NCBI]
|
6.5745e-06
|
|
|
SMN1
|
[NCBI]
|
6.53234e-06
|
|
|
CDKN2A
|
[NCBI]
|
6.48537e-06
|
|
|
FECD2
|
[NCBI]
|
6.45646e-06
|
|
|
visceral neuropathy, familial, autosomal recessive
|
[NCBI]
|
6.45646e-06
|
|
|
nevi flammei, familial multiple
|
[NCBI]
|
6.45646e-06
|
|
|
molar i reinclusion
|
[NCBI]
|
6.45646e-06
|
|
|
HBD
|
[NCBI]
|
6.45646e-06
|
|
|
x inactivation, familial skewed, 2
|
[NCBI]
|
6.45646e-06
|
|
|
spinal muscular atrophy, childhood, proximal, autosomal dominant
|
[NCBI]
|
6.45646e-06
|
|
|
syndactyly, type i
|
[NCBI]
|
6.45646e-06
|
|
|
SPG23
|
[NCBI]
|
6.45646e-06
|
|
|
EFMR
|
[NCBI]
|
6.45646e-06
|
|
|
cerebral palsy, ataxic, autosomal recessive
|
[NCBI]
|
6.45646e-06
|
|
|
anosmia, congenital
|
[NCBI]
|
6.45646e-06
|
|
|
MJD
|
[NCBI]
|
6.3527e-06
|
|
|
costello syndrome
|
[NCBI]
|
6.32256e-06
|
|
|
mitochondrial complex iv deficiency
|
[NCBI]
|
6.32256e-06
|
|
|
TGFBR2
|
[NCBI]
|
6.29533e-06
|
|
|
ACVRL1
|
[NCBI]
|
6.29533e-06
|
|
|
IL1B
|
[NCBI]
|
6.29533e-06
|
|
|
RBP4
|
[NCBI]
|
6.29533e-06
|
|
|
CLN6
|
[NCBI]
|
6.25044e-06
|
|
|
KNO
|
[NCBI]
|
6.25044e-06
|
|
|
ulna and fibula, absence of, with severe limb deficiency
|
[NCBI]
|
6.25044e-06
|
|
|
HMS
|
[NCBI]
|
6.25044e-06
|
|
|
hypotrichosis simplex of scalp
|
[NCBI]
|
6.25044e-06
|
|
|
MCOPS9
|
[NCBI]
|
6.25044e-06
|
|
|
palmoplantar hyperkeratosis with squamous cell carcinoma of skin and sex reversal
|
[NCBI]
|
6.25044e-06
|
|
|
legg-calve-perthes disease
|
[NCBI]
|
6.25044e-06
|
|
|
ichthyosis, bullous type
|
[NCBI]
|
6.25044e-06
|
|
|
pneumothorax, primary spontaneous
|
[NCBI]
|
6.25044e-06
|
|
|
avascular necrosis of femoral head, primary
|
[NCBI]
|
6.25044e-06
|
|
|
HGPPS
|
[NCBI]
|
6.25044e-06
|
|
|
SHEP3
|
[NCBI]
|
6.25044e-06
|
|
|
frontonasal dysplasia
|
[NCBI]
|
6.25044e-06
|
|
|
anonychia congenita
|
[NCBI]
|
6.25044e-06
|
|
|
wolfram syndrome, mitochondrial form
|
[NCBI]
|
6.25044e-06
|
|
|
DSAP1
|
[NCBI]
|
6.25044e-06
|
|
|
acromesomelic dysplasia, hunter-thompson type
|
[NCBI]
|
6.25044e-06
|
|
|
pierson syndrome
|
[NCBI]
|
6.25044e-06
|
|
|
DSS
|
[NCBI]
|
6.25044e-06
|
|
|
ectodermal dysplasia, anhidrotic
|
[NCBI]
|
6.25044e-06
|
|
|
CCM3
|
[NCBI]
|
6.25044e-06
|
|
|
SPMM
|
[NCBI]
|
6.25044e-06
|
|
|
CPVT
|
[NCBI]
|
6.25044e-06
|
|
|
aplastic anemia
|
[NCBI]
|
6.25044e-06
|
|
|
SLC6A4
|
[NCBI]
|
6.24304e-06
|
|
|
HOS
|
[NCBI]
|
6.18482e-06
|
|
|
NOS3
|
[NCBI]
|
6.11934e-06
|
|
|
krabbe disease
|
[NCBI]
|
6.11828e-06
|
|
|
MTACR1
|
[NCBI]
|
6.05365e-06
|
|
|
short rib-polydactyly syndrome, type iii
|
[NCBI]
|
6.05365e-06
|
|
|
CTS1
|
[NCBI]
|
6.05365e-06
|
|
|
MET
|
[NCBI]
|
6.02856e-06
|
|
|
COL6A1
|
[NCBI]
|
6.02856e-06
|
|
|
neuraminidase deficiency with beta-galactosidase deficiency
|
[NCBI]
|
6.02856e-06
|
|
|
IL18
|
[NCBI]
|
6.02856e-06
|
|
|
ALDH3A2
|
[NCBI]
|
6.02856e-06
|
|
|
SLC40A1
|
[NCBI]
|
6.02856e-06
|
|
|
alopecia areata 1
|
[NCBI]
|
6.02167e-06
|
|
|
AIC
|
[NCBI]
|
6.02167e-06
|
|
|
glaucoma-related pigment dispersion syndrome
|
[NCBI]
|
6.02167e-06
|
|
|
PAND1
|
[NCBI]
|
6.02167e-06
|
|
|
ABP1
|
[NCBI]
|
5.96163e-06
|
|
|
ST7
|
[NCBI]
|
5.94595e-06
|
|
|
CYP3A7
|
[NCBI]
|
5.94595e-06
|
|
|
CHX10
|
[NCBI]
|
5.94595e-06
|
|
|
SSTR1
|
[NCBI]
|
5.94595e-06
|
|
|
ADRA1B
|
[NCBI]
|
5.94595e-06
|
|
|
DPEP1
|
[NCBI]
|
5.94595e-06
|
|
|
CHRD
|
[NCBI]
|
5.94595e-06
|
|
|
ERCC4
|
[NCBI]
|
5.94595e-06
|
|
|
GRHPR
|
[NCBI]
|
5.94595e-06
|
|
|
MYLK
|
[NCBI]
|
5.94595e-06
|
|
|
CHRND
|
[NCBI]
|
5.94595e-06
|
|
|
CENPC1
|
[NCBI]
|
5.94595e-06
|
|
|
SDC3
|
[NCBI]
|
5.94595e-06
|
|
|
FHL1
|
[NCBI]
|
5.94595e-06
|
|
|
SIRT3
|
[NCBI]
|
5.94595e-06
|
|
|
SCG2
|
[NCBI]
|
5.94595e-06
|
|
|
GPR98
|
[NCBI]
|
5.94595e-06
|
|
|
PGAM1
|
[NCBI]
|
5.94595e-06
|
|
|
LAMC2
|
[NCBI]
|
5.94595e-06
|
|
|
GRIK1
|
[NCBI]
|
5.94595e-06
|
|
|
GNAL
|
[NCBI]
|
5.94595e-06
|
|
|
CDC2L1
|
[NCBI]
|
5.94595e-06
|
|
|
SCGB3A2
|
[NCBI]
|
5.94595e-06
|
|
|
HTR2C
|
[NCBI]
|
5.94595e-06
|
|
|
DR1
|
[NCBI]
|
5.94595e-06
|
|
|
hemojuvelin
|
[NCBI]
|
5.94595e-06
|
|
|
PRG1
|
[NCBI]
|
5.94595e-06
|
|
|
AIPL1
|
[NCBI]
|
5.94595e-06
|
|
|
GNAI2
|
[NCBI]
|
5.94595e-06
|
|
|
GCLM
|
[NCBI]
|
5.94595e-06
|
|
|
ADORA2A
|
[NCBI]
|
5.94595e-06
|
|
|
PITPN
|
[NCBI]
|
5.94595e-06
|
|
|
DSC2
|
[NCBI]
|
5.94595e-06
|
|
|
CRLF1
|
[NCBI]
|
5.94595e-06
|
|
|
SOD3
|
[NCBI]
|
5.94595e-06
|
|
|
MKKS
|
[NCBI]
|
5.94595e-06
|
|
|
SLC30A4
|
[NCBI]
|
5.94595e-06
|
|
|
KRT19
|
[NCBI]
|
5.94595e-06
|
|
|
CLCNKB
|
[NCBI]
|
5.94595e-06
|
|
|
heat-shock protein, 75-kd
|
[NCBI]
|
5.94595e-06
|
|
|
PRKCD
|
[NCBI]
|
5.94595e-06
|
|
|
DAXX
|
[NCBI]
|
5.94595e-06
|
|
|
GART
|
[NCBI]
|
5.94595e-06
|
|
|
CD9
|
[NCBI]
|
5.94595e-06
|
|
|
SEMA5A
|
[NCBI]
|
5.94595e-06
|
|
|
PPP2R2B
|
[NCBI]
|
5.94595e-06
|
|
|
SMARCA2
|
[NCBI]
|
5.94595e-06
|
|
|
complement component c1r deficiency
|
[NCBI]
|
5.94595e-06
|
|
|
CCL3L1
|
[NCBI]
|
5.94595e-06
|
|
|
OTX1
|
[NCBI]
|
5.94595e-06
|
|
|
LRP1
|
[NCBI]
|
5.8418e-06
|
|
|
TERC
|
[NCBI]
|
5.77343e-06
|
|
|
IL8
|
[NCBI]
|
5.77343e-06
|
|
|
MTND5
|
[NCBI]
|
5.77343e-06
|
|
|
gastric cancer
|
[NCBI]
|
5.70484e-06
|
|
|
IBM2
|
[NCBI]
|
5.66072e-06
|
|
|
pseudohypoparathyroidism, type ib
|
[NCBI]
|
5.66072e-06
|
|
|
KAL2
|
[NCBI]
|
5.66072e-06
|
|
|
INSR
|
[NCBI]
|
5.56372e-06
|
|
|
CFI
|
[NCBI]
|
5.52924e-06
|
|
|
GRPR
|
[NCBI]
|
5.52924e-06
|
|
|
SAA1
|
[NCBI]
|
5.52924e-06
|
|
|
GHRH
|
[NCBI]
|
5.49173e-06
|
|
|
DDC
|
[NCBI]
|
5.45607e-06
|
|
|
RCC1
|
[NCBI]
|
5.41887e-06
|
|
|
CEBPE
|
[NCBI]
|
5.39468e-06
|
|
|
TRPC6
|
[NCBI]
|
5.39468e-06
|
|
|
KCNJ6
|
[NCBI]
|
5.39468e-06
|
|
|
ARF3
|
[NCBI]
|
5.39468e-06
|
|
|
PAPSS1
|
[NCBI]
|
5.39468e-06
|
|
|
EDAR
|
[NCBI]
|
5.39468e-06
|
|
|
PHKA1
|
[NCBI]
|
5.39468e-06
|
|
|
MT2A
|
[NCBI]
|
5.39468e-06
|
|
|
SLC18A1
|
[NCBI]
|
5.39468e-06
|
|
|
HBE1
|
[NCBI]
|
5.39468e-06
|
|
|
AMT
|
[NCBI]
|
5.39468e-06
|
|
|
IMPDH1
|
[NCBI]
|
5.39468e-06
|
|
|
GRHL3
|
[NCBI]
|
5.39468e-06
|
|
|
FGF5
|
[NCBI]
|
5.39468e-06
|
|
|
TUB
|
[NCBI]
|
5.39468e-06
|
|
|
AKT2
|
[NCBI]
|
5.39468e-06
|
|
|
GNAO1
|
[NCBI]
|
5.39468e-06
|
|
|
TACSTD2
|
[NCBI]
|
5.39468e-06
|
|
|
SDC4
|
[NCBI]
|
5.39468e-06
|
|
|
SOS1
|
[NCBI]
|
5.39468e-06
|
|
|
TYK2
|
[NCBI]
|
5.39468e-06
|
|
|
SYN1
|
[NCBI]
|
5.39468e-06
|
|
|
EPHX2
|
[NCBI]
|
5.39468e-06
|
|
|
CLDN16
|
[NCBI]
|
5.39468e-06
|
|
|
EYA2
|
[NCBI]
|
5.39468e-06
|
|
|
BMP6
|
[NCBI]
|
5.39468e-06
|
|
|
ITGA4
|
[NCBI]
|
5.39468e-06
|
|
|
DSG4
|
[NCBI]
|
5.39468e-06
|
|
|
CDKL5
|
[NCBI]
|
5.39468e-06
|
|
|
SYT2
|
[NCBI]
|
5.39468e-06
|
|
|
CD3E
|
[NCBI]
|
5.39468e-06
|
|
|
CHRNA7
|
[NCBI]
|
5.39468e-06
|
|
|
APBA1
|
[NCBI]
|
5.39468e-06
|
|
|
GAS1
|
[NCBI]
|
5.39468e-06
|
|
|
CD151
|
[NCBI]
|
5.39468e-06
|
|
|
PHYH
|
[NCBI]
|
5.39468e-06
|
|
|
ELAVL4
|
[NCBI]
|
5.39468e-06
|
|
|
OXTR
|
[NCBI]
|
5.39468e-06
|
|
|
XRCC1
|
[NCBI]
|
5.39468e-06
|
|
|
LARGE
|
[NCBI]
|
5.39468e-06
|
|
|
CTSG
|
[NCBI]
|
5.39468e-06
|
|
|
ATP8B1
|
[NCBI]
|
5.39468e-06
|
|
|
PPBP
|
[NCBI]
|
5.39468e-06
|
|
|
WNT7A
|
[NCBI]
|
5.39468e-06
|
|
|
CDH13
|
[NCBI]
|
5.39468e-06
|
|
|
SLC2A4
|
[NCBI]
|
5.36128e-06
|
|
|
PRKDC
|
[NCBI]
|
5.29536e-06
|
|
|
GLB1
|
[NCBI]
|
5.29536e-06
|
|
|
FMO3
|
[NCBI]
|
5.29536e-06
|
|
|
RARA
|
[NCBI]
|
5.29536e-06
|
|
|
TGFB1
|
[NCBI]
|
5.27959e-06
|
|
|
AIS
|
[NCBI]
|
5.25024e-06
|
|
|
CCD
|
[NCBI]
|
5.19764e-06
|
|
|
TYRP1
|
[NCBI]
|
5.07121e-06
|
|
|
MTCO2
|
[NCBI]
|
5.07121e-06
|
|
|
GDF5
|
[NCBI]
|
5.07121e-06
|
|
|
ACH
|
[NCBI]
|
4.92007e-06
|
|
|
SLC1A5
|
[NCBI]
|
4.90989e-06
|
|
|
GUCA2B
|
[NCBI]
|
4.90989e-06
|
|
|
CXCL9
|
[NCBI]
|
4.90989e-06
|
|
|
CD2
|
[NCBI]
|
4.90989e-06
|
|
|
ZFX
|
[NCBI]
|
4.90989e-06
|
|
|
ERG
|
[NCBI]
|
4.90989e-06
|
|
|
TIMP2
|
[NCBI]
|
4.90989e-06
|
|
|
CSPG2
|
[NCBI]
|
4.90989e-06
|
|
|
FGD1
|
[NCBI]
|
4.90989e-06
|
|
|
OAS1
|
[NCBI]
|
4.90989e-06
|
|
|
HTR1A
|
[NCBI]
|
4.90989e-06
|
|
|
TEF
|
[NCBI]
|
4.90989e-06
|
|
|
TAS1R3
|
[NCBI]
|
4.90989e-06
|
|
|
GLI
|
[NCBI]
|
4.90989e-06
|
|
|
LRP6
|
[NCBI]
|
4.90989e-06
|
|
|
SMAD7
|
[NCBI]
|
4.90989e-06
|
|
|
AAAS
|
[NCBI]
|
4.90989e-06
|
|
|
PDCD2
|
[NCBI]
|
4.90989e-06
|
|
|
CFD
|
[NCBI]
|
4.90989e-06
|
|
|
APH
|
[NCBI]
|
4.90989e-06
|
|
|
SGKL
|
[NCBI]
|
4.90989e-06
|
|
|
CD247
|
[NCBI]
|
4.90989e-06
|
|
|
RORA
|
[NCBI]
|
4.90989e-06
|
|
|
NEUROD1
|
[NCBI]
|
4.90989e-06
|
|
|
CSF2RA
|
[NCBI]
|
4.90989e-06
|
|
|
SLC17A5
|
[NCBI]
|
4.90989e-06
|
|
|
PLAGL1
|
[NCBI]
|
4.90989e-06
|
|
|
TAGLN
|
[NCBI]
|
4.90989e-06
|
|
|
T
|
[NCBI]
|
4.90989e-06
|
|
|
SGCG
|
[NCBI]
|
4.90989e-06
|
|
|
HPR
|
[NCBI]
|
4.90989e-06
|
|
|
SGCB
|
[NCBI]
|
4.90989e-06
|
|
|
LIM2
|
[NCBI]
|
4.90989e-06
|
|
|
CD38
|
[NCBI]
|
4.90989e-06
|
|
|
ALPI
|
[NCBI]
|
4.90989e-06
|
|
|
MUC2
|
[NCBI]
|
4.90989e-06
|
|
|
CTSE
|
[NCBI]
|
4.90989e-06
|
|
|
LAMA3
|
[NCBI]
|
4.90989e-06
|
|
|
ATP2B2
|
[NCBI]
|
4.90989e-06
|
|
|
CCL4
|
[NCBI]
|
4.90989e-06
|
|
|
CD80
|
[NCBI]
|
4.90989e-06
|
|
|
LAMB1
|
[NCBI]
|
4.90989e-06
|
|
|
GAS6
|
[NCBI]
|
4.90989e-06
|
|
|
ABCC6
|
[NCBI]
|
4.85624e-06
|
|
|
GNAS
|
[NCBI]
|
4.831e-06
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
4.77297e-06
|
|
|
HEPOD
|
[NCBI]
|
4.73554e-06
|
|
|
KTCN1
|
[NCBI]
|
4.73554e-06
|
|
|
stroke, ischemic
|
[NCBI]
|
4.73554e-06
|
|
|
SCA10
|
[NCBI]
|
4.73554e-06
|
|
|
EL1
|
[NCBI]
|
4.73554e-06
|
|
|
ornithine aminotransferase deficiency
|
[NCBI]
|
4.64998e-06
|
|
|
CYP3A4
|
[NCBI]
|
4.64998e-06
|
|
|
BGN
|
[NCBI]
|
4.64998e-06
|
|
|
spinal muscular atrophy, proximal, adult, autosomal dominant
|
[NCBI]
|
4.62198e-06
|
|
|
mast cell disease
|
[NCBI]
|
4.62198e-06
|
|
|
IBMPFD
|
[NCBI]
|
4.62198e-06
|
|
|
pseudo-von willebrand disease
|
[NCBI]
|
4.62198e-06
|
|
|
char syndrome
|
[NCBI]
|
4.62198e-06
|
|
|
EPD
|
[NCBI]
|
4.62198e-06
|
|
|
GLYS1
|
[NCBI]
|
4.62198e-06
|
|
|
AITD3
|
[NCBI]
|
4.62198e-06
|
|
|
HRD
|
[NCBI]
|
4.62198e-06
|
|
|
epiphyseal dysplasia, multiple, with early-onset diabetes mellitus
|
[NCBI]
|
4.62198e-06
|
|
|
KCS
|
[NCBI]
|
4.62198e-06
|
|
|
chondrodysplasia, grebe type
|
[NCBI]
|
4.62198e-06
|
|
|
kuru, susceptibility to
|
[NCBI]
|
4.62198e-06
|
|
|
IDD
|
[NCBI]
|
4.62198e-06
|
|
|
antiphospholipid syndrome
|
[NCBI]
|
4.62198e-06
|
|
|
FANCB
|
[NCBI]
|
4.62198e-06
|
|
|
EBS-MP
|
[NCBI]
|
4.62198e-06
|
|
|
ear wax, wet/dry
|
[NCBI]
|
4.62198e-06
|
|
|
MDC1C
|
[NCBI]
|
4.62198e-06
|
|
|
BPP
|
[NCBI]
|
4.62198e-06
|
|
|
LADD
|
[NCBI]
|
4.62198e-06
|
|
|
deafness, autosomal recessive
|
[NCBI]
|
4.62198e-06
|
|
|
desmoid disease, hereditary
|
[NCBI]
|
4.62198e-06
|
|
|
AGER
|
[NCBI]
|
4.56033e-06
|
|
|
STAT1
|
[NCBI]
|
4.56033e-06
|
|
|
hypophosphatasia, infantile
|
[NCBI]
|
4.53143e-06
|
|
|
alopecia, androgenetic
|
[NCBI]
|
4.49219e-06
|
|
|
KRT17
|
[NCBI]
|
4.47944e-06
|
|
|
GOT2
|
[NCBI]
|
4.47944e-06
|
|
|
IVL
|
[NCBI]
|
4.47944e-06
|
|
|
MAP3K8
|
[NCBI]
|
4.47944e-06
|
|
|
MCM6
|
[NCBI]
|
4.47944e-06
|
|
|
PFN1
|
[NCBI]
|
4.47944e-06
|
|
|
PAX9
|
[NCBI]
|
4.47944e-06
|
|
|
ITPA
|
[NCBI]
|
4.47944e-06
|
|
|
ADH3
|
[NCBI]
|
4.47944e-06
|
|
|
FLCN
|
[NCBI]
|
4.47944e-06
|
|
|
SLC7A9
|
[NCBI]
|
4.47944e-06
|
|
|
MLC1
|
[NCBI]
|
4.47944e-06
|
|
|
BCL2A1
|
[NCBI]
|
4.47944e-06
|
|
|
POLB
|
[NCBI]
|
4.47944e-06
|
|
|
AMBP
|
[NCBI]
|
4.47944e-06
|
|
|
RARB
|
[NCBI]
|
4.47944e-06
|
|
|
ITPR1
|
[NCBI]
|
4.47944e-06
|
|
|
CYP7A1
|
[NCBI]
|
4.47944e-06
|
|
|
FMN
|
[NCBI]
|
4.47944e-06
|
|
|
NLRP3
|
[NCBI]
|
4.47944e-06
|
|
|
SLC6A2
|
[NCBI]
|
4.47944e-06
|
|
|
MATN1
|
[NCBI]
|
4.47944e-06
|
|
|
MYF5
|
[NCBI]
|
4.47944e-06
|
|
|
PEA15
|
[NCBI]
|
4.47944e-06
|
|
|
PON1
|
[NCBI]
|
4.46379e-06
|
|
|
ADRB2
|
[NCBI]
|
4.45197e-06
|
|
|
DRD4
|
[NCBI]
|
4.40428e-06
|
|
|
UCP1
|
[NCBI]
|
4.3473e-06
|
|
|
PKLR
|
[NCBI]
|
4.26179e-06
|
|
|
GAMT
|
[NCBI]
|
4.26179e-06
|
|
|
DSG1
|
[NCBI]
|
4.26179e-06
|
|
|
AGTR1
|
[NCBI]
|
4.26179e-06
|
|
|
EVA
|
[NCBI]
|
4.17745e-06
|
|
|
KCNH2
|
[NCBI]
|
4.16047e-06
|
|
|
JAK2
|
[NCBI]
|
4.16047e-06
|
|
|
SLC4A1
|
[NCBI]
|
4.14077e-06
|
|
|
MAP3K5
|
[NCBI]
|
4.13677e-06
|
|
|
SOD1
|
[NCBI]
|
4.11413e-06
|
|
|
KRT18
|
[NCBI]
|
4.09423e-06
|
|
|
MID1
|
[NCBI]
|
4.09423e-06
|
|
|
SFTPD
|
[NCBI]
|
4.09423e-06
|
|
|
COL6A2
|
[NCBI]
|
4.09423e-06
|
|
|
OTX2
|
[NCBI]
|
4.09423e-06
|
|
|
SPINK5
|
[NCBI]
|
4.09423e-06
|
|
|
LCN1
|
[NCBI]
|
4.09423e-06
|
|
|
SELL
|
[NCBI]
|
4.09423e-06
|
|
|
CNTFR
|
[NCBI]
|
4.09423e-06
|
|
|
CLCN7
|
[NCBI]
|
4.09423e-06
|
|
|
ATP2A1
|
[NCBI]
|
4.09423e-06
|
|
|
FCGR2B
|
[NCBI]
|
4.09423e-06
|
|
|
OCRL
|
[NCBI]
|
4.09423e-06
|
|
|
SPN
|
[NCBI]
|
4.09423e-06
|
|
|
ICOS
|
[NCBI]
|
4.09423e-06
|
|
|
PRDX5
|
[NCBI]
|
4.09423e-06
|
|
|
PSG1
|
[NCBI]
|
4.09423e-06
|
|
|
TREX1
|
[NCBI]
|
4.09423e-06
|
|
|
ZNF198
|
[NCBI]
|
4.09423e-06
|
|
|
LTA4H
|
[NCBI]
|
4.09423e-06
|
|
|
RIMS1
|
[NCBI]
|
4.09423e-06
|
|
|
CD209
|
[NCBI]
|
4.09423e-06
|
|
|
BLNK
|
[NCBI]
|
4.09423e-06
|
|
|
RPGRIP1
|
[NCBI]
|
4.09423e-06
|
|
|
SIRT2
|
[NCBI]
|
4.09423e-06
|
|
|
IGSF4
|
[NCBI]
|
4.09423e-06
|
|
|
SEPT9
|
[NCBI]
|
4.09423e-06
|
|
|
ZAP70
|
[NCBI]
|
4.09423e-06
|
|
|
SILV
|
[NCBI]
|
4.09423e-06
|
|
|
EDN1
|
[NCBI]
|
4.07905e-06
|
|
|
MYH11
|
[NCBI]
|
4.07905e-06
|
|
|
STK11
|
[NCBI]
|
4.07905e-06
|
|
|
IFNA1
|
[NCBI]
|
4.07278e-06
|
|
|
PCI
|
[NCBI]
|
4.07278e-06
|
|
|
HHF2
|
[NCBI]
|
4.06841e-06
|
|
|
ARSA
|
[NCBI]
|
4.01388e-06
|
|
|
RIEG1
|
[NCBI]
|
3.92184e-06
|
|
|
HSAN1
|
[NCBI]
|
3.92184e-06
|
|
|
mismatch repair cancer syndrome
|
[NCBI]
|
3.92184e-06
|
|
|
EBR1
|
[NCBI]
|
3.92184e-06
|
|
|
H19
|
[NCBI]
|
3.9034e-06
|
|
|
PARK2
|
[NCBI]
|
3.89013e-06
|
|
|
TPO
|
[NCBI]
|
3.85719e-06
|
|
|
ACTG1
|
[NCBI]
|
3.74727e-06
|
|
|
FLI1
|
[NCBI]
|
3.74727e-06
|
|
|
IKBKAP
|
[NCBI]
|
3.74727e-06
|
|
|
ATXN2
|
[NCBI]
|
3.74727e-06
|
|
|
LDLRAP1
|
[NCBI]
|
3.74727e-06
|
|
|
GABRA1
|
[NCBI]
|
3.74727e-06
|
|
|
KCNJ1
|
[NCBI]
|
3.74727e-06
|
|
|
FANCD2
|
[NCBI]
|
3.74727e-06
|
|
|
PDE4D
|
[NCBI]
|
3.74727e-06
|
|
|
DAZL
|
[NCBI]
|
3.74727e-06
|
|
|
LAMR1
|
[NCBI]
|
3.74727e-06
|
|
|
MTP
|
[NCBI]
|
3.74727e-06
|
|
|
ACAT1
|
[NCBI]
|
3.74727e-06
|
|
|
CEP290
|
[NCBI]
|
3.74727e-06
|
|
|
ODC1
|
[NCBI]
|
3.74727e-06
|
|
|
FYN
|
[NCBI]
|
3.74727e-06
|
|
|
GOT1
|
[NCBI]
|
3.74727e-06
|
|
|
CCS
|
[NCBI]
|
3.74727e-06
|
|
|
SRA2
|
[NCBI]
|
3.74727e-06
|
|
|
CYP3A5
|
[NCBI]
|
3.74727e-06
|
|
|
tyrosine transaminase deficiency
|
[NCBI]
|
3.74727e-06
|
|
|
ABCA4
|
[NCBI]
|
3.7345e-06
|
|
|
TCRG
|
[NCBI]
|
3.7345e-06
|
|
|
PNMT
|
[NCBI]
|
3.71744e-06
|
|
|
BMP2
|
[NCBI]
|
3.65171e-06
|
|
|
down syndrome
|
[NCBI]
|
3.61604e-06
|
|
|
HEXB
|
[NCBI]
|
3.57204e-06
|
|
|
ADIPOQ
|
[NCBI]
|
3.57204e-06
|
|
|
GLA
|
[NCBI]
|
3.57204e-06
|
|
|
MTCYB
|
[NCBI]
|
3.57204e-06
|
|
|
PJS
|
[NCBI]
|
3.56252e-06
|
|
|
TSHR
|
[NCBI]
|
3.53688e-06
|
|
|
LEP
|
[NCBI]
|
3.45498e-06
|
|
|
SF1
|
[NCBI]
|
3.4331e-06
|
|
|
S100A8
|
[NCBI]
|
3.4331e-06
|
|
|
PCSK9
|
[NCBI]
|
3.4331e-06
|
|
|
PFKL
|
[NCBI]
|
3.4331e-06
|
|
|
MTMR2
|
[NCBI]
|
3.4331e-06
|
|
|
EPM2A
|
[NCBI]
|
3.4331e-06
|
|
|
RNR1
|
[NCBI]
|
3.4331e-06
|
|
|
SCCA1
|
[NCBI]
|
3.4331e-06
|
|
|
CGA
|
[NCBI]
|
3.4331e-06
|
|
|
ETS2
|
[NCBI]
|
3.4331e-06
|
|
|
PRPH
|
[NCBI]
|
3.4331e-06
|
|
|
ADAR
|
[NCBI]
|
3.4331e-06
|
|
|
PRX
|
[NCBI]
|
3.4331e-06
|
|
|
AGXT
|
[NCBI]
|
3.4331e-06
|
|
|
SCN2A
|
[NCBI]
|
3.4331e-06
|
|
|
LMO2
|
[NCBI]
|
3.4331e-06
|
|
|
CLEC4M
|
[NCBI]
|
3.4331e-06
|
|
|
KRT10
|
[NCBI]
|
3.4331e-06
|
|
|
SORBS1
|
[NCBI]
|
3.4331e-06
|
|
|
HSPG2
|
[NCBI]
|
3.4331e-06
|
|
|
CD1D
|
[NCBI]
|
3.4331e-06
|
|
|
SNCA
|
[NCBI]
|
3.42488e-06
|
|
|
ESR1
|
[NCBI]
|
3.40776e-06
|
|
|
osteogenic sarcoma
|
[NCBI]
|
3.35456e-06
|
|
|
iron overload in africa
|
[NCBI]
|
3.35456e-06
|
|
|
gitelman syndrome
|
[NCBI]
|
3.35456e-06
|
|
|
OCA3
|
[NCBI]
|
3.35456e-06
|
|
|
IHCM
|
[NCBI]
|
3.35456e-06
|
|
|
morquio syndrome b
|
[NCBI]
|
3.35456e-06
|
|
|
LRS1
|
[NCBI]
|
3.35456e-06
|
|
|
RHN
|
[NCBI]
|
3.35456e-06
|
|
|
immunoosseous dysplasia, schimke type
|
[NCBI]
|
3.35456e-06
|
|
|
SYNS1
|
[NCBI]
|
3.35456e-06
|
|
|
hypoalphalipoproteinemia, primary
|
[NCBI]
|
3.35456e-06
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant, 2
|
[NCBI]
|
3.35456e-06
|
|
|
HMN2A
|
[NCBI]
|
3.35456e-06
|
|
|
DFNA3
|
[NCBI]
|
3.35456e-06
|
|
|
polydactyly, postaxial, type a1
|
[NCBI]
|
3.35456e-06
|
|
|
NPHP3
|
[NCBI]
|
3.35456e-06
|
|
|
mucolipidosis iii, complementation group c
|
[NCBI]
|
3.35456e-06
|
|
|
hydrops-ectopic calcification-moth-eaten skeletal dysplasia
|
[NCBI]
|
3.35456e-06
|
|
|
SCA12
|
[NCBI]
|
3.35456e-06
|
|
|
XPB
|
[NCBI]
|
3.35456e-06
|
|
|
DAZ
|
[NCBI]
|
3.26531e-06
|
|
|
RUNX1
|
[NCBI]
|
3.26531e-06
|
|
|
LNS
|
[NCBI]
|
3.25064e-06
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency
|
[NCBI]
|
3.22854e-06
|
|
|
CHAC
|
[NCBI]
|
3.20871e-06
|
|
|
AMC
|
[NCBI]
|
3.17117e-06
|
|
|
IGFBP3
|
[NCBI]
|
3.14733e-06
|
|
|
UBE1
|
[NCBI]
|
3.14733e-06
|
|
|
PKHD1
|
[NCBI]
|
3.14733e-06
|
|
|
SDC1
|
[NCBI]
|
3.14733e-06
|
|
|
RHOA
|
[NCBI]
|
3.14733e-06
|
|
|
ATRN
|
[NCBI]
|
3.14733e-06
|
|
|
MMP7
|
[NCBI]
|
3.14733e-06
|
|
|
TUBB
|
[NCBI]
|
3.14733e-06
|
|
|
CRB1
|
[NCBI]
|
3.14733e-06
|
|
|
NFATC2
|
[NCBI]
|
3.14733e-06
|
|
|
SLC1A3
|
[NCBI]
|
3.14733e-06
|
|
|
CNP
|
[NCBI]
|
3.14733e-06
|
|
|
IGLC1
|
[NCBI]
|
3.14733e-06
|
|
|
porphyria cutanea tarda
|
[NCBI]
|
3.12051e-06
|
|
|
GCPS
|
[NCBI]
|
3.07239e-06
|
|
|
CLN3
|
[NCBI]
|
3.07239e-06
|
|
|
CCND1
|
[NCBI]
|
3.06083e-06
|
|
|
PTN
|
[NCBI]
|
2.99648e-06
|
|
|
ABCA1
|
[NCBI]
|
2.9811e-06
|
|
|
TCF7L2
|
[NCBI]
|
2.9811e-06
|
|
|
CTSC
|
[NCBI]
|
2.9811e-06
|
|
|
APCS
|
[NCBI]
|
2.9811e-06
|
|
|
factor x deficiency
|
[NCBI]
|
2.9811e-06
|
|
|
TSC1
|
[NCBI]
|
2.9811e-06
|
|
|
PANK2
|
[NCBI]
|
2.8864e-06
|
|
|
SCARB1
|
[NCBI]
|
2.8864e-06
|
|
|
PLIN
|
[NCBI]
|
2.8864e-06
|
|
|
NCF1
|
[NCBI]
|
2.8864e-06
|
|
|
TPH1
|
[NCBI]
|
2.8864e-06
|
|
|
FST
|
[NCBI]
|
2.8864e-06
|
|
|
SCN9A
|
[NCBI]
|
2.8864e-06
|
|
|
PRKCA
|
[NCBI]
|
2.8864e-06
|
|
|
CAMK2A
|
[NCBI]
|
2.8864e-06
|
|
|
LEF1
|
[NCBI]
|
2.8864e-06
|
|
|
CDH2
|
[NCBI]
|
2.8864e-06
|
|
|
UTRN
|
[NCBI]
|
2.8864e-06
|
|
|
TXNIP
|
[NCBI]
|
2.8864e-06
|
|
|
CNR1
|
[NCBI]
|
2.8864e-06
|
|
|
GPR24
|
[NCBI]
|
2.8864e-06
|
|
|
LCAT
|
[NCBI]
|
2.87009e-06
|
|
|
osteogenesis imperfecta, type iia
|
[NCBI]
|
2.86864e-06
|
|
|
COMP
|
[NCBI]
|
2.81129e-06
|
|
|
LPO
|
[NCBI]
|
2.74285e-06
|
|
|
NTRK1
|
[NCBI]
|
2.71758e-06
|
|
|
MBL2
|
[NCBI]
|
2.70936e-06
|
|
|
ANGPTL4
|
[NCBI]
|
2.64738e-06
|
|
|
EN1
|
[NCBI]
|
2.64738e-06
|
|
|
MEF2A
|
[NCBI]
|
2.64738e-06
|
|
|
DLG4
|
[NCBI]
|
2.64738e-06
|
|
|
DDR1
|
[NCBI]
|
2.64738e-06
|
|
|
RNASEL
|
[NCBI]
|
2.64738e-06
|
|
|
PAX1
|
[NCBI]
|
2.64738e-06
|
|
|
CCR2
|
[NCBI]
|
2.64738e-06
|
|
|
CMPK1
|
[NCBI]
|
2.64738e-06
|
|
|
SLC45A2
|
[NCBI]
|
2.64738e-06
|
|
|
orotic aciduria i
|
[NCBI]
|
2.64738e-06
|
|
|
CSH1
|
[NCBI]
|
2.64738e-06
|
|
|
PIP
|
[NCBI]
|
2.64738e-06
|
|
|
FGFR3
|
[NCBI]
|
2.604e-06
|
|
|
CDG1A
|
[NCBI]
|
2.59735e-06
|
|
|
COH1
|
[NCBI]
|
2.59735e-06
|
|
|
MTAP
|
[NCBI]
|
2.59306e-06
|
|
|
MSD
|
[NCBI]
|
2.58676e-06
|
|
|
PSNP1
|
[NCBI]
|
2.58676e-06
|
|
|
MLC
|
[NCBI]
|
2.58676e-06
|
|
|
atypical mycobacteriosis, familial
|
[NCBI]
|
2.47575e-06
|
|
|
lung cancer
|
[NCBI]
|
2.47575e-06
|
|
|
SERPINA6
|
[NCBI]
|
2.47474e-06
|
|
|
isoniazid inactivation
|
[NCBI]
|
2.47312e-06
|
|
|
HBA2
|
[NCBI]
|
2.45474e-06
|
|
|
G6PC2
|
[NCBI]
|
2.42784e-06
|
|
|
PAPPA
|
[NCBI]
|
2.42784e-06
|
|
|
TRHR
|
[NCBI]
|
2.42784e-06
|
|
|
SURF1
|
[NCBI]
|
2.42784e-06
|
|
|
NEFL
|
[NCBI]
|
2.42784e-06
|
|
|
GLRA1
|
[NCBI]
|
2.42784e-06
|
|
|
H2AFX
|
[NCBI]
|
2.42784e-06
|
|
|
CD40
|
[NCBI]
|
2.42784e-06
|
|
|
TCRD
|
[NCBI]
|
2.42784e-06
|
|
|
TAL1
|
[NCBI]
|
2.42784e-06
|
|
|
RAF1
|
[NCBI]
|
2.42784e-06
|
|
|
ACTA1
|
[NCBI]
|
2.42784e-06
|
|
|
PLAUR
|
[NCBI]
|
2.37445e-06
|
|
|
PARK1
|
[NCBI]
|
2.36738e-06
|
|
|
alzheimer disease 4
|
[NCBI]
|
2.36738e-06
|
|
|
lymphedema, hereditary, i
|
[NCBI]
|
2.36738e-06
|
|
|
JWS
|
[NCBI]
|
2.36738e-06
|
|
|
kindler syndrome
|
[NCBI]
|
2.36738e-06
|
|
|
alport syndrome, autosomal recessive
|
[NCBI]
|
2.36738e-06
|
|
|
situs inversus viscerum
|
[NCBI]
|
2.36738e-06
|
|
|
alzheimer disease, susceptibility to, mitochondrial
|
[NCBI]
|
2.36738e-06
|
|
|
schwannomatosis
|
[NCBI]
|
2.36738e-06
|
|
|
GBD1
|
[NCBI]
|
2.36738e-06
|
|
|
17-@beta hydroxysteroid dehydrogenase iii deficiency
|
[NCBI]
|
2.36738e-06
|
|
|
HCHWAD
|
[NCBI]
|
2.36738e-06
|
|
|
ATLD
|
[NCBI]
|
2.36738e-06
|
|
|
liddle syndrome
|
[NCBI]
|
2.36738e-06
|
|
|
corneal dystrophy, gelatinous drop-like
|
[NCBI]
|
2.36738e-06
|
|
|
WZS
|
[NCBI]
|
2.36738e-06
|
|
|
muenke syndrome
|
[NCBI]
|
2.36738e-06
|
|
|
LGMD2E
|
[NCBI]
|
2.36738e-06
|
|
|
DA1
|
[NCBI]
|
2.36738e-06
|
|
|
COL1A2
|
[NCBI]
|
2.36106e-06
|
|
|
PSAP
|
[NCBI]
|
2.35758e-06
|
|
|
MTND1
|
[NCBI]
|
2.35758e-06
|
|
|
IHH
|
[NCBI]
|
2.34763e-06
|
|
|
BCHE
|
[NCBI]
|
2.2808e-06
|
|
|
FMR1
|
[NCBI]
|
2.26175e-06
|
|
|
GALT
|
[NCBI]
|
2.24628e-06
|
|
|
3-@beta-hydroxysteroid dehydrogenase, type ii, deficiency of
|
[NCBI]
|
2.22572e-06
|
|
|
AOF2
|
[NCBI]
|
2.22572e-06
|
|
|
ID2
|
[NCBI]
|
2.22572e-06
|
|
|
SGCE
|
[NCBI]
|
2.22572e-06
|
|
|
FGF3
|
[NCBI]
|
2.22572e-06
|
|
|
FLT4
|
[NCBI]
|
2.22572e-06
|
|
|
FOXL2
|
[NCBI]
|
2.22572e-06
|
|
|
XRCC9
|
[NCBI]
|
2.22572e-06
|
|
|
G6PT1
|
[NCBI]
|
2.22572e-06
|
|
|
FRAXE
|
[NCBI]
|
2.22572e-06
|
|
|
PER2
|
[NCBI]
|
2.22572e-06
|
|
|
MMP12
|
[NCBI]
|
2.22572e-06
|
|
|
KCNE1
|
[NCBI]
|
2.22572e-06
|
|
|
HNF1A
|
[NCBI]
|
2.19737e-06
|
|
|
aHUS
|
[NCBI]
|
2.17012e-06
|
|
|
AT
|
[NCBI]
|
2.16951e-06
|
|
|
aortic valve disease
|
[NCBI]
|
2.16239e-06
|
|
|
ITGB2
|
[NCBI]
|
2.13907e-06
|
|
|
HDAC1
|
[NCBI]
|
2.13753e-06
|
|
|
PC
|
[NCBI]
|
2.13753e-06
|
|
|
andersen cardiodysrhythmic periodic paralysis
|
[NCBI]
|
2.04788e-06
|
|
|
SCDO1
|
[NCBI]
|
2.04788e-06
|
|
|
alcohol dependence
|
[NCBI]
|
2.04788e-06
|
|
|
SN
|
[NCBI]
|
2.03927e-06
|
|
|
TMOD
|
[NCBI]
|
2.03927e-06
|
|
|
SFTPB
|
[NCBI]
|
2.03927e-06
|
|
|
ERCC6
|
[NCBI]
|
2.03927e-06
|
|
|
BMP1
|
[NCBI]
|
2.03927e-06
|
|
|
phenylketonuria ii
|
[NCBI]
|
2.03927e-06
|
|
|
EPB41
|
[NCBI]
|
2.03927e-06
|
|
|
NNMT
|
[NCBI]
|
2.03927e-06
|
|
|
MME
|
[NCBI]
|
2.03927e-06
|
|
|
CYP2C19
|
[NCBI]
|
2.03927e-06
|
|
|
NEB
|
[NCBI]
|
2.03927e-06
|
|
|
NFATC1
|
[NCBI]
|
2.03927e-06
|
|
|
LCP1
|
[NCBI]
|
2.03927e-06
|
|
|
gaucher disease, type iii
|
[NCBI]
|
2.03358e-06
|
|
|
ODDD
|
[NCBI]
|
2.03358e-06
|
|
|
SRC
|
[NCBI]
|
2.02186e-06
|
|
|
ALS1
|
[NCBI]
|
2.01245e-06
|
|
|
HSCR1
|
[NCBI]
|
2.00449e-06
|
|
|
SI
|
[NCBI]
|
1.96476e-06
|
|
|
PIGR
|
[NCBI]
|
1.96476e-06
|
|
|
LBR
|
[NCBI]
|
1.9363e-06
|
|
|
CPB2
|
[NCBI]
|
1.90815e-06
|
|
|
MC1R
|
[NCBI]
|
1.90815e-06
|
|
|
CUBN
|
[NCBI]
|
1.86701e-06
|
|
|
FLT3
|
[NCBI]
|
1.86701e-06
|
|
|
CR1
|
[NCBI]
|
1.86701e-06
|
|
|
PYGM
|
[NCBI]
|
1.86701e-06
|
|
|
ORM1
|
[NCBI]
|
1.86701e-06
|
|
|
MAP4K2
|
[NCBI]
|
1.86701e-06
|
|
|
CTSD
|
[NCBI]
|
1.86701e-06
|
|
|
ITGB1
|
[NCBI]
|
1.86701e-06
|
|
|
GJB6
|
[NCBI]
|
1.86701e-06
|
|
|
BIRC4
|
[NCBI]
|
1.86701e-06
|
|
|
CPI
|
[NCBI]
|
1.85853e-06
|
|
|
ADHD
|
[NCBI]
|
1.84596e-06
|
|
|
GNRHR
|
[NCBI]
|
1.84049e-06
|
|
|
LAD
|
[NCBI]
|
1.83991e-06
|
|
|
ABL
|
[NCBI]
|
1.83991e-06
|
|
|
APOE
|
[NCBI]
|
1.79485e-06
|
|
|
TBP
|
[NCBI]
|
1.75824e-06
|
|
|
SLC2A2
|
[NCBI]
|
1.74821e-06
|
|
|
VIM
|
[NCBI]
|
1.74139e-06
|
|
|
GHSR
|
[NCBI]
|
1.70764e-06
|
|
|
ASIP
|
[NCBI]
|
1.70764e-06
|
|
|
MC2R
|
[NCBI]
|
1.70764e-06
|
|
|
PAX5
|
[NCBI]
|
1.70764e-06
|
|
|
CPM
|
[NCBI]
|
1.70764e-06
|
|
|
CYCS
|
[NCBI]
|
1.70764e-06
|
|
|
GHRHR
|
[NCBI]
|
1.70764e-06
|
|
|
SELP
|
[NCBI]
|
1.70764e-06
|
|
|
OR1D2
|
[NCBI]
|
1.70764e-06
|
|
|
IFNAR1
|
[NCBI]
|
1.70764e-06
|
|
|
ATP2A2
|
[NCBI]
|
1.70764e-06
|
|
|
F12
|
[NCBI]
|
1.70764e-06
|
|
|
CYP27B1
|
[NCBI]
|
1.70764e-06
|
|
|
NSF
|
[NCBI]
|
1.68686e-06
|
|
|
porphyria variegata
|
[NCBI]
|
1.63387e-06
|
|
|
myopathy, myofibrillar, desmin-related
|
[NCBI]
|
1.62484e-06
|
|
|
glycogen storage disease ib
|
[NCBI]
|
1.62484e-06
|
|
|
EFE
|
[NCBI]
|
1.62484e-06
|
|
|
GH1
|
[NCBI]
|
1.62106e-06
|
|
|
KITLG
|
[NCBI]
|
1.62094e-06
|
|
|
kawasaki disease
|
[NCBI]
|
1.60407e-06
|
|
|
Ii
|
[NCBI]
|
1.60407e-06
|
|
|
SLSN1
|
[NCBI]
|
1.60407e-06
|
|
|
RMS2
|
[NCBI]
|
1.60407e-06
|
|
|
BDC
|
[NCBI]
|
1.60407e-06
|
|
|
WSS
|
[NCBI]
|
1.60407e-06
|
|
|
BOS1
|
[NCBI]
|
1.60407e-06
|
|
|
MCOPS3
|
[NCBI]
|
1.60407e-06
|
|
|
phosphoglycerate kinase 1 deficiency
|
[NCBI]
|
1.60407e-06
|
|
|
gracile syndrome
|
[NCBI]
|
1.60407e-06
|
|
|
PFHB1A
|
[NCBI]
|
1.60407e-06
|
|
|
brody myopathy
|
[NCBI]
|
1.60407e-06
|
|
|
MHA
|
[NCBI]
|
1.58498e-06
|
|
|
ehlers-danlos syndrome, type iv, autosomal dominant
|
[NCBI]
|
1.58498e-06
|
|
|
hyperekplexia, hereditary
|
[NCBI]
|
1.58498e-06
|
|
|
PRLR
|
[NCBI]
|
1.57945e-06
|
|
|
IL4
|
[NCBI]
|
1.57945e-06
|
|
|
CDH1
|
[NCBI]
|
1.5738e-06
|
|
|
CLTC
|
[NCBI]
|
1.56005e-06
|
|
|
FOS
|
[NCBI]
|
1.56005e-06
|
|
|
NRTN
|
[NCBI]
|
1.56005e-06
|
|
|
MRE11A
|
[NCBI]
|
1.56005e-06
|
|
|
RPE65
|
[NCBI]
|
1.56005e-06
|
|
|
LAMB3
|
[NCBI]
|
1.56005e-06
|
|
|
CRIP1
|
[NCBI]
|
1.56005e-06
|
|
|
VAMP2
|
[NCBI]
|
1.56005e-06
|
|
|
ACE
|
[NCBI]
|
1.55929e-06
|
|
|
LMNA
|
[NCBI]
|
1.55721e-06
|
|
|
PTGS2
|
[NCBI]
|
1.52659e-06
|
|
|
AIRE
|
[NCBI]
|
1.52659e-06
|
|
|
AR
|
[NCBI]
|
1.52558e-06
|
|
|
OXT
|
[NCBI]
|
1.49551e-06
|
|
|
IDE
|
[NCBI]
|
1.49505e-06
|
|
|
TYR
|
[NCBI]
|
1.49505e-06
|
|
|
MTND4
|
[NCBI]
|
1.49144e-06
|
|
|
HNF4A
|
[NCBI]
|
1.49144e-06
|
|
|
SLS
|
[NCBI]
|
1.44284e-06
|
|
|
NPC1
|
[NCBI]
|
1.44284e-06
|
|
|
IL12A
|
[NCBI]
|
1.42323e-06
|
|
|
ACOX1
|
[NCBI]
|
1.42323e-06
|
|
|
PMM2
|
[NCBI]
|
1.42323e-06
|
|
|
TRAF6
|
[NCBI]
|
1.42323e-06
|
|
|
CYP11B1
|
[NCBI]
|
1.42323e-06
|
|
|
NF2
|
[NCBI]
|
1.41219e-06
|
|
|
BLM
|
[NCBI]
|
1.34705e-06
|
|
|
CYP19A1
|
[NCBI]
|
1.33593e-06
|
|
|
CEACAM1
|
[NCBI]
|
1.33593e-06
|
|
|
OPRM1
|
[NCBI]
|
1.32105e-06
|
|
|
GUSB
|
[NCBI]
|
1.31845e-06
|
|
|
RPS19
|
[NCBI]
|
1.29635e-06
|
|
|
HK1
|
[NCBI]
|
1.29635e-06
|
|
|
HLA-DRB1
|
[NCBI]
|
1.29635e-06
|
|
|
MYH9
|
[NCBI]
|
1.29635e-06
|
|
|
SLC3A1
|
[NCBI]
|
1.29635e-06
|
|
|
CLOCK
|
[NCBI]
|
1.29635e-06
|
|
|
PLTP
|
[NCBI]
|
1.29475e-06
|
|
|
LDLR
|
[NCBI]
|
1.29372e-06
|
|
|
FGF1
|
[NCBI]
|
1.2712e-06
|
|
|
CLN1
|
[NCBI]
|
1.25244e-06
|
|
|
glycogen storage disease iii
|
[NCBI]
|
1.25244e-06
|
|
|
MADA
|
[NCBI]
|
1.25244e-06
|
|
|
MADD
|
[NCBI]
|
1.25244e-06
|
|
|
bartter syndrome, type 3
|
[NCBI]
|
1.25244e-06
|
|
|
hodgkin lymphoma
|
[NCBI]
|
1.25244e-06
|
|
|
myasthenic syndrome, congenital, associated with acetylcholine receptor deficiency
|
[NCBI]
|
1.25244e-06
|
|
|
JAK3
|
[NCBI]
|
1.19205e-06
|
|
|
CD59
|
[NCBI]
|
1.17862e-06
|
|
|
FGF4
|
[NCBI]
|
1.17862e-06
|
|
|
HPX
|
[NCBI]
|
1.17862e-06
|
|
|
LYZ
|
[NCBI]
|
1.17862e-06
|
|
|
ETS1
|
[NCBI]
|
1.17862e-06
|
|
|
CACNA1C
|
[NCBI]
|
1.17862e-06
|
|
|
BMP15
|
[NCBI]
|
1.17862e-06
|
|
|
DAG1
|
[NCBI]
|
1.17862e-06
|
|
|
GJA1
|
[NCBI]
|
1.11145e-06
|
|
|
LBP
|
[NCBI]
|
1.07832e-06
|
|
|
RPS6
|
[NCBI]
|
1.06938e-06
|
|
|
SLC22A5
|
[NCBI]
|
1.06938e-06
|
|
|
CTSK
|
[NCBI]
|
1.06938e-06
|
|
|
NOS1
|
[NCBI]
|
1.06938e-06
|
|
|
GSTM1
|
[NCBI]
|
1.06938e-06
|
|
|
CD4
|
[NCBI]
|
1.06938e-06
|
|
|
EYA1
|
[NCBI]
|
1.06938e-06
|
|
|
MVK
|
[NCBI]
|
1.06938e-06
|
|
|
LRP8
|
[NCBI]
|
1.06938e-06
|
|
|
MLP
|
[NCBI]
|
1.06938e-06
|
|
|
GZMA
|
[NCBI]
|
1.06938e-06
|
|
|
AHSG
|
[NCBI]
|
1.06938e-06
|
|
|
ATXN8OS
|
[NCBI]
|
1.06938e-06
|
|
|
IL6
|
[NCBI]
|
1.06835e-06
|
|
|
lynch syndrome i
|
[NCBI]
|
1.04534e-06
|
|
|
CMT4A
|
[NCBI]
|
1.02375e-06
|
|
|
gaucher disease, type ii
|
[NCBI]
|
1.02375e-06
|
|
|
leiomyoma, hereditary multiple, of skin
|
[NCBI]
|
1.02375e-06
|
|
|
sertoli cell-only syndrome, y-linked
|
[NCBI]
|
1.02375e-06
|
|
|
CLN5
|
[NCBI]
|
1.02375e-06
|
|
|
HHS
|
[NCBI]
|
1.02375e-06
|
|
|
MCDC1
|
[NCBI]
|
1.02375e-06
|
|
|
DA2B
|
[NCBI]
|
1.02375e-06
|
|
|
pycnodysostosis
|
[NCBI]
|
1.02375e-06
|
|
|
PMDS
|
[NCBI]
|
1.02375e-06
|
|
|
abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism
|
[NCBI]
|
1.02375e-06
|
|
|
XPF
|
[NCBI]
|
1.02375e-06
|
|
|
corticosterone methyloxidase type ii deficiency
|
[NCBI]
|
1.02375e-06
|
|
|
myotonia congenita, autosomal recessive
|
[NCBI]
|
1.02375e-06
|
|
|
CDSP
|
[NCBI]
|
1.00696e-06
|
|
|
SLC17A7
|
[NCBI]
|
9.68007e-07
|
|
|
MUT
|
[NCBI]
|
9.68007e-07
|
|
|
CD8A
|
[NCBI]
|
9.68007e-07
|
|
|
ATF4
|
[NCBI]
|
9.68007e-07
|
|
|
CHRNE
|
[NCBI]
|
9.68007e-07
|
|
|
adenylyl cyclase, soluble
|
[NCBI]
|
9.68007e-07
|
|
|
PTCH1
|
[NCBI]
|
9.68007e-07
|
|
|
FGF2
|
[NCBI]
|
9.6144e-07
|
|
|
PTEN
|
[NCBI]
|
9.6144e-07
|
|
|
ASD1
|
[NCBI]
|
9.47092e-07
|
|
|
renal failure, progressive, with hypertension
|
[NCBI]
|
9.47092e-07
|
|
|
MCOP1
|
[NCBI]
|
9.47092e-07
|
|
|
DBQD
|
[NCBI]
|
9.47092e-07
|
|
|
pseudohyperkalemia, familial, 1, due to red cell leak
|
[NCBI]
|
9.47092e-07
|
|
|
renal cell carcinoma, papillary, 3
|
[NCBI]
|
9.47092e-07
|
|
|
TAPVR1
|
[NCBI]
|
9.47092e-07
|
|
|
ECA1
|
[NCBI]
|
9.47092e-07
|
|
|
MENOQ1
|
[NCBI]
|
9.47092e-07
|
|
|
neuropathy, hereditary motor and sensory, russe type
|
[NCBI]
|
9.47092e-07
|
|
|
DSPP
|
[NCBI]
|
9.3646e-07
|
|
|
cardiofaciocutaneous syndrome
|
[NCBI]
|
9.19697e-07
|
|
|
donohue syndrome
|
[NCBI]
|
9.19697e-07
|
|
|
megaloblastic anemia 1
|
[NCBI]
|
9.19697e-07
|
|
|
CNC1
|
[NCBI]
|
9.19697e-07
|
|
|
aortic aneurysm, abdominal
|
[NCBI]
|
9.19697e-07
|
|
|
mannosidosis, alpha b, lysosomal
|
[NCBI]
|
9.19697e-07
|
|
|
ETL2
|
[NCBI]
|
9.12495e-07
|
|
|
LCT
|
[NCBI]
|
8.9659e-07
|
|
|
CASR
|
[NCBI]
|
8.81232e-07
|
|
|
C1NH
|
[NCBI]
|
8.7397e-07
|
|
|
ARSB
|
[NCBI]
|
8.7397e-07
|
|
|
TFF1
|
[NCBI]
|
8.7397e-07
|
|
|
IPF1
|
[NCBI]
|
8.7397e-07
|
|
|
SLC3A2
|
[NCBI]
|
8.7397e-07
|
|
|
BACE1
|
[NCBI]
|
8.7397e-07
|
|
|
PRSS1
|
[NCBI]
|
8.7397e-07
|
|
|
COL17A1
|
[NCBI]
|
8.7397e-07
|
|
|
HMGA2
|
[NCBI]
|
8.7397e-07
|
|
|
RCDP1
|
[NCBI]
|
8.62987e-07
|
|
|
EVC
|
[NCBI]
|
8.62987e-07
|
|
|
NGFR
|
[NCBI]
|
8.5893e-07
|
|
|
breast cancer
|
[NCBI]
|
8.57087e-07
|
|
|
VHL
|
[NCBI]
|
8.53017e-07
|
|
|
PLN
|
[NCBI]
|
8.53017e-07
|
|
|
IL10
|
[NCBI]
|
8.23538e-07
|
|
|
GHR
|
[NCBI]
|
7.89047e-07
|
|
|
CHGA
|
[NCBI]
|
7.86775e-07
|
|
|
RYR2
|
[NCBI]
|
7.86775e-07
|
|
|
HSPB1
|
[NCBI]
|
7.86775e-07
|
|
|
HDAC2
|
[NCBI]
|
7.86775e-07
|
|
|
NOS2A
|
[NCBI]
|
7.86775e-07
|
|
|
KLRK1
|
[NCBI]
|
7.86775e-07
|
|
|
FOP
|
[NCBI]
|
7.77896e-07
|
|
|
F2R
|
[NCBI]
|
7.70553e-07
|
|
|
PPARG
|
[NCBI]
|
7.46451e-07
|
|
|
BGLAP
|
[NCBI]
|
7.29407e-07
|
|
|
MTHFR
|
[NCBI]
|
7.27033e-07
|
|
|
VCP
|
[NCBI]
|
7.19803e-07
|
|
|
BMP4
|
[NCBI]
|
7.07604e-07
|
|
|
EDN3
|
[NCBI]
|
7.05981e-07
|
|
|
ATXN1
|
[NCBI]
|
7.05981e-07
|
|
|
MSH6
|
[NCBI]
|
7.05981e-07
|
|
|
CYP11B2
|
[NCBI]
|
7.05981e-07
|
|
|
STAT4
|
[NCBI]
|
7.05981e-07
|
|
|
CAV3
|
[NCBI]
|
7.05981e-07
|
|
|
IFNB1
|
[NCBI]
|
7.05981e-07
|
|
|
PRODH
|
[NCBI]
|
7.05981e-07
|
|
|
GRIN1
|
[NCBI]
|
7.05981e-07
|
|
|
KCNJ11
|
[NCBI]
|
7.05981e-07
|
|
|
TWIST1
|
[NCBI]
|
7.05981e-07
|
|
|
WHS
|
[NCBI]
|
7.04192e-07
|
|
|
BSG
|
[NCBI]
|
6.86681e-07
|
|
|
IL3
|
[NCBI]
|
6.71227e-07
|
|
|
porphyria, acute intermittent
|
[NCBI]
|
6.67327e-07
|
|
|
JPS
|
[NCBI]
|
6.67327e-07
|
|
|
fabry disease
|
[NCBI]
|
6.48891e-07
|
|
|
ARNT
|
[NCBI]
|
6.47182e-07
|
|
|
HRG
|
[NCBI]
|
6.47182e-07
|
|
|
PSEN1
|
[NCBI]
|
6.46368e-07
|
|
|
ERCC2
|
[NCBI]
|
6.31188e-07
|
|
|
CAPN3
|
[NCBI]
|
6.31188e-07
|
|
|
fructose intolerance, hereditary
|
[NCBI]
|
6.31188e-07
|
|
|
GCH1
|
[NCBI]
|
6.31188e-07
|
|
|
SMAD4
|
[NCBI]
|
6.31188e-07
|
|
|
PTPN11
|
[NCBI]
|
6.31188e-07
|
|
|
ALPL
|
[NCBI]
|
6.31188e-07
|
|
|
hyperoxaluria, primary, type i
|
[NCBI]
|
6.30383e-07
|
|
|
APL
|
[NCBI]
|
6.30383e-07
|
|
|
osteogenesis imperfecta, type iii
|
[NCBI]
|
6.30383e-07
|
|
|
SCA17
|
[NCBI]
|
6.30383e-07
|
|
|
FGA
|
[NCBI]
|
6.24767e-07
|
|
|
PAX6
|
[NCBI]
|
6.24767e-07
|
|
|
chondrodysplasia punctata, autosomal dominant
|
[NCBI]
|
5.95804e-07
|
|
|
ALS2
|
[NCBI]
|
5.95804e-07
|
|
|
OPPG
|
[NCBI]
|
5.95804e-07
|
|
|
bartter syndrome, antenatal, type 2
|
[NCBI]
|
5.95804e-07
|
|
|
denys-drash syndrome
|
[NCBI]
|
5.95804e-07
|
|
|
cutis laxa, autosomal recessive, type ii
|
[NCBI]
|
5.95804e-07
|
|
|
ACCPN
|
[NCBI]
|
5.95804e-07
|
|
|
pick disease of brain
|
[NCBI]
|
5.95804e-07
|
|
|
MCDS
|
[NCBI]
|
5.95804e-07
|
|
|
DSMA1
|
[NCBI]
|
5.95804e-07
|
|
|
crouzon syndrome
|
[NCBI]
|
5.95804e-07
|
|
|
sacral defect with anterior meningocele
|
[NCBI]
|
5.95804e-07
|
|
|
neural tube defects
|
[NCBI]
|
5.93556e-07
|
|
|
POF1
|
[NCBI]
|
5.93556e-07
|
|
|
MLH1
|
[NCBI]
|
5.80368e-07
|
|
|
XIST
|
[NCBI]
|
5.80368e-07
|
|
|
TRPS2
|
[NCBI]
|
5.75219e-07
|
|
|
oca2 gene
|
[NCBI]
|
5.62033e-07
|
|
|
COL10A1
|
[NCBI]
|
5.62033e-07
|
|
|
MARCKS
|
[NCBI]
|
5.62033e-07
|
|
|
IL12B
|
[NCBI]
|
5.62033e-07
|
|
|
HBG1
|
[NCBI]
|
5.37977e-07
|
|
|
UGB
|
[NCBI]
|
5.34021e-07
|
|
|
CP
|
[NCBI]
|
5.33701e-07
|
|
|
CLCN1
|
[NCBI]
|
4.98182e-07
|
|
|
POU1F1
|
[NCBI]
|
4.98182e-07
|
|
|
EWSR1
|
[NCBI]
|
4.98182e-07
|
|
|
IL5
|
[NCBI]
|
4.98182e-07
|
|
|
KDR
|
[NCBI]
|
4.70107e-07
|
|
|
SLC11A2
|
[NCBI]
|
4.59016e-07
|
|
|
MKS2
|
[NCBI]
|
4.55878e-07
|
|
|
blood group--lutheran inhibitor
|
[NCBI]
|
4.55878e-07
|
|
|
myopathy with deficiency of succinate dehydrogenase and aconitase
|
[NCBI]
|
4.55878e-07
|
|
|
HMN7A
|
[NCBI]
|
4.55878e-07
|
|
|
NIDDM2
|
[NCBI]
|
4.55878e-07
|
|
|
spondyloepimetaphyseal dysplasia with multiple dislocations
|
[NCBI]
|
4.55878e-07
|
|
|
HCFP1
|
[NCBI]
|
4.55878e-07
|
|
|
RNANC
|
[NCBI]
|
4.55878e-07
|
|
|
pierre robin sequence with pectus excavatum and rib and scapular anomalies
|
[NCBI]
|
4.55878e-07
|
|
|
immunoglobulin m, level of
|
[NCBI]
|
4.55878e-07
|
|
|
microcephaly, hiatus hernia, and nephrotic syndrome
|
[NCBI]
|
4.55878e-07
|
|
|
CDAN3
|
[NCBI]
|
4.55878e-07
|
|
|
MCOPS6
|
[NCBI]
|
4.55878e-07
|
|
|
cataract and cardiomyopathy
|
[NCBI]
|
4.55878e-07
|
|
|
CHED1
|
[NCBI]
|
4.55878e-07
|
|
|
STHAG4
|
[NCBI]
|
4.55878e-07
|
|
|
macular edema, cystoid
|
[NCBI]
|
4.55878e-07
|
|
|
NNO1
|
[NCBI]
|
4.55878e-07
|
|
|
CNC2
|
[NCBI]
|
4.55878e-07
|
|
|
COMT
|
[NCBI]
|
4.39781e-07
|
|
|
FABP3
|
[NCBI]
|
4.39334e-07
|
|
|
SST
|
[NCBI]
|
4.31906e-07
|
|
|
IDUA
|
[NCBI]
|
4.22349e-07
|
|
|
MITF
|
[NCBI]
|
4.11881e-07
|
|
|
PEDF
|
[NCBI]
|
4.10867e-07
|
|
|
CTNS
|
[NCBI]
|
4.00338e-07
|
|
|
LRRK2
|
[NCBI]
|
3.9645e-07
|
|
|
TNC
|
[NCBI]
|
3.94315e-07
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-positive
|
[NCBI]
|
3.88846e-07
|
|
|
AAA
|
[NCBI]
|
3.88846e-07
|
|
|
polycythemia vera
|
[NCBI]
|
3.88846e-07
|
|
|
osteogenesis imperfecta, type i
|
[NCBI]
|
3.87192e-07
|
|
|
SLAMF1
|
[NCBI]
|
3.8521e-07
|
|
|
GDXY
|
[NCBI]
|
3.8521e-07
|
|
|
CXCR4
|
[NCBI]
|
3.8521e-07
|
|
|
ICAM1
|
[NCBI]
|
3.8521e-07
|
|
|
GHRL
|
[NCBI]
|
3.8521e-07
|
|
|
aspartylglucosaminuria
|
[NCBI]
|
3.8521e-07
|
|
|
mycobacterium tuberculosis, susceptibility to
|
[NCBI]
|
3.79221e-07
|
|
|
leiomyomatosis and renal cell cancer, hereditary
|
[NCBI]
|
3.79221e-07
|
|
|
factor v deficiency
|
[NCBI]
|
3.54415e-07
|
|
|
PAI1
|
[NCBI]
|
3.35554e-07
|
|
|
PTHR1
|
[NCBI]
|
3.35554e-07
|
|
|
MDM2
|
[NCBI]
|
3.35554e-07
|
|
|
H6PD
|
[NCBI]
|
3.33825e-07
|
|
|
PENK
|
[NCBI]
|
3.33825e-07
|
|
|
STAT6
|
[NCBI]
|
3.23061e-07
|
|
|
mucopolysaccharidosis type iiic
|
[NCBI]
|
2.96717e-07
|
|
|
CDS
|
[NCBI]
|
2.96717e-07
|
|
|
FRA16A
|
[NCBI]
|
2.96717e-07
|
|
|
LQT3
|
[NCBI]
|
2.96717e-07
|
|
|
progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal recessive
|
[NCBI]
|
2.96717e-07
|
|
|
sitosterolemia
|
[NCBI]
|
2.96717e-07
|
|
|
cerebrotendinous xanthomatosis
|
[NCBI]
|
2.96717e-07
|
|
|
HSCR2
|
[NCBI]
|
2.96717e-07
|
|
|
AGS1
|
[NCBI]
|
2.96717e-07
|
|
|
pineal hyperplasia, insulin-resistant diabetes mellitus, and somatic abnormalities
|
[NCBI]
|
2.96717e-07
|
|
|
langer mesomelic dysplasia
|
[NCBI]
|
2.96717e-07
|
|
|
FTD
|
[NCBI]
|
2.96608e-07
|
|
|
MYC
|
[NCBI]
|
2.93394e-07
|
|
|
FGG
|
[NCBI]
|
2.90132e-07
|
|
|
JAK1
|
[NCBI]
|
2.90132e-07
|
|
|
BAX
|
[NCBI]
|
2.90132e-07
|
|
|
ALDH2
|
[NCBI]
|
2.90132e-07
|
|
|
ATP7A
|
[NCBI]
|
2.90132e-07
|
|
|
RET
|
[NCBI]
|
2.86302e-07
|
|
|
CCR5
|
[NCBI]
|
2.7561e-07
|
|
|
ANG
|
[NCBI]
|
2.7561e-07
|
|
|
FGFR1
|
[NCBI]
|
2.64254e-07
|
|
|
nijmegen breakage syndrome
|
[NCBI]
|
2.54776e-07
|
|
|
GRIA2
|
[NCBI]
|
2.48726e-07
|
|
|
SHOX
|
[NCBI]
|
2.48726e-07
|
|
|
MICA
|
[NCBI]
|
2.48726e-07
|
|
|
PTPRC
|
[NCBI]
|
2.48726e-07
|
|
|
FANCC
|
[NCBI]
|
2.48726e-07
|
|
|
TPI1
|
[NCBI]
|
2.48726e-07
|
|
|
APOD
|
[NCBI]
|
2.48232e-07
|
|
|
TFF3
|
[NCBI]
|
2.48232e-07
|
|
|
THPO
|
[NCBI]
|
2.48232e-07
|
|
|
BCNS
|
[NCBI]
|
2.38191e-07
|
|
|
NR5A1
|
[NCBI]
|
2.22053e-07
|
|
|
SLC1A2
|
[NCBI]
|
2.11135e-07
|
|
|
PPT1
|
[NCBI]
|
2.11135e-07
|
|
|
PDYN
|
[NCBI]
|
2.11135e-07
|
|
|
OMP
|
[NCBI]
|
2.03977e-07
|
|
|
CHH
|
[NCBI]
|
2.01585e-07
|
|
|
thyroid carcinoma, papillary
|
[NCBI]
|
2.0119e-07
|
|
|
CBAVD
|
[NCBI]
|
2.00118e-07
|
|
|
TTDP
|
[NCBI]
|
2.00118e-07
|
|
|
JBS
|
[NCBI]
|
2.00118e-07
|
|
|
GCCR
|
[NCBI]
|
1.97106e-07
|
|
|
PEE1
|
[NCBI]
|
1.78343e-07
|
|
|
SMN2
|
[NCBI]
|
1.77174e-07
|
|
|
SNRPN
|
[NCBI]
|
1.77174e-07
|
|
|
SOCS3
|
[NCBI]
|
1.73427e-07
|
|
|
NOTCH1
|
[NCBI]
|
1.73427e-07
|
|
|
CD36
|
[NCBI]
|
1.73427e-07
|
|
|
EIF4E
|
[NCBI]
|
1.51055e-07
|
|
|
GBA
|
[NCBI]
|
1.48708e-07
|
|
|
SIRT1
|
[NCBI]
|
1.46669e-07
|
|
|
LIFR
|
[NCBI]
|
1.46669e-07
|
|
|
kartagener syndrome
|
[NCBI]
|
1.40186e-07
|
|
|
UGT1A1
|
[NCBI]
|
1.30029e-07
|
|
|
IRS1
|
[NCBI]
|
1.30029e-07
|
|
|
BTC
|
[NCBI]
|
1.30029e-07
|
|
|
TNFRSF1A
|
[NCBI]
|
1.29819e-07
|
|
|
UCP2
|
[NCBI]
|
1.20514e-07
|
|
|
LCN2
|
[NCBI]
|
1.1039e-07
|
|
|
MMP2
|
[NCBI]
|
1.1039e-07
|
|
|
hypophosphatasia, adult type
|
[NCBI]
|
1.08032e-07
|
|
|
potocki-shaffer syndrome
|
[NCBI]
|
1.08032e-07
|
|
|
complement factor h deficiency
|
[NCBI]
|
1.08032e-07
|
|
|
chromosome 5q deletion syndrome
|
[NCBI]
|
1.08032e-07
|
|
|
HPE3
|
[NCBI]
|
1.08032e-07
|
|
|
esophageal cancer
|
[NCBI]
|
1.08032e-07
|
|
|
muckle-wells syndrome
|
[NCBI]
|
1.08032e-07
|
|
|
ichthyosis congenita, harlequin fetus type
|
[NCBI]
|
1.08032e-07
|
|
|
PPCD1
|
[NCBI]
|
1.08032e-07
|
|
|
BCPM
|
[NCBI]
|
1.00748e-07
|
|
|
BRAF
|
[NCBI]
|
9.53964e-08
|
|
|
GRIA1
|
[NCBI]
|
9.53964e-08
|
|
|
TF
|
[NCBI]
|
7.74596e-08
|
|
|
KRAS
|
[NCBI]
|
7.54503e-08
|
|
|
WT1
|
[NCBI]
|
7.54503e-08
|
|
|
GSC
|
[NCBI]
|
7.54503e-08
|
|
|
HRAS
|
[NCBI]
|
7.54503e-08
|
|
|
WRN
|
[NCBI]
|
7.50491e-08
|
|
|
SOX9
|
[NCBI]
|
7.43389e-08
|
|
|
CYP17A1
|
[NCBI]
|
7.43389e-08
|
|
|
USF1
|
[NCBI]
|
7.43389e-08
|
|
|
POLG
|
[NCBI]
|
7.43389e-08
|
|
|
APRT
|
[NCBI]
|
7.13457e-08
|
|
|
FBS
|
[NCBI]
|
7.00757e-08
|
|
|
bladder cancer
|
[NCBI]
|
7.00757e-08
|
|
|
PAM
|
[NCBI]
|
6.92168e-08
|
|
|
homocystinuria
|
[NCBI]
|
6.80319e-08
|
|
|
EPOR
|
[NCBI]
|
6.20148e-08
|
|
|
ASL
|
[NCBI]
|
6.02423e-08
|
|
|
ENPEP
|
[NCBI]
|
6.02423e-08
|
|
|
MMP9
|
[NCBI]
|
6.02423e-08
|
|
|
MRD
|
[NCBI]
|
5.92434e-08
|
|
|
drug metabolism, poor, cyp2d6-related
|
[NCBI]
|
5.83624e-08
|
|
|
meningioma, familial
|
[NCBI]
|
5.83624e-08
|
|
|
GSR
|
[NCBI]
|
5.61567e-08
|
|
|
leber optic atrophy
|
[NCBI]
|
5.06391e-08
|
|
|
MAPK14
|
[NCBI]
|
4.07273e-08
|
|
|
RELN
|
[NCBI]
|
4.07273e-08
|
|
|
periodic fever, familial, autosomal dominant
|
[NCBI]
|
2.99994e-08
|
|
|
CREBBP
|
[NCBI]
|
2.79362e-08
|
|
|
TNFRSF6
|
[NCBI]
|
2.79362e-08
|
|
|
DMPK
|
[NCBI]
|
2.79362e-08
|
|
|
TPT1
|
[NCBI]
|
2.79362e-08
|
|
|
NAT1
|
[NCBI]
|
2.42734e-08
|
|
|
AVSD
|
[NCBI]
|
2.25388e-08
|
|
|
PAEP
|
[NCBI]
|
1.96927e-08
|
|
|
HBG2
|
[NCBI]
|
1.76756e-08
|
|
|
ADAM17
|
[NCBI]
|
1.76756e-08
|
|
|
NFKB1
|
[NCBI]
|
1.56861e-08
|
|
|
robinow syndrome, autosomal recessive
|
[NCBI]
|
1.49963e-08
|
|
|
coumarin resistance
|
[NCBI]
|
1.49963e-08
|
|
|
pyruvate carboxylase deficiency
|
[NCBI]
|
1.49963e-08
|
|
|
NBIA1
|
[NCBI]
|
1.49963e-08
|
|
|
helicobacter pylori infection, susceptibility to
|
[NCBI]
|
1.49963e-08
|
|
|
seckel syndrome 1
|
[NCBI]
|
1.49963e-08
|
|
|
GSD
|
[NCBI]
|
1.49963e-08
|
|
|
immunodeficiency-centromeric instability-facial anomalies syndrome
|
[NCBI]
|
1.12641e-08
|
|
|
HCH
|
[NCBI]
|
1.12641e-08
|
|
|
HCRT
|
[NCBI]
|
9.84426e-09
|
|
|
AANAT
|
[NCBI]
|
9.84426e-09
|
|
|
CTSL
|
[NCBI]
|
9.84426e-09
|
|
|
MSTN
|
[NCBI]
|
9.84426e-09
|
|
|
PRF1
|
[NCBI]
|
9.84426e-09
|
|
|
FGF23
|
[NCBI]
|
9.84426e-09
|
|
|
HNPP
|
[NCBI]
|
9.31357e-09
|
|
|
TFRC
|
[NCBI]
|
8.89901e-09
|
|
|
TFPI2
|
[NCBI]
|
8.89901e-09
|
|
|
SLC18A2
|
[NCBI]
|
8.89901e-09
|
|
|
FGFR2
|
[NCBI]
|
8.28886e-09
|
|
|
diarrhea 1, secretory chloride, congenital
|
[NCBI]
|
5.63073e-09
|
|
|
NPHS1
|
[NCBI]
|
5.63073e-09
|
|
|
pituitary dwarfism iii
|
[NCBI]
|
5.63073e-09
|
|
|
GACI
|
[NCBI]
|
5.63073e-09
|
|
|
PHA
|
[NCBI]
|
5.63073e-09
|
|
|
SRY
|
[NCBI]
|
4.89166e-09
|
|
|
LHCGR
|
[NCBI]
|
3.97655e-09
|
|
|
PVR
|
[NCBI]
|
1.09389e-09
|
|
|
HMGB1
|
[NCBI]
|
9.86491e-10
|
|
|
UNG
|
[NCBI]
|
9.86491e-10
|
|
|
RLBP1
|
[NCBI]
|
9.86491e-10
|
|
|
AN2
|
[NCBI]
|
3.07134e-10
|
|
|
MCP
|
[NCBI]
|
3.05694e-10
|
|
|
FH
|
[NCBI]
|
3.99379e-13
|
|
|
SCN5A
|
[NCBI]
|
3.99379e-13
|
|